Quarterlytics / Basic Materials / Chemicals - Specialty / Directa Plus plc

Directa Plus plc

dcta · LSE Basic Materials
Claim this profile
Ticker dcta
Exchange LSE
Sector Basic Materials
Industry Chemicals - Specialty
Employees 51-200
← All annual reports
FY2021 Annual Report · Directa Plus plc
Sign in to download
Loading PDF…
Directa Plus Plc 
3rd Floor 
11-12 St. James’s Square 
London 
SW1Y 4LB 
United Kingdom 

www.directa-plus.com

Graphene is the 
material of  the future 

D
i
r
e
c
t
a
P
l
u
s
A
n
n
u
a
l

R
e
p
o
r
t
&
A
c
c
o
u
n
t
s
2
0
2
1

Annual Report & Accounts 2021

 
 
 
 
 
 
 
Directa Plus  
Annual Report & Accounts 2021 

Directa Plus  
Annual Report & Accounts 2021 

Directa Plus in 2021

Discover how we are using graphene to help customers’  
revolutionise the performance of their products. 

Directa Plus is one of the largest producers and suppliers 
worldwide of graphene nanoplatelets-based products for use 
in consumer and industrial markets. 

Our graphene nanoplatelets-based products are natural, chemical-free and 
sustainably produced. Our production process is designed to meet large 
supply chains' requirements for volume, cost and quality control. 

By incorporating Directa Plus’s unique graphene blends, identified by  
the G+® brand, our customers can revolutionise the performances  
of their own end products in commercial applications such as 
textiles, composite materials and environmental solutions. 
We partner with our customers to enable them to 
offer the high-performance benefits of  G+® in 
their own products. 

Our company has a unique and patented 
technology process and a scalable and portable 
manufacturing model. We produce graphene 
nanoplatelets-based products at our own 
factory near Milan, Italy, and can set up 
additional production at customer locations to 
reduce transport costs, waste and time-to-
utilisation. We are strongly committed to 
environmental sustainability and abided by a strong 
Code of Ethics in all aspects of our business practice.

Contents

01 Highlights 
02 Chairman’s review 
03 At a glance   
04 Target market progress 
06 Our strategy and business model 
08 Market review  
10 Chief Executive Officer’s review  
16 Chief Financial Officer’s review  
18 Directors’ biographies 
20 Section 172 
21 Directors’ report  
24 Corporate governance report 

28 Directors’ remuneration report  
30 Audit Committee report  
31 Remuneration Committee report  
32 Independent auditor’s report 
38 Consolidated statement of comprehensive income  
39 Consolidated and Company statement of financial position 
40 Consolidated statement of changes in equity  
40 Company statement of changes in equity  
41 Consolidated and Company statement of cash flows  
42 Notes to the consolidated financial statements 
IBC Directors, secretary and advisers  

Directors, secretary and advisers

Directors 
Sir Peter Middleton – Non-Executive Chairman 

Giulio Cesareo – CEO and Founder 

Giorgio Bonfanti – Chief Financial Officer 

David Gann – Non-Executive Director 

Neil Warner – Non-Executive Director 

Richard Hickinbotham – Non-Executive Director  

Company Secretary 
Giorgio Bonfanti 

Registration number 
04679109 

Registered office 
3rd Floor 
11-12 St James’s Square 
London SW1Y 4LB 
United Kingdom 

Principal place of business 
Directa Plus Plc 
ComoNExT Science Park 
Via Cavour 2 
22074 Lomazzo (Co)  
Italy 

Nominated adviser and joint  broker 
Cenkos Securities 
6.7.8 Tokenhouse Yard 
London EC2R 7AS 
United Kingdom 

Joint broker 
Singer Capital Markets 
1 Bartholomew Lane 
London EC2N 2AX 
United Kingdom 

Auditors  
BDO LLP 
55 Baker Street 
London W1U 7EU 
United Kingdom 

Legal advisers 
Fox Williams LLP 
10 Finsbury Square 
London EC2A 1AF 
United Kingdom 

Registrar 
Link Market Services Limited 
The Registry 
34 Beckenham Road 
Beckenham 
Kent BR3 4TU 
United Kingdom 

Financial PR adviser 
Tavistock  
1 Cornhill 
London EC3V 3ND 
United Kingdom 

y
b
d
e
c
u
d
o
r
p
d
n
a
d
e
n
g
i
s
e
D

Printed sustainably in the UK  
by Pureprint, a CarbonNeutral® 
company with FSC® chain  
of custody and an ISO 14001-
certified environmental 
management system recycling 
over 99% of all dry waste.

 
 
 
 
Directa Plus  
Annual Report & Accounts 2021 

01

.

€
8
6
2
m

i
l
l
i

o
n
s
a
e
s

l

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Highlights

Proven, successful strategy maintained 

• Target existing products and markets that can be significantly improved with the 

addition of Directa Plus products  

• Working with established manufacturers and vendors worldwide, we are able to  
gain market insight and access, further develop our technologies, bring products  
to market faster, and capture maximum value from the supply chain by providing 
expertise, know-how and services as well as materials  

• Focus on those markets in which the Company can gain strong traction – 

environmental remediation, textiles, composites, paints and other verticals 

Financial and operational highlights 

• Product sales and service revenue increased by 33.9% to €8.62m (2020: €6.43m), 

slightly above market expectations 

• Total income (including grants) increased by 39.3% to €9.45m (2020: €6.78m) 

• LBITDA* improved to  €1.99m (2020: €2.62m) 

• Reported (basic) loss per share was €0.06 (2020: €0.07) 

• Cash and cash equivalents at year end of €11.13m (2020: €7.08m) 

• Total patents granted at year end of 72 (2020: 38) 

• Approximately 29k of cubic meters of sludge treated and 7k metric tonnes of 

hydrocarbons recovered ** 

• 63k metres of textile printed, dyed and laminated in 2021 

*    LBITDA represents loss from operating activities before tax, interest, depreciation and amortisation 
** Only with reference to the main project with OMV Petrom

Product sales and service revenue 
increased by 33.9% to €8.62m 
(2020: €6.43m).

Total income (including grants) increased  
by 39.3% to €9.45m (2020: €6.78m).

Cash and cash equivalents at year end  
of €11.13m (2020: €7.08m).

€8.62  million

€9.45  million 

€11.13  million

63k metres of textile printed, padded  
and laminated in 2021. 

Approximately 29k of cubic meters  
of sludge treated and 7k metric tonnes  
of hydrocarbons recovered. **

Total patents granted at year end 72  
(2020: 38).

63k metres

c.29k  
cubic meters 

72 patents

 
 
 
02 

Directa Plus  
Annual Report & Accounts 2021 

Chairman’s review

“Our robust and sustainable strategy remains at the centre  
of our operations. With strong foundations, laid over the 
last few years, we are well positioned for further growth  
and increased traction in all areas. We are encouraged by 
increased levels of interest in the Directa Plus offering,  
and we continue to gain wider recognition for our proven 
innovative products.”

The macro economic challenges of 2020 
continued into 2021 and 2022 with the 
Covid-19 pandemic and the war in Ukraine. 
However, Directa Plus has continued to 
execute against its strategy and deliver growth, 
and continues to take actions to mitigate cost 
increases through price increases, expected 
productivity gains and cost reductions, whilst 
accelerating investments in key capabilities. 
Our teams have continued to perform above 
expectations throughout this prolonged 
period of volatility and I would like to share the 
Board’s appreciation for their hard work and 
dedication. 2021 saw further strategic progress 
for the Company as new partnerships and new 
markets were established, supporting our 
long-term growth ambitions. I am pleased 
with the progress the business is making in 
refining the strategic plan to prioritise the 
verticals with higher potential in terms of 
commercialisation and financial returns. 

2021 saw continued growth for the business 
with revenues from products and services 
increased by 33.9% to €8.62 million (2020: 
€6.43 million), and total income by 39.3%  
to €9.45 million (2020: €6.78 million).  

In December 2021 we successfully raised  
£7 million from our supportive shareholder 
base to accelerate our goal to commercialise 
our graphene-based products with an ever 
increasing and diverse customer base.  
We enter the new financial year well 
capitalised and ready to continue executing 
on our strategy.  

Giorgio Bonfanti joined the Company in  
May 2021 and we welcomed him to the Board 
in November. He brings with him a wealth  
of experience and has already delivered 
significant contributions to the Company in  
his first year of service.  

In recognition of our strong environmental 
credentials and contribution to sustainable 
business practices, the London Stock Exchange 
awarded the Company the Green Economy 
Mark in November of 2021. This award is given 
to businesses across all industries that make 
significant contributions to the transition to  
a sustainable, low carbon economy. 

Innovation remains at the heart of our 
product development and as an example, in 
December 2021 we were granted an EU-wide 
patent covering the use of the Company’s G+® 
pristine graphene nanoplatelets to boost the 
performance of rubber-based shoe outsoles. 
Our IP portfolio now comprises 19 patent 
families with 72 patents granted and 27 patents 
pending and we continue to grow the portfolio. 

We started the new financial year announcing  
that Oxfordshire County Council had started 
its second trial of a patented asphalt concrete 
modifier developed by Iterchimica and 
enhanced by the Company’s G+®. This trial 
followed a successful pilot scheme in 
Curbridge, Oxfordshire in 2019. 

At the end of March 2022, we announced that 
Grafysorber®, our patented decontamination 
technology had been granted authorization 
for use in the United States by the US 
Environmental Protection Agency, paving the 
way for entry into one of the world’s largest 
markets for decontamination of oil spills. 

Our robust and sustainable strategy remains 
at the centre of our operations. With strong 
foundations, laid over the last few years,  
we are well positioned for further growth  
and increased traction in all areas. We are 
encouraged by increased levels of interest  
in the Directa Plus offering, and we continue 
to gain wider recognition for our proven 
innovative products. We have partnered with 
a number of new organisations in the year 
and we are confident in our future 
commercial opportunities.  

I would like to take this opportunity to thank 
our team, customers and shareholders for 
their continued support. The Board looks 
forward to the new financial year and  
beyond with optimism, albeit tempered by 
the potential economic consequences of  
war and commodity price spikes.  

Sir Peter Middleton 
Chairman 
4 May 2022

 
 
Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

At a glance

Directa Plus  
Annual Report & Accounts 2021

03

C
o
r
e

f
o
c
u
s
m
a
r
k
e
t
s

Our graphene nanoplatelets-based products are natural, chemical-free  
and sustainably produced. Our production process is designed to meet  
large supply chains' requirements for volume, cost and quality control. 

Our vision is to produce nanoplatelets-based products that are 
natural, chemical-free and sustainable. 

G+® Technology 

Under our G+® brand, we offer a range of graphene nanoplatelets-based products – either 
ready-to-use or custom-blended to meet customers' specific technical requirements. 

Benefits of our products 

• Chemical-free  • Certified as non-toxic  • High purity  • Consistent quality 
• Taylor-made particles shape  • Abundant, safe and non-toxic raw material 

Target vertical markets

 1 
Environmental 
remediation  

Using our Grafysorber® 
technology to help the oil  
& gas industry to tackle 
environmental issues from 
hydrocarbon pollution. 

1

2 

3 

Textiles  

Other verticals  

Printing our nanoplatelets  
on fabrics, and enhanced 
membranes for the sports,  
luxury, fashion, workwear and 
military markets. 

Exploring and launching a wide 
range of other applications for our 
technology such as composites, 
paints and batteries. 

2

3

3

 
 
 
 
 
04 

Directa Plus  
Annual Report & Accounts 2021 

 1 
 Environmental remediation (76% of revenue (2020: 68%)) 

•  In March 2021, completed the draining, cleaning and washing of a first oil storage unit for Petrotel Lukoil S.A.  

for a total amount of c. €0.4 million of services revenue. 

•  In early 2021, secured an extension and increase of the contract with OMV Petrom for the provision of 

decontamination and oil recovery services using Grafysorber® technology. 

•  In July 2021, won an additional tender with OMV Petrom for a four-year contract, with a total value of more  
than €3.2 million, to treat approximately 80,000 cubic meters of sludge and waste produced during the first 
upstream separation process. 

•  In April 2022, received authorisation from the United States Environment Protection Agency for the Company's 

Grafysorber® technology to be used on any oil contamination on US territory. 

•  In April 2022, received the first order of Grafysorber® based absorbent materials from a UK company. 

•  Established a pipeline of active contract tenders across Europe, including a number of high value opportunities. 

 2 
Textiles (21% of revenue (2020: 30%)) 

•  In the first half of 2021, launched Directa Plus’ own line of performance sportswear, the Cosmic Collection,  

which provides a showcase for the versatility of G+® and increases brand awareness. 

•  In November 2021, won a project tender from the state of Lombardy's TECH FAST, for a total duration of  
12 months and a total value of c. €0.3 million, of which 50 per cent is non-refundable. The programme  
will support the Company in developing applications for G+® graphene in industrial filtration, such as for  
air-conditioning or transportation filters. 

•  In December 2021, signed a Letter of Intent with Radici Group,  an Italian-based global chemicals and materials 
group and a major player in the non-woven materials industry to collaborate on an exclusive basis to develop 
specific products for the global air and water filtration markets. 

T
a
r
g
e
t
m
a
r
k
e
t
p
r
o
g
r
e
s
s

April 2022, authorisation from the United 
States Environment Protection Agency for 
the Company's Grafysorber® technology to be 
used on any oil contamination on US territory.

Won an additional tender with OMV Petrom 
for a four-year contract, with a total value  
of more than €3.2m, to treat approximately 
80,000 cubic meters of sludge and waste.

Grafysorber®

€3.2 million

Left: Grafysorber®-based absorbing boom for oil 
recovery spills. 

Right: Our technology is chemical free and has 
been fully demonstrated to have significant  
anti-viral properties without any issue or potential 
damage on the human body. 

 
 
Directa Plus  
Annual Report & Accounts 2021 

05

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

 3 
Other verticals 

•  In February 2021, signed a 3-year supply agreement and joint R&D collaboration with NexTech for the  

supply and development of new grades of G+® graphene nanoplatelets for the production of  
Lithium-Sulphur batteries. 

•  In March 2022, Oxfordshire County Council began its second trial of a patented asphalt concrete  

modifier enhanced by the Company's G+® graphene. Half of a 700-metre stretch of the road will be  
laid with Gipave®, while the rest will be resurfaced using conventional asphalt, so that the two 
surfaces can be compared. 

•  In June 2021, NexTech’s European subsidiary was established in Italy with the initial objective being to 

evaluate the feasibility of producing cathode active materials in Italy, using G+® graphene nanoplatelets. 

 4 
Awards 

•  Awarded the London Stock Exchange's Green Economy Mark, which recognises Directa Plus as 

contributing to the global green economy. 

•  The Company received a special mention for Directa Plus as a Rising Star in the 2021 Company Excellence 

Awards hosted by the Italian Stock Exchange and sponsored by Harvard Business Review Italy, the 
management consultants GEA and the Milan based fund managers ARCA. 

“I believe that Directa Plus is now at an inflection point – we are successfully transitioning 
from a research focused company into a commercial company with a number of exciting 
opportunities in our targeted markets. The Company operates in fast changing 
environment, and it is currently refining its strategic plan to prioritise the verticals with 
higher potential in terms of commercialisation and financial returns. The fundraise 
completed in December 2021 will allow us to accelerate growth in the most promising of 
these areas, where the Group continues to build an active pipeline of contract tenders.” 
Giulio Cesareo, Founder and CEO of Directa Plus 

T
a
r
g
e
t
m
a
r
k
e
t
p
r
o
g
r
e
s
s

Above: A picture taken during the resurfacing of  
a 700-metre stretch of Marsh Lane in Oxford that 
will be laid with Gipave®, a graphene-enhanced 
supermodifier for asphalt pavements, with the 
rest resurfaced using conventional asphalt,  
so that the two can be accurately compared. 

Above right: Graphene nanoplatelets. 

In June 2021, establishment of NexTech’s 
European subsidiary in Italy with the initial 
objective being to evaluate the feasibility of 
producing cathode active materials in Italy, 
using G+® graphene nanoplatelets.

NexTech

Award of the London Stock Exchange's Green 
Economy Mark, which recognises Directa Plus 
by London Stock Exchange as contributing to 
the global green economy.

Green  
Economy Mark

 
 
06 

Directa Plus  
Annual Report & Accounts 2021 

Our strategy

Welcome to the Graphene Age. 
G+® graphene is not just a material. It's a vision. Our vision.  
It's the way we are changing everything in the world. 

Our vision is for a world that is cleaner and healthier by producing graphene 
products that not only are natural and chemical free but help achieve  
this and enhance clients own products. 

Directa Plus has developed a proprietary scalable, modular manufacturing 
process to produce and supply high quality engineered graphene materials – 
marketed under its ‘Graphene Plus’ (G+®) brand – which can be used by third 
parties in a wide variety of industrial and commercial applications.  

Our Core Values  

1. DIVERSITY  Directa Plus has always invested in diversity. The desire to differentiate 

ourselves has been reflected over the years in our product: G+® – Graphene Plus, a unique  
and inimitable creation whose main features are its purity and sustainability. The uniqueness 
of this material, in all its forms, comes directly from the production method: at Directa Plus  
we transform every single gram of graphite into a gram of graphene, through a process  
based entirely on the principles of physics, without any chemical processing. 

2. QUALITY  Graphene Plus is a different material, unique and absolutely pure. In order to 

guarantee the highest quality of our products and of the services we provide, Directa Plus has 
developed innovative working methods, and we have organised the Advanced Development 
Area, a lab specialised in the applications of G+® graphene. 

3. SAFETY  For Directa Plus, safety has always been a core value. Over the years we have invested 
effort and resources in the creation of a material that is able to ensure maximum safety, both for 
those who use it and for those who work on it. The safety of our G+® graphene is proven by the 
independent certifications of non-toxicity and non-cytotoxicity of all G+® products. 

H
o
w
w
e
c
r
e
a
t
e
v
a
u
e

l

 
 
 
Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

07 

Directa Plus has a unique and proven process for the production 
of pristine, chemical free graphene nanoplatelets, tailored to  
our partners’ and customers’ requirements, which is both  
flexible and scalable. Production is located at our factory near 
Milan, Italy, and we have a Grafysorber® production unit in our 
subsidiary Setcar in Romania, but can also be set up at customer 
locations to reduce transport costs, waste and lead times. 

We are strongly committed to environmental sustainability  
and abide by a strong Code of Ethics in all aspects of our  
business practice. 

We create value through partnering with leading industrial 
entities with large international footprints that provide 
significant growth opportunities, but also important reference 
customers to support the roll out of graphene enhanced 
products and services globally. The success of this strategy can 
be seen in our progress in the environmental remediation and 
textiles markets, and other areas where we see great potential. 

i

B
u
s
n
e
s
s
m
o
d
e

l

Brand 
strength and 
endurance 

Sector-
specialist 
knowledge

Flexible
approach

®

Operational
excellence

International 
reach

Exceptional
service

+     Integrating our intellectual property into 

new products allows our customers to gain 
significant competitive advantage. 

+     The commercialisation model we  
follow is based on capturing for our 
shareholders a proportion of customers’ 
additional revenues and profits.  

+    This could be royalty payments, upfront 

enabling licence payments, joint-ventures 
to get closer to end-users or a combination 
of all three. 

+    As a company, we are committed to sharing 
in the proceeds of customers’ growth from 
new products, rather than merely supplying 
an essential ingredient.

 
08 

Directa Plus  
Annual Report & Accounts 2021 

Market review

Our graphene nanoplatelets-based products are natural, chemical-free 
and sustainably produced. Our production process is designed to meet 
large supply chains’ requirements for volume, cost and quality control. 

Our vision is to produce nanoplatelets-based products that are natural, 
chemical-free and sustainable. 

By incorporating Directa Plus’s unique graphene blends, identified by the  
G+® brand, our customers can revolutionise the performances of their own 
end products in commercial applications such as textiles, tyres, asphalts and 
environmental solutions. We partner with our customers to enable them  
to offer the high-performance benefits of G+® in their own products. 

Our company has a unique and patented technology process and a scalable 
and portable manufacturing model. We produce graphene nanoplatelets-
based products at our own factory near Milan, Italy, and can set up  
additional production at customer locations to reduce transport costs,  
waste and time-to-utilisation.  

We are strongly committed to environmental sustainability and abided  
by a strong Code of Ethics in all aspects of our business practice.

H
o
w
w
e
d
o

i
t

Left : G+® nanoplatelets, our production  
process uses a unique technique we call Plasma 
Super Expansion. Starting from natural graphite, 
each step of the process – expansion, exfoliation 
and drying – creates graphene nanoplatelets- 
based materials. 

Nano-platelets

 
 
 
Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

09

G+® Technology  

Patented, modular process 

We offer a range of graphene nanoplatelets-based 
products – either ready-to-use or custom-blended 
to meet customers’ specific technical requirements. 

Benefits of our products: 
+  Chemical-free 
+  Certified as non-toxic 
+  High purity 
+  Consistent quality 
+  Taylor-made particles shape 
+ Abundant, safe and non-toxic raw material

Our production process uses a unique technique we 
call Plasma Super Expansion. Starting from natural 
graphite, each step of the process – expansion, 
exfoliation and drying – creates graphene 
nanoplatelets-based materials ready for a variety  
of uses and available in different forms such as 
powder, liquid and paste.  

Our production process produces a highly consistent 
graphene nanoplatelets product – an important 
factor for commercial customers – and does not 
need any chemical or solvent additives.

Tailor-made for customer needs 

Scalable, portable production 

When used in consumer and industrial applications, 
G+® enables end-products to perform better while 
remaining affordable.  

We partner with customers to develop bespoke 
graphene blends that have just the right 
morphology for their particular application. We 
produce the precise ingredient to make our 
customer’s product stand out from the competition.

Our factory near Milan can produce industrial 
quantities of graphene nanoplatelets-based 
products each year to supply large supply chains. 
In addition, we can set up production directly at 
customer locations, thus adding scalable 
capacity and reducing transport costs, waste 
and time-to-utilisation.

p
r
o
d
u
c
t
i
o
n
p
r
o
c
e
s
s

C
h
e
m
c
a

i

l

f
r
e
e

Our production process is designed to  
meet the clients' requirements for volume, 
cost and quality control.

Unique patented 
technology

Left: Thermal camera attached to a pad  
to demonstrate the properties of our G+® Planar 
Thermal Circuit®. 

Above: Printed denim used for aesthetic 
pursposes by the designer Romy Calzado during 
the 2021 Milan Fashion Week. 

 
 
 
10 

Directa Plus  
Annual Report & Accounts 2021 

Chief Executive Officer’s review

Introduction 
Directa Plus continued to grow during 2021 
despite the headwinds created by the 
worldwide pandemic and associated 
lockdowns. The Company has become an 
acknowledged global leader in the production 
of graphene and its applications in existing 
and new products for consumers and industry. 
We expect global graphene demand to 
continue to increase significantly and intend 
to position Directa Plus at the forefront of 
development using our patented process for 
the production of pristine, chemical free 
graphene nanoplatelets, tailored to partners’ 
and customers’ requirements. We expect to 
build a substantial business by positioning 
Directa Plus in the verticals where technology 
capabilities, at attractive costs, meet with  
market opportunities and growing customer 
acceptance. 

The fundraise we completed at the end  
of the year under review will allow the  
Company to undertake the next phase of 
growth and to take advantage of existing  
and new opportunities both in Europe and 
further afield. 

Strategy and business model 
Our strategy is primarily to target existing 
products and markets that can be 
significantly improved with the addition of 
Directa Plus products. The Company works 
with key partners, benefitting from their 
knowledge of the market, strong reputation 
and commercial channels. 

Our proprietary scalable, modular 
manufacturing process to produce and 
supply high quality engineered tunable 

Giulio Cesareo 
CEO

“I believe that Directa Plus is now at an inflection point –  
we have many opportunities across many different vertical 
markets, diversifying our business risks. The recent fundraise 
will allow us to accelerate growth in the most promising of 
these vertical markets and to keep investing in high potential 
opportunities in other areas.”

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Annual Report & Accounts 2021  11 

Directa Plus  

The Company operates in fast changing 
environment, and it is currently refining its 
strategic plan to prioritise the verticals with 
higher potential in terms of commercialisation 
and financial returns. 

Environmental remediation 
The Group’s Setcar subsidiary has again 
delivered strong growth. It is leading the 
expansion of Directa Plus’ Grafysorber® 
technology into new markets and is rapidly 
gaining traction in the global oil & gas 
industry as a step change improvement from 
existing water treatment products and 
services. Setcar has integrated well into the 
Group and is now examining opportunities  
to expand its service offering, based on our 
Grafysorber® products, internationally. 

Reusable and sustainably produced, 
Grafysorber® is five times more effective  
at hydrocarbon clean-up than competitor 
products and allows for the recovery of 
financially valuable oils and sludges.  
In addition, Grafysorber® is sustainably 
produced, non-flammable and reusable, with 
the adsorbed hydrocarbons recoverable. 

The Group continues to build an active 
pipeline of contract tenders, including high 
value opportunities. 

In March 2021 we completed the draining, 
cleaning and washing of a first oil storage unit 
for Petrotel Lukoil S.A. for a total amount of  
c. €0.4 million of services. 

In early 2021, the contract with OMV Petrom 
was extended and increased. Initially  
awarded in July 2019, the contract was for  
the provision of decontamination and oil 
recovery services using Grafysorber® 
technology. The initial value of the contract 

graphene materials at low production costs 
and 100% chemical free puts sustainability  
at the heart of our operations and acts as a 
powerful differentiator from competitors.  
We have amassed 43 certifications over the 
years, all reporting the absence of negative 
impacts on biological systems. We consider 
the health and safety of all stakeholders and 
environmental protection as top priorities  
and we have implemented a proactive 
approach by continuously monitoring our 
production process and products.  

We currently target four key markets in which 
we already have cornerstone customers  
and partners: 
•    Environmental remediation – through our 
successful Setcar subsidiary, using Directa 
Plus’ Grafysorber® technology to help the 
oil and gas industry to tackle environmental 
issues from hydrocarbon pollution; 

•    Textiles – printing nanoplatelets on fabrics, 
and graphene enhanced membranes for  
the sports, luxury, fashion, workwear and 
military markets; 

•    Composites – introducing the next 

generation of graphene-enhanced asphalts 
that are recyclable for a lower carbon 
world; and 

•    Lithium-Sulphur batteries – the 

development of a Lithium-Sulphur battery 
using the Directa Plus’ G+® pristine graphene 
nanoplatelets as a key cathode component. 

In addition to these key verticals, we 
continuously monitor other high potential 
markets where we believe that for a relatively 
small investment we can develop products 
that can generate high commercial traction 
and which have a fast time to market, such as 
paints, consumer electronics and filtration.  

c.+50% revenue from the environmental 
remediation services in 2021. Our subsidiary 
Setcar is playing a key role in expanding  
the Grafysorber applications, bringing 
significant value to the Group.

c.+50% revenue

Right: Reusable and sustainably produced, 
Grafysorber® is five times more effective at 
hydrocarbon clean-up than competitor products 
and allows for the recovery of financially valuable 
oils and sludges.  

Above: Setcar has again delivered strong growth, 
leading the expansion of Directa Plus’ 
Grafysorber® technology into new markets.

was €150,000 and this was increased to 
€410,000 for a six-month services period.  
In July 2021, an additional tender with OMV 
Petrom was won for a four-year contract,  
with a total value of more than €3.2 million,  
to treat some 80,000 cubic meters of sludge 
and waste produced during the first upstream 
separation process. Up to 20,000 tons of crude 
oil with impurities below 1% will be recovered 
and sent to the refinery. At current oil prices 
(c. $700-800 per ton) this is generating 
significant value for the client. Directa Plus will 
supply a total of 700 high-performance 
adsorbent devices containing Grafysorber®  
to OMV Petrom. As at the time of writing, we 
have treated 36,000 cubic meters of sludge 
and recovered 8,900 tons of crude oil. 

We believe that Grafysorber® has significant 
export potential overseas and the Company 
continues to evaluate opportunities in 
discussion with possible partners focused on 
decontamination from hydrocarbons. A vital 
first step in addressing the US market was 
achieved in late March 2022 with the grant  
of authorisation by the United States 
Environment Protection Agency to use 
Grafysorber® at any oil spill on US territory. 

Directa Plus will supply a total of 700 high-
performance adsorbent devices containing 
Grafysorber® to OMV Petrom. So far we have 
treated 36,000 cubic meters of sludge and 
recovered 8,900 tons of crude oil.

700 devices

An additional tender with OMV Petrom was 
won for a four-year contract, with a total 
value of more than €3.2m, to treat 80,000 
cubic meters of sludge and waste produced 
during the first upstream separation process.

€3.2 million

12 

Directa Plus  
Annual Report & Accounts 2021 

Chief Executive Officer’s review continued

In April 2022, the Company signed a first order 
of Grafysorber® based absorbing products 
with a major UK reselling company, with the 
aim to initially target mainly the northern 
European markets. 

As announced at the time of the Fundraise in 
December, we plan to invest in the further 
development of Grafysorber® technology to 
broaden the number of applications we can 
offer. This will involve constructing a water 
treatment plant as well as providing 
dedicated equipment for in-house treatment 
of industrial water and for the removal of 
hydrocarbons and other organic pollutants. 
The Company also has recently located  
a Grafysorber® production unit in Sectar’s 
premises in Romania, close to existing 
customers, and launched the production  
of absorbent materials such as 
Grafysorber®-made booms, pillows, socks 
and pads for the oil and gas industry.  

Textiles 
In 2020, the Covid-19 pandemic led Directa 
Plus to rapidly respond to the global crisis  
by developing the Co-mask™, a product to 
alleviate the effects of the pandemic by 
helping to reduce transmission of the virus. 
The development and commercialisation of 
the Co-mask™ accelerated studies around the 
filter applications of G+® technology, which is 
proven to have anti-viral properties, is non- 
toxic and has no negative impacts on human 
skin. This work is now producing additional 
applications which leverage the antimicrobial 
and antiviral properties of G+®and provides 
the basis for entry into the large global  
filter market. 

human skin. A total of eight in vitro test results 
now show that Pure G+® has no potential 
negative impact on human health. 

In April 2021, the new G+® graphene coating 
for fabrics was tested by an independent 
third-party laboratory and found to be 
suitable for human skin contact. The results 
showed zero erythema and oedema reactions 
across all subjects participating in the test and 
the G+® coated fabric was reported to be 
‘dermatologically tested’ and non-irritating. 

In July 2021, the peer-reviewed interdisciplinary 
open-access journal iScience published a 
scientific paper titled “Graphene Nanoplatelet 
and Graphene Oxide Functionalization of Face 
Mask Materials Inhibits Infectivity of Trapped 
SARS-CoV-2”. The paper provides scientific 
evidence that the Company’s G+® graphene 
nanomaterials and those from graphene 
oxide present a critical opportunity to 
significantly increase face mask efficacy. In 
relation to the anti-SARS-CoV2 capability of 
Directa Plus’ G+® graphene, the paper certifies 
that G+® filter fabric treated with PU G+® can 
inactivate 97% of the virus while G+® cotton 
can inactivate 99% of the virus. 

The antibacterial and antiviral properties of 
the Company’s G+® pristine graphene 
nanoplatelets represent significant 
opportunities for Directa Plus in textile and 
biomedical applications. The efficacy of G+® 
and its non-toxic and sustainable production 
characteristics overcome the problems of the 
current state-of-the-art solutions that are 
based on metal-ion or halogen treatments, 
which could be dangerous to human health 
and detrimental to the environment. 

In March 2021, Directa Plus announced a 
further test result relating to the absence of 
absorption of its pristine graphene 
nanoplatelets powder (Pure G+®) through 

As a result of the fundraise we plan to 
advance the application of G+® technology to 
non-woven fabrics to confer antibacterial and 
antiviral properties for the industrial filtration 

Above: In July 2021 Annemiek van Vleuten from 
the Netherlands team about to win the golden 
medal in the individual time trail.

Above: Grafylon® 3D. The 3D printing filament, 
enhanced with G+®, is used by Playcast to 
produce customised medical casts.

market. In December, Directa Plus signed a 
Letter of Intent with Radici Group, an Italian- 
based global chemicals and materials group 
and a major player in the non-woven 
materials industry, to collaborate on an 
exclusive basis for an initial period of 12 months. 
The collaboration will see G+® technologies 
combined with those of the Radici to develop 
specific products for the global air and water 
filtration markets. If the technical results 
envisaged are achieved, the two companies 
will negotiate a technical and commercial 
partnership agreement with Directa Plus to 
benefit from a revenue-sharing business model. 

In July 2021 members of the Dutch and 
Belgian cycling teams won four medals at the 
Tokyo Olympics (one gold, two silver and one 
bronze) in the road race event wearing a shirt 
printed with Directa Plus’ patented and 
proprietary technology, the G+® Planar Thermal 
Circuit®. The shirts for the national cycling 
teams at the Games were made by premium 
cycling brand, Bioracer, using fabric supplied 
by Italian company, Taiana, with the unique 
and high-performance print made using 
Directa Plus’ sustainable graphene. This is an 
additional illustration of how the Company’s 
G+® graphene supports the natural 

In the UK, Oxfordshire County Council has 
started its second Gipave® trial. Half of  
a 700-metre stretch of the road will be  
laid with Gipave®, while the rest will be 
resurfaced using conventional asphalt,  
so that the two surfaces can be compared.

700 metre trial 

Directa Plus launched its own line of 
performance sportswear, the Cosmic 
Collection, in the first half of 2021. The 
collection offers consumers advanced 
technology, which is also sustainable and 
provides a showcase for the versatility of 
G+® and its applications.

Cosmic collection 

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Annual Report & Accounts 2021  13 

Directa Plus  

G+® membrane which is integrated into the 
Dyneema® one-piece woven upper lining in 
the toe box of the shoes. This provides the 
runner with additional comfort due to the 
thermal conductivity and abrasion resistance 
of the graphene G+® membrane while adding 
almost zero additional weight. Gear Patrol, 
the influential buying magazine, ranked 
norda™ 001 the most innovative trail running 
shoe of 2022. 

We continue to strengthen our relationships 
with existing important customers in the 
workwear and luxury segments and to 
promote our presence in the textiles vertical 
Directa Plus launched its own line of 
performance sportswear, the Cosmic 
Collection, in the first half of 2021. This 
collection aims to offer consumers advanced 
technology, which is also sustainable. The 
Cosmic Collection provides a showcase for 
the versatility of G+® and its applications and 
will help to increase awareness of the 
Company and our technologies.  

Composites 
The asphalt and bitumen applications of  
G+® graphene technology is generating 
considerable traction, and the interest in the 
market for Iterchimica’s Gipave® product, 
developed with Directa Plus, is growing 
internationally. We have signed a three-year 
agreement with Iterchimica for the exclusive 
supply of G+® graphene products for the 
sector worldwide and have extended the 
partnership with a significant pipeline of 
opportunities. 

In the UK, Oxfordshire County Council has 
now started its second trial to further test the 
benefits that Gipave® can bring. The new trial 
will see two identical stretches of Marsh Lane 
in Oxford, which carries around 10,000 
vehicles a day along a key city route, 

Above: Microfiber substrate coated with G+® 
Graphene Plus coating, presented by Plinio il 
Giovane at the Milan Design Week 2021.

resurfaced with different materials. Half of a 
700-metre stretch of the road will be laid with 
Gipave®, while the rest will be resurfaced  
using conventional asphalt, so that the two 
surfaces can be compared. This second trial 
follows a successful first pilot scheme in 
Curbridge, Oxfordshire in 2019. Analysis of  
this scheme showed Gipave® increases the 
lifespan of the surface by up to 70% compared 
to conventional resurfacing methods. 

Lithium-Sulphur Batteries 
Next generation Lithium-Sulphur battery 
chemistry offers advantages over Lithium-Ion 
as it has a superior energy density, significant 
cost advantages and a superior safety profile. 
Our collaboration with NexTech, a leading 
company in the field of Lithium-Sulphur 
batteries based in Nevada, USA, is making 
strong progress.  

In November 2020, a memorandum of 
understanding was signed with NexTech.  
In February 2021, both parties agreed to 
form a stronger partnership, with a 
three-year supply agreement for the 
provision of a specific grade of G+® pristine 
graphene nanoplatelets and a joint R&D 
collaboration to develop new specific 

Above: G+® coating on microfiber substrate for 
vegan leather applications. 

Left: Grafyshield ® is a semi-finished product:  
an additive for the paint production.

thermoregulation of the body, providing 
athletes with a competitive advantage. 

In September 2021 Directa Plus’ new G+® 
graphene coatings have being shown in two 
collections at the prestigious Milan Design 
Week. The Company’s revolutionary new 
covering material has been selected for 
inclusion in collections being shown by two 
Italian companies. Plinio il Giovane is a central 
Milan based producer of high-end furniture 
and upholstery and is showcasing a collection 
of chairs and sofas with G+® coverings. 
Danese Milano, a subsidiary of lighting 
company Artemide S.p.A., is an innovative 
producer of interior design accessories and  
is showing a desk pad covered with the G+® 
coating. Plinio il Giovane and Danese Milano 
both selected Directa’s innovative material 
technology as a result of its disruptive 
performance compared to traditional 
upholstery fabrics and coatings. G+® coatings 
on organic and non-organic fabrics are 
antibacterial and antiviral against SARS-CoV2; 
resistant to abrasion and wear and tear; 
resistant to UV light, and; thermally conductive 
for achieving the highest thermal comfort. 

In April 2022 Directa Plus has signed a 
non-binding Letter of Intent with a leading 
worldwide supplier of automotive interiors  
to Tier 1 manufacturers. The partners intend 
to develop a suite of new products for the 
automotive industry based on the 
antimicrobial properties (antibacterial and 
antiviral), thermal comfort and electrical 
conductivity properties of the Company’s  
G+® enhanced fabrics. 

In November 2021, the Company announced 
that a specially developed graphene 
membrane is integrated into the lining of the 
norda™ 001 G+® Spike high performance trail 
shoes. Directa Plus was responsible for the 

Directa Plus continues to invest in Italdesign, 
(part of Volkswagen AG) a global leader in 
automotive design and engineering to jointly 
develop a wide range of automotive 
components. In April 2022 Directa Plus signed 
a LOI with a leading worldwide supplier of 
automotive interiors to Tier 1 manufacturers.

Automotive 
applications

The Company is close to starting to 
commercialise graphene-based paints with 
significant anti-flame and anti-corrosion 
properties. 

Paints

14 

Directa Plus  
Annual Report & Accounts 2021 

Chief Executive Officer’s review continued

Automotive 
Directa Plus continues to invest in the 
technical and commercial agreement with 
Italdesign, part of Volkswagen AG, a global 
leader in automotive design and engineering. 
The agreement will see Directa Plus and 
Italdesign jointly develop a wide range of 
automotive components enhanced by the 
Company’s graphene expertise. 

Paints 
In February 2021, research undertaken by 
scientists at the Polytechnic of Turin was 
published in an article in the journal Polymers 
showing that the use of water-based G+® 
graphene ink to coat polymeric foam confers 
significant flame-retardant properties.  
A simple application of G+® ink to the external 
faces of the foam provided good flame- 
retardant properties, tested in both horizontal 
and vertical planes.  

Using this study as a base, the Company is 
close to starting the commercialisation of 
graphene-based paints with significant 
anti-flame and anti-corrosion properties 
compared to normal paints. We see great 
potential in this developing technology. 

Intellectual property 
As at March 2022, the Group’s patent portfolio 
comprised 72 patents granted and 27 pending, 
grouped into 19 families.  

In March 2021, Directa Plus was granted an 
EU-wide patent covering the use of its G+® 
graphene in golf ball applications. The patent 
covers a family of formulations and compounds 
containing G+® graphene nanoplatelets.  
Using these compounds at different loadings 
provides the basis for developing a new 
generation of high-performance golf balls 
aimed at both the professional and 
recreational markets. 

Above: Sport jersey made by EE Sport, pinnacle 
for cycing technolgies with an integrated app 
for SOS emergency calls.

In May 2021, Directa Plus was granted an 
EU-wide patent covering the production 
process for its G+® graphene nanoplatelets. 
The patent, titled ‘Process for Preparing 
Graphene Nanoplatelets’ covers the use of 
Directa Plus’ unique water-based exfoliation 
technology for converting super-expanded 
graphite to pristine graphene nanoplatelets 
using no chemicals and with a very high 
conversion yield. 

In December 2021 the Company has been 
granted an EU-wide patent covering the use 
of the Company’s G+® pristine graphene 
nanoplatelets to boost the performance of 
rubber-based shoe outsoles. The patent, 
titled ‘Shoe sole comprising graphene’,  
covers G+® graphene embedded in outsoles. 
The specific formulation of G+® graphene  
for soles provides the ability to balance 
opposite performance characteristics such  
as durability and grip, in both dry and wet 
conditions. This ability to balance opposing 
performance traits is unique to Directa Plus’ 
G+® graphene and becomes markedly 
apparent on rubber-based technical shoe 
soles such as those used for running, trail 

grades of nanoplatelets. A joint laboratory 
has been established in Lomazzo, where 
Directa Plus is located and both parties will 
dedicate selected scientists from their 
respective R&D teams.  

We continue to support NexTech in the 
development of this disruptive technology,  
in which G+® will play a key role in terms of 
technical properties and the supply of our 
product at the scale necessary to satisfy  
the needs of the market. In June 2021, 
NexTech established its European subsidiary 
in Italy (“NexTech Italia SpA”), with the initial 
objective being to evaluate the feasibility of 
producing cathode active materials in Italy, 
using our G+® graphene nanoplatelets, for 
the manufacture of Lithium-Sulphur (Li-S) 
batteries throughout Europe. 

The Company is now ready to target other 
Lithium-Sulphur battery producers to 
accelerate the technology’s commercialisation. 

Other verticals 
Consumer electronics 
In December 2020, Directa Plus signed a 
development agreement with the soft goods 
division of a major international developer 
and manufacturer of consumer electronics 
and related services. The agreement covers 
the potential application of G+® graphene  
as a protective covering for consumer  
devices, exploiting the antiviral-antibacterial 
properties of G+® graphene as well as its 
thermal and electrical conductivity. The 
partnership has delivered exceptional results  
to date. In 2021 we received some promising 
orders for our G+® graphene and this 
collaboration continues to demonstrate the 
potential for significant volumes in the 
coming years. 

A specially developed graphene membrane 
is integrated into the lining of the norda™ 
001 G+® Spike high performance trail shoes. 
Gear Patrol, the influential buying magazine, 
ranked norda™ 001 the most innovative trail 
running shoe of 2022. 

norda™ trainers

Above: Directa Plus membrane integrated into the 
Dyneema® one-piece woven upper lining in the  
toe box of the shoes. Providing the runner with 
additional comfort due to the thermal conductivity 
and abrasion resistance of the graphene G+®.  

Right: Printed with the G+® Planar Thermal Circuit®.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Annual Report & Accounts 2021  15 

Directa Plus  

Above: A desk pad designed by Giulio Iacchetti, 
well known designer from Danese, realised  
with a G+® coating for antibacterial property  
and aesthetic effect. 

running, hiking, and on motorbikes. The 
patent covers both the formula for the 
compound and the final product outsole 
made with the compound. 

Environmental, Social and  
Governance policies 
Environmental sustainability is at the heart  
of Directa Plus’ business – our research, 
manufacturing, commercialisation, and 
purpose – and we have been ISO 14001 certified 
since 2016, which have been recently renovated. 

From the earliest stages of our research into 
graphene applications we were determined  
to design manufacturing processes for our 
pristine nanoplatelets that would avoid the 
need for chemical processes and so avoid 
wasteful by-products. We continue this 
approach now – always seeking to design  
the most efficient manufacturing and  
proving the safety and sustainability of our 
products working with recognised 
environmental organisations. 

When deciding our commercialisation 
strategy, we made it a priority to work only 
with environmentally responsible industrial 

The Company's G+® graphene coatings are 
being shown in two collections at the 
prestigious Milan Design Week held from  
5 to 10 September 2021.

Milan  
Fashion Week

Right: Dress created by the designer Romy 
Calzado for the 2021 Milan Fashion Week.  
This dress was named Naomi 1.5 in honour  
of Naomi Campbell who wore it during  
the exhibition.

partners, and to seek to improve on products 
in existing markets. This means that we can 
help produce and sell better quality products 
than are currently available, with better 
performance and longer life for end-users. 

We monitor all applicable performance 
indicators. In our production process we 
consider raw materials supply chains, energy 
consumption, water and wastewater, 
atmospheric emissions, the production  
of waste and any effect on biodiversity.  
Our commitment to sustainability is also 
demonstrated by our Grafysorber® based 
technology and products, which are 
environmentally friendly solutions aimed at 
solving both historical pollution problems 
and oil spills. 

In Social and Governance, Directa Plus has 
held certifications ISO 9001 (for quality 
management standards) and ISO 14001 
(environmental management systems) since 
2016, successfully renewed annually. We are 
also committed to identifying suppliers and 
partners who share the same sensitivity on 
sustainability issues as we do. We carefully 
consider all aspects of employee rights, equal 
opportunities, health and safety at work and 
training and education.  

Finally, with respect to our local community, 
Directa Plus is well-known and deeply rooted 
in the Milan area. We promote our regional 
economy by identifying local suppliers, with 
whom it is possible to structure lasting 
partnerships. We believe it is essential to 
actively contribute to initiatives that can have 
a positive impact on the social fabric of the 
area and in 2021, through the sale of 
CO-Mask™ face masks, we financed the 
Christmas meal for the Opera San Francesco 
in Milan.  

Outlook 
I believe that Directa Plus is now ready to 
enter into a new stage of growth. We have 
many opportunities across different vertical 
markets, diversifying our business risks.  
The recent fundraise will allow us to 
accelerate growth in the most promising of 
these vertical markets and to keep investing 
in high potential opportunities in other areas.  

We are closely monitoring and assessing 
possible impacts from the war in Ukraine and 
will adjust our strategy if necessary. We do no 
business in Russia or Ukraine and so we are 
not directly exposed to this region, and we 
believe the rise in the oil prices may increase 
demand for our decontamination and 
recovery services. 

Year to date, the Company is trading in line 
with FY2021, with an expected acceleration 
through the second quarter and into the 
second half of the year. Accordingly, we are 
confident of the Company’s continued 
growth trend, and we remain comfortable 
with current consensus forecasts for FY2022. 
In addition, we are waiting on the final 
decision on the award of a significant  
tender in Romania for our Environmental 
Remediation services, which is expected to 
be communicated shortly and, if awarded,  
to start in the second half of 2022. 

In summary, despite the challenges faced by 
all businesses, we retain a positive outlook 
for growth and our future success. 

Giulio Cesareo 
Chief Executive Officer 
4 May 2022

Directa Plus is well-known and deeply rooted 
in the Como area. We believe it is essential to 
contribute to initiatives that have a positive 
impact on the social fabric of the area and in 
2020, through the sale of CO-Mask™ face 
masks, we financed the Christmas meal for 
the Opera San Francesco in Milan.  

CO-Mask™

 
 
16 

Directa Plus  
Annual Report & Accounts 2021 

Chief Financial Officer’s review

Key Performance Indicators 
The Board measures the performance of the 
Group through a number of important 
financial and non-financial KPIs. In a young 
business with a number of different vertical 
markets, identifying measurable data that will 
provide useful insight year-on-year is not 
always straightforward but the KPIs below 
should help shareholders understand the 
Group’s progress. Our financial KPIs show 
significant improvement compared to 2020. 

The table below summarises the financial 
KPIs with further details contained later in  
this report. 

•  Product sales and service revenue 

increased by 33.9% to €8.62m (2020: 
€6.43m), slightly above market expectations. 

•  Total income (including grants) increased 

by 39.3% to €9.45m (2020: €6.78m). 

•  LBITDA* improved to €1.99m (2020: 

€2.62m). 

•  Reported (basic) loss per share was €0.06  

(2020: €0.07). 

•  Cash and cash equivalents at year end  

of €11.13m (2020: €7.08m). 

* LBITDA represents loss from operating activities 
before tax, interest, depreciation and amortisation.

Giorgio Bonfanti 
Chief Financial Officer

“I am pleased to report the results of another important year  
of progress for the Group. During 2021, the finance team has 
worked hard to support our strategic decision-making and to 
manage efficiently our financial resources. The successful  
capital raise in December 2021 will be key in accelerating our 
business growth in the Group’s next phase of development  
in 2022 and beyond.”

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Annual Report & Accounts 2021  17 

Directa Plus  

       – produce absorbent materials such as 
Grafysorber®- made booms, pillows, 
socks and pads. 

    • advance the application of Directa Plus’ 
G+® technology to non-woven fabrics to 
confer antibacterial and antiviral 
properties. The Company has signed a 
Letter of Intent with Radici Group to 
collaborate on an exclusive basis to 
develop specific products for the global  
air and water filtration markets. 

•  providing the financial strength necessary 

to fund the Company’s continued 
investment in exploring and developing 
new growth opportunities;  

•  providing the balance sheet strength to 

support the Company and its subsidiaries 
in responding to significant new tenders 
currently in progress; and  

•  providing additional liquidity for its general 

working capital purposes. 

In the short term, the Group’s priorities 
continue to be focused on the reduction of 
cash consumption and improving 
profitability.  

A description of the principal risks and 
uncertainties facing the Group is set out in 
the Directors’ Report. The war in Ukraine in 
particular creates new, unforeseen risks.  
In summary, the Directors believe that 
overall, the conflict will not affect the going 
concern of the Group and although we are 
seeing some inflation of costs (principally 
energy), the Company is keeping the 
margins under control.  

Giorgio Bonfanti 
Chief Financial Officer 
4 May 2022

Financial review 
2021 represented another year of continued 
growth for the business. Revenues from 
products and services increased by 33.9% to 
€8.62m (2020: €6.43 million), and total income 
+39.3% to €9.45m (2020: €6.78 million). 

The increase in revenues was mainly driven 
by growth in the environmental remediation 
services of 50% to €6.56m. The Group’s 
Romanian subsidiary Setcar, acquired in 
November 2019, is playing a key role in the 
growth of our environmental services offering 
and is delivering excellent results for the Group. 

Other income increased by 140% to €0.83m. 
This result was positively affected by a €0.50 
million one-off income from Setcar, as a result 
of the release of an undue obligation. The 
remainder consists of grants and R&D 
expenditure credits, specific incentives and 
financing schemes that support the Group 
in its R&D activities. 

The EBITDA loss for the period was €1.99m, 
decreasing by 24.1% compared to 2020 (loss  
of €2.62 million). The Group is closely 
monitoring increases in energy and 
transportation costs and the effects of 
increased inflation were seen in the second 
half of 2021 and this trend is intensifying into 
2022, as a consequence of the war in Ukraine. 
The Group is taking all possible measures to 
avoid margin reduction and is reacting 
promptly to increase product prices to reduce 
any impact on profitability. 

Net loss for the period was reduced by 24.3% 
to €3.43m (2020: €4.53m). 

At the end of 2021 the Group strengthened its 
funding position, and cash and cash 
equivalents at year end were €11.13m (2020: 
€7.08m). In addition, during the year, Directa 
Plus raised a total of €1 million of bank loans, 
provided by two major Italian banks, under 
the Italian Government’s Covid-19 Recovery 
Plan. The loans are 80-90% guaranteed by the 
Italian Government and have allowed the 
Company to take advantage of the low-cost 
liquidity offered.  

In December 2021, the Group completed a 
fundraising with gross proceeds of £7 million, 
by way of a placing and subscription. Directa 
Plus issued 4,666,667 new Ordinary Shares at 
a price of 150p each, with almost no discount 
to the market price at the time of transaction.  

The proceeds from the capital raise will be 
used for: 

•  funding two significant future growth 

opportunities in the main existing verticals; 
• development of Grafysorber® to broaden 
the number of applications offered.  
The Group is locating a Grafysorber® 
production unit in Setcar’s premises in 
Romania to: 
– construct a water treatment plant, 
providing dedicated equipment for 
in-house treatment of industrial water 
and for the removal of hydrocarbons  
and other organic pollutants using its 
Grafysorber® technology, and  

 KEY PERFORMANCE INDICATORS & FINANCIAL SUMMARY                                      2021                             2020 

 Revenue from product and service sales (€’m)                                           8.62                        6.43 

 Total income* (€’m)                                                                                                  9.45                        6.78 

 LBITDA** (€’m)                                                                                                          (1.99)                     (2.62) 

 Loss after tax*** (€’m)                                                                                            (3.43)                     (4.53) 

 Reported basic loss per share (€)                                                                     (0.06)                     (0.07) 

 Cash and cash equivalents (€’m)                                                                     11.13                        7.08 

 Total number of patents granted****                                                                   72                            38 

* Total income comprises revenue from product and service sales (€8.62m), and other income mainly including windfall profits 
(€0.50m) government grants (€0.17m) and RDEC – Research and Development Expenditure Credit (€0.03m).  
** LBITDA represents results from operating activities before depreciation and amortisation of €1.54m (2020: €1.69m). 
Management believes that LBITDA provides a better reflection of operational performance by removing interest, tax, 
depreciation and amortisation. EBITDA is a non-GAAP measure.  
*** The loss for the year of €3.43m is split between a €3.65m loss owned by the Company and a €0.22m profit in respect of 
non-controlling interests. 
**** Number of grants in portfolio at the end of the period.

 
18 

Directa Plus  
Annual Report & Accounts 2021 

Directors’ biographies

Sir Peter Middleton 
Non-Executive Chairman 

Relevant strengths 
•

Track record and credentials in 
financial markets 

•

•

Deep financial expertise 

Corporate governance and 
investors relations 

Giulio Cesareo 
CEO and Founder 

Giorgio Bonfanti 
CFO 

Relevant strengths 
•

Industry knowledge and credentials 

Relevant strengths 
•

Financial reporting and accounting 

•

•

Strategic and business expertise 

Engineering expertise 

•

•

Budget and business plan 

M&A and funding 

Giorgio is a professional with corporate 
finance, M&A, and accounting experience. 
Before joining Directa Plus in May 2021, 
Giorgio was a Senior Manager at PwC, in their 
Deals practice. He supported national and 
international clients in M&A transactions, such 
as acquisitions, disposal, joint ventures, IPOs 
and business plans. He also has a previous 
experience at KPMG as an auditor. 

Giorgio holds a degree in Business 
Administration and a Master of Science in 
Accounting, Finance and Control from 
Bocconi University.

Sir Peter Middleton GCB is Chairman of Burford 
Capital. He was Chairman of Marsh Ltd 
between 2005 and 2013, UK Chairman of 
Marsh & McLennan Companies between 2007 
and 2014 and Chairman of Mercer Ltd between 
2009 and 2014. He was also previously 
Chairman of Camelot Group plc and Chairman 
of the Centre for Effective Dispute Resolution. 
He was a Director, Chairman and Deputy 
Chairman of United Utilities from 1994-2007, 
a Board member of OJSC Mobile Telesystems 
from 2005-2007 and a board member of Bass 
plc from 1992-2001 and General Accident (later 
CGU) from 1992-1995. 

Sir Peter spent nearly 30 years at HM Treasury, 
working closely with nine Chancellors, and 
was Permanent Secretary from 1983 to 1991. 
Sir Peter became Group Chairman of Barclays 
Bank plc in April 1999 and retired in August 
2004. He joined Barclays in 1991 as Group 
Deputy Chairman and Executive Chairman of 
BZW, became Chairman of Barclays Capital 
following the reorganisation of BZW in 
October 1997 and was Group Chief Executive 
from November 1998 until October 1999. 
He was also President of the British Bankers 
Association from 2004-2006 and a member 
of the National Institute for Economic 
Research from 1996-2007.

Giulio Cesareo is one of the founders of 
Directa Plus. He began his professional career 
in 1982 in Italy working for Falck and Techint. 
From 1986 to 2004, he worked in the carbon 
and graphite business for Union Carbide, 
UCAR and Graftech, reaching the positions of 
the President and CEO of the Italian company 
and Vice President and General Manager of 
the worldwide Advanced Carbon and Graphite 
business unit. In his role at Union Carbide, 
Giulio managed business units in USA, France 
and Italy. Giulio is Advisory Board member 
and member of the Industry Council of the 
US National Graphene Association 

Giulio Cesareo was awarded a degree in 
Mechanical Engineering from the Polytechnic 
University of Milan, an MBA and an Executive 
MBA from Bocconi University of Milan and 
attended Strategic and Financial Management 
Programs at Stanford University (USA). He 
serves as a board member of Fondazione 
Quarta, a non-profit organisation focused on 
scientific research in areas of social activity 
and was also Board Member of: Centro di 
cultura scientifica “Alessandro Volta”, an 
organisation aimed at promoting the practical 
applications of a scientific culture.

 
 
 
 
Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

19 

David Gann 
Non-Executive Director 

Relevant strengths 
•

Innovation management 

•

•

Business strategy 

Engineering expertise 

Neil Warner 
Non-Executive Director 

Richard Hickinbotham 
Non-Executive Director 

Relevant strengths 
•

Financial reporting and accounting 

Relevant strengths 
•

Deep understanding of AIM markets 

•

•

Growing businesses and M&A 

Corporate governance 

•

Investor relations and financial 
communication 

•

Growing businesses and funding 

David Gann CBE CEng FICE FCGI is a 
renowned expert on technological innovation 
and an accomplished business and academic 
leader. He is Chairman, UK Atomic Energy 
Authority. He is Pro-Vice-Chancellor, 
Development and External Affairs, at Oxford 
University. He was Professor of Innovation & 
Technology Management, Imperial College 
London and was Vice-President (Innovation) 
and member of the College’s Executive Board. 
He has deep experience mentoring start-ups, 
supporting fast growth technology businesses 
and developing long-term strategic 
partnerships with multinational technology 
corporations. He has a PhD in Industrial 
Economics and is a Chartered Civil Engineer, 
a Fellow of the Institution of Civil Engineers, 
an Honorary Fellow of the Royal College of Art 
and Fellow, City & Guilds Institute. He was 
appointed Commander of the Order of the 
British Empire (CBE) in the 2010 Queen’s 
Birthday Honours for services to engineering, 
and received the 2014 Tjalling C. Koopmans 
Asset Award for extraordinary contributions to 
the economic sciences. David is a senior 
government advisor. His industrial experience 
includes serving as Laing O’Rourke plc’s Group 
Executive for research and innovation 
between 2007 and 2011. He advises executives 
and boards on innovation and technology 
management, including Citigroup, IBM, 
McLaren, NEC and Tata Group.

Neil Warner has strong financial and 
managerial experience in multinational 
businesses. He recently served as the senior 
independent Director and Chairman of the 
Audit Committee at Trifast plc and as a Non-
Executive Director and Audit Committee 
Chairman of Vectura Group plc. He previously 
served as the senior independent Director and 
Audit Committee Chairman of Dechra 
Pharmaceuticals plc, and was Non-Executive 
Chairman of Enteq Upstream plc. He was 
Finance Director at Chloride Group plc, a 
position he held for 14 years until its acquisition 
by Emerson Electric. Prior to this, Neil spent six 
years at Exel plc (formerly Ocean Group plc and 
now part of DHL following its acquisition by 
Deutsche Post) where he held a number of 
senior posts in financial planning, treasury and 
control. He has also held senior positions in 
Balfour Beatty plc (formerly BICC Group plc), 
Alcoa and PricewaterhouseCoopers.

Richard Hickinbotham is an experienced City 
professional and Head of Equity Research at 
Singer Capital Markets, having served 
previously as Head of Equity Research at 
Cantor Fitzgerald Europe and Charles Stanley. 
He has also held a number of senior positions 
at Investec, including Global Head of Research 
and Co-Head of UK Investment Banking and 
as Head of Pan-European Small and Midcap 
Research at S.G. Warburg & Co. (acquired by 
UBS). Richard is a Non-Executive Director of 
AB Dynamics Plc where he is Chairman of the 
Remuneration Committee and a member of 
the Audit and Nomination Committees. 
Richard holds a BSc. in Mechanical 
Engineering from Imperial College and is 
a qualified Chartered Accountant. 

®

 
 
 
 
 
 
20 

Directa Plus  
Annual Report & Accounts 2021 

Section 172

Section 172(1)(a) to (f) of the Companies Act 2006 requires Directors to 
take into consideration the interests of stakeholders in their decision 
making, to this effect the Board of Directors of Directa Plus Plc consider 
that they have acted in such a way that would be most likely to 
promote the success of the company in the long term, taking into 
consideration the interests of all the stakeholders (investors, 
employees, customers, suppliers and local communities). 

a) The likely consequences of any decision in the long-term. Annually 
the company reviews its medium to long term plan, which focuses on 
the strategic direction of the Group as well as looking at the threats, 
and opportunities it is facing. This plan is designed to ensure the long-
term optimal direction of the company, ensuring, at the same time, 
the consideration of long-term requirements of the stakeholders. 

b) The interests of the company’s employees. The Board considers 

the employees as one of the key stakeholders within the Group and 
as such welcomes any feedback to ensure the alignment of both 
party’s interests and given the nature of the business their greatest 
asset. The interests of the employees are always considered when 
determining the strategic direction and vision of the Group. 

Details of the Company’s process to obtain feedback from 
employees are listed in the section “Stakeholder and social 
responsibilities” of Corporate Governance Statement at page 24. 

c) The need to foster the company’s business relationships with 
suppliers, customers and others. The Board recognises that the 
success of the Company is reliant on the stakeholders of the 
business and, to this effect, the Company engages with these 
stakeholder groups on a regular basis. Details of the Company’s 
process to obtain feedback from customers and supplier are listed 
in the section “Stakeholder and social responsibilities” of 
Corporate Governance Statement at page 24. 

d) The impact of the company’s operations on the community and 

environment. The Board has always considered the health and safety 
of people and environmental protection as top priorities. In order to 
seek to manage its environmental responsibilities in a systematic and 
proactive manner both Directa Plus S.p.A. and Setcar implemented 
the ISO 14001 certification that helps the Group to achieve the 
intended outcomes of its environmental management system which 
provide value for the environment, the organization and the 
interested parties. The Board recognises its responsibilities with 
regards the environment and wider community and takes actions to 
reduce the risk of any potential negative impact the provision of its 
services and products could have in this area. In 2020 the Covid-19 
pandemic encouraged the Board to strengthen its security and health 
measures towards its employees and community in general. The 
Group implemented an anti-contamination protocol shared with all 
its employees, foreseeing the provision of protection tools, constant 
disinfection of all areas and common rooms, safety distancing and 
body temperature controls. As the pandemic evolved, the Group 
maintained the same protocol also for the entire 2021. 

e) The desirability of the company maintaining a reputation for high 
standards of business conduct. In order to ensure that the business 
maintains its reputation and integrity, the Board promotes a 
corporate culture based on sound ethical values and behaviours, 
which are essential to maximise shareholder value. Those core 
values serve as a common language that allows all members of staff 
to work together as an effective team and, it is these values and our 
shared long-term business vision and strategy that we believe will 

drive growth in shareholder value over the long term. Ethical code 
and whistleblowing process are in place and reviewed regularly. 
Further details of the Company’s Ethical value and behaviours are 
listed in the section “Ethical values and behaviours” of the Corporate 
Governance Statement at page 24. 

f) The need to act fairly as between members of the company. 

The Group’s Board currently consists of four Non-Executive Directors, 
and two Executive Directors. The Board considers it collectively has an 
appropriate balance of skills and experience, as well as an appropriate 
balance of personal qualities and capabilities to ensure that all decisions 
are made such that the impact toward the stakeholders is fairly and 
equal, so they too may benefit from the successful delivery of our plan. 

We define principal decisions as both those that have long-term 
strategic impact and are material to the Group, but also those that are 
significant to our key stakeholder groups. In making the following 
principal decisions, the Board considered the outcome from its 
stakeholder engagement, the need to maintain a reputation for high 
standards of business conduct and the need to act fairly between the 
members of the Company. 

Global graphene demand is expected to increase significantly over 
the next 10 years. The Group is well positioned to benefit from this 
market growth and to play a key role in its near-term development. 
The Group’s strategy is to target existing products and markets that can 
be significantly improved with the addition of Directa Plus products. 
The Company works with key partners, benefiting from their knowledge 
of the market, strong reputation and commercial channels. 

The Group is currently targeting two key markets (Environmental 
remediation and Textiles – including air and water filtration), currently 
at an advance stage of products and services commercialisation, and 
keeps developing and monitoring other verticals such as Composites, 
Lithium-Sulphur batteries, and Paints. 

The Group operates in a fast-changing environment, and it its currently 
reshaping its strategic plan with the support of external advisors. The 
Group will exploit the competitive advantage gained so far and it will 
prioritise the verticals with a faster commercial traction and higher 
financial returns. 

In December 2021 the Group raised £7 million of gross proceeds to: 

•

•

•

Fund specific projects in the two key existing verticals. A water 
treatment plant and absorbent materials to develop Grafysorber® and 
broaden the number of applications offered, and air and water filters 
to advance the application of Directa Plus’ G+® technology to non-
woven fabrics to confer antibacterial and antiviral properties; 

Keep investing in exploring and developing new growth 
opportunities, and 

Provide the balance sheet strength to support the Company and its 
subsidiaries in responding to significant new tenders currently in 
progress, and to provide additional liquidity for its general working 
capital purposes. 

Giulio Cesareo 
Chief Executive Officer 
4 May 2022

 
Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directors’ report

Directa Plus  
Annual Report & Accounts 2021 

21 

Principal activities 
Directa Plus is a technological Group pursuing the development of 
innovative manufacturing processes to produce and supply high 
quality engineered graphene-based products which can be used by 
third parties in a wide variety of industrial and commercial applications. 
With the acquisition of the majority stake in Setcar SA, completed in 
November 2019, Directa Plus entered the environmental service market 
with the aim to supply a complete range of services, from chemical 
analysis for waste identification to water and soil treatment, leveraging 
on the unique properties of the graphene-based products in our 
portfolio. The Group’s strategy is to partner with potential customers at 
an early stage and work with them to develop tailor-made graphene 
forms that have the desired morphology for each potential customer’s 
specific applications to enable them to capitalise on the high-
performance benefits of graphene. 

The Group’s main country of operation and place of business is Italy 
and its registered office address is 11-12 St. James’s Square, London, 
SW1Y 4LB, UK. Setcar is based in Romania, which is also its main 
country of operations, and its registered office address is 6 Gradinii 
Publice Street, 810022, Braila. 

Business and strategic review 
The information that fulfils the requirements of the strategic report and 
business review, including details of the results for the year ended 31 
December 2021, research and development, KPIs and the outlook for 
future years, are set out in the Chairman’s Statement, Chief Executive 
Officer’s Review and Chief Financial Officer’s Review on pages 2 to 17 
(The Strategic Report), and in this Directors’ Report, together with the 
description of principal risks and uncertainties. Going concern 
assessment is set out in the Corporate Governance report and is 
reported on page 27. Post balance sheet events are reported in Note 27. 

Dividends 
The Directors’ current intention is that for the foreseeable future, all future 
earnings at the Group level will be reinvested in the business in order to 
fund the ongoing growth strategy. In the future, if it is commercially 
prudent to do so, the Board may consider the payment of a dividend. 

Directors’ indemnity 
The Company has arranged appropriate Directors’ and officers’ 
insurance to indemnify the Directors against liability in respect of 
proceedings brought by third parties. Such provisions remain in force 
at the date of this report. 

Directors 
The following Directors held office as indicated below for the year 
ended 31 December 2021 and up to the date of signing this report 
(where not specifically mentioned): 

•
•
•

Sir Peter Middleton 
Giulio Giuseppe Cesareo 
Marco Ferrari (resigned from the BoD on 19 March 2021)

•

•
•
•

Giorgio Bonfanti (appointed as a board member on  
16 November 2021) 
David Michael Gann 
Neil William Warner 
Richard Hickinbotham 

Directors’ Remuneration and Interests 
The Directors’ Remuneration Report is set out on pages 28 to 29. It 
includes details of Directors’ remuneration, interests in the ordinary 
shares of the Company and share options. 

Corporate Governance 
The Chairman’s Corporate Governance Statement is set out on 
pages 24 to 27. 

Share Capital and Substantial shareholdings 
Details of the share capital of the Company as at 31 December 2021 are set 
out in Note 17 to the consolidated financial statements. At 31 December 
2021, a total of 66,032,126 ordinary shares were outstanding. The 
following Shareholders own 3% or more of the ordinary shares: 

                                                                                                                                                  Percentage of  
                                                                                                              Number of          issued ordinary 
Shareholder                                                                          ordinary shares                share capital 

Nant Capital / Patrick Soon-Shiong               18,963,652                        28.72 

Dompè Group                                                             8,091,873                        12.25 

Unicorn Asset Management                                 5,873,333                           8.89 

Dr. Jean Marc Droulers / 
Finanziaria Le Perray *                                            4,466,449                           6.76 

Galbiga Immobiliare S.r.l.**                                   3,958,228                           5.99 

Schroders Investment Management                3,857,247                           5.84 

Ruffer                                                                              2,406,666                           3.64 

* Finanziaria Le Perray S.p.A. is a company owned and controlled by Dr. Jean Marc Droulers. 
** Galbiga Immobiliare S.r.l. is a company owned and controlled by Giulio Cesareo, 

the CEO of Directa Plus. 

Risk management 
The Group’s financial risk management is discussed in Note 22 to the 
financial statements. The Directors continually considers how to 
identify and mitigate the key business risks. Directors ensure that the 
management of Company prides leadership and direction to 
employees so that our overall risk-taking activity is kept within the 
desired risk appetite. The Group’s tolerance for risk in the area of Health 
Safety and Environmental Protection (HSEP) is low. Directa Plus 
dedicates significant resources to managing and monitoring these 
risks on a daily basis. The following list considers those could have 
a serious adverse impact on Group’s performance.

®

22 

Directa Plus  
Annual Report & Accounts 2021 

Directors’ report 
continued

Risk

Mitigation and management strategy

Likelihood*

Impact (on 
the Group)**

Ukrainian conflict 
Directors are monitoring the conflict in Ukraine and 
assessing all the potential impacts on the Group’s 
business, and consequently re-adjusting – where 
necessary – its strategy and operational priorities. 
The Group will be likely impacted by inflation 
trends (as a consequence of the increase in energy 
and transportation costs) and, presumably, by 
some contracts slowdown.

Covid-19 
Covid 19 pandemic is materially affecting the 
worldwide market, causing a general deterioration 
of the economic outlook.

Changes in government policy and legal 
and regulatory compliance 
The Group operates in highly regulated industry 
(Environmental services and waste disposal) 
through its controlled subsidiaries Setcar SA. 
Any changes to government policy, standards 
or regulatory requirements could affect the 
Group’s operations and results.

M&A strategy and delivery 
Directa Plus, after the acquisition in 2019, considers 
that integration risks and issues could arise 
impacting the delivery of the expected benefit.

Technological risk 
Directa Plus operates in an industry where 
competitive advantage has a certain dependency 
on the technology adopted. It is possible that 
future technological development or potential 
substitute materials may affect the acceptance of, 
and the attribution of value to the Group’s 
graphene production technology and Group’s 
graphene based products.

Certain

Major

Certain

Moderate

The Group does not have any contracts with 
Russian or Ukrainian clients, or companies that 
could be subject to international sanctions. 
Moreover, the Group has c. 15-20 major long-term 
clients and additional c. 150-200 minor clients. 
The major clients’ business activity appears – 
in general – not to be currently at risk. 

Overall, Directors believe that the conflict will not 
affect the going concern of the Group, and – under 
certain circumstances – it will create some 
potential opportunities. In fact, the value increase 
of the oil and waste recovered or the opening of 
other kind of applications of G+® could have 
positive out-turns for the Group.

The Board and the Management are constantly 
monitoring the situation. Management has 
undertaken scenario based analysis on future 
financial projections. To mitigate the adverse effect 
of Covid-19 on revenues in 2020 Management 
decided to target the personal protective equipment 
market, leveraging on graphene G+® properties. 

In 2022 the health emergency is giving the first 
signs of slowdown, and the Company seems to 
have overcome the difficult macro-economic 
period with limited adverse effects.

Regulatory framework is constantly monitored 
by Management, trying to have prompt 
understanding of proposed changes.

Possible

Major

An integration plan and skilled resources have 
been deployed to manage the post-acquisition 
integration. Setcar has operated in the Group over 
the last two years and the Board of Directors 
believes that the integration has reached a good 
level of effectiveness. The Board of Directors is 
constantly considering how to improve the 
integration and is kept promptly up to date.

Directa Plus continually monitors the market and 
its competition and has resources to invest in 
technological development and product 
development as appropriate.

Unlikely

Moderate

Possible 

Critical

Intellectual property protection risks 
Failure to protect the Group’s IP may result in 
another party copying, using or taking advantage 
from Group’s proprietary content and technology 
without authorization. There may not be adequate 
protection for IP in every country in which the 
Group’s products are or will be made available.

The Group monitors scientific papers, news flow 
and graphene products brought to the market as 
far as reasonably possible and will take cost-
effective legal action if required. The Group is 
advised by suitably qualified and experienced 
patent agents and meetings with the patent 
agents are scheduled regularly.

Possible

Moderate

Key employees risks 
The Group depends upon the continued service 
and performance of the Executive Officers and key 
employees. The loss of the services of any of 
Executive Officers or other key employees could 
have an adverse impact on the Group’s operations, 
reputation and business activities. 

Risks is mitigated by providing share options to key 
employees, building a motivated management 
team, together with significant opportunities for 
carrier development. 

Possible 

Major

Change***

New

↓

→

↓

→

→

→

 
Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

23 

Risk

Mitigation and management strategy

Likelihood*

Impact (on 
the Group)**

Change***

Funding risk 
The Group’s growth requires access to funding. 
It is possible that the Group will need to raise extra 
capital in the future to continue to develop the 
Group’s business or to take advantage of future 
acquisition opportunities. No assurance can be 
given that any such additional financing will be 
available or that, if available, it will be available on 
terms favourable to the Group or to the Group’s 
shareholders.

Risk is mitigated by maintaining good 
relationships with the Group’s main shareholders. 
The Company successfully concluded a capital 
raise in December 2021. 

In addition, the Group has access to potential 
additional sources of debt funding with major Italian 
banks, which could lessen any further funding risk. 
In 2021 the Group raised €1m additional debt 
funding backed by the Italian Government.

* Unlikely, Possible, Likely, Certain 
** None, Minor, Moderate, Major, Critical 
*** Defines the direction on the change in the risk: new risk (New), risk increased (↑), risk decreased (↓), no change (→)

Possible

Major

→

The Group’s policies, procedures and practices used to identify, 
monitor and control a variety of risks may, in some cases, not be 
effective. The Group’s risk management methods rely on a combination 
of internally developed technical controls, standard practices, 
observation of market behaviour and human supervision. 

Annual general meeting 
The notice for the convening of the AGM 2022 together with the 
proposed resolutions will be contained in a Notice of AGM sent to all 
shareholders and available via the Company’s website. 

Statement of Directors responsibilities 
The Directors are responsible for preparing the annual report and the 
financial statements in accordance with applicable law and regulations. 

Company law requires the Directors to prepare financial statements for 
each financial year. Under that law the Directors have elected to 
prepare the Group and Company financial statements in accordance 
with the UK adopted international accounting standards. Under 
company law the Directors must not approve the financial statements 
unless they are satisfied that they give a true and fair view of the state of 
affairs of the Group and Company and of the profit or loss of the Group 
for that period. The Directors are also required to prepare financial 
statements in accordance with the rules of the London Stock Exchange 
for companies trading securities on the AIM. 

In preparing these financial statements, the Directors are required to: 

•

•

•

•

select suitable accounting policies and then apply them consistently; 

make judgements and estimates that are reasonable and prudent; 

state whether they have been prepared in accordance with UK 
adopted international accounting standards, subject to any material 
departures disclosed and explained in the financial statements; and 

prepare the financial statements on the going concern basis unless it 
is inappropriate to presume that the Group and the Company will 
continue in business.

The Directors are responsible for keeping adequate accounting records 
that are sufficient to show and explain the Company’s transactions and 
disclose with reasonable accuracy at any time the financial position of 
the Company and enable them to ensure that the financial statements 
comply with the Companies Act 2006. They are also responsible for 
safeguarding the assets of the Company and hence for taking reasonable 
steps for the prevention and detection of fraud and other irregularities. 

Website publication 
The Directors are responsible for ensuring the annual report and the 
financial statements are made available on the corporate website. 
Financial statements are published on the Company’s website in 
accordance with legislation in the United Kingdom governing the 
preparation and dissemination of financial statements, which may vary 
from legislation in other jurisdictions. The maintenance and integrity of 
the Company’s website is the responsibility of the Directors. The 
Director’s responsibility also extends to the ongoing integrity of the 
financial statements contained therein. 

Auditors 
Each of the persons who is a Director at the date of approval of this 
annual report confirms that: 

•

•

so far as the Director is aware, there is no relevant audit information 
of which the Company’s auditors are unaware; and 

the Director has taken all the steps that he ought to have taken as a 
Director in order to make himself aware of any relevant audit 
information and to establish that the Company’s auditors are aware 
of that information. 

This confirmation is given and should be interpreted in accordance 
with the provisions of Section 418 of the Companies Act 2006. 

BDO LLP have expressed their willingness to continue in office as 
auditors and a resolution to reappoint them will be proposed at the 
forthcoming Annual General Meeting. 

For and on behalf of the Board of Directors 

®

4 May 2022

 
24 

Directa Plus  
Annual Report & Accounts 2021 

Corporate governance report

Chairman’s corporate governance statement 
The Board of Directa Plus plc (the “Company”) fully supports good corporate governance and recognises that it enhances 
its decision-making processes by improving the success of the Company and increasing shareholder value over the 
medium to long-term. The Quoted Companies Alliance corporate governance code (the “QCA Code”) sets out a minimum 
best practice standard for small and mid-sized quoted companies, particularly AIM companies. The Company complies 
with the QCA Code and the Directors propose that the Company should continue to do so having regard to the Company’s 
size, board structure, stage of development and resources. There have been no significant changes in governance 
arrangements during the 2021 financial year. 

In 2020 we started a review process of the Company’s culture and how it is consistent with our strategy, objectives and 
business model. We have identified some opportunities of improvement in our daily operations. In 2021 we have focused 
our efforts on upgrading some operations in the accounting and finance division, which is playing a central role in facilitating 
the collaboration and alignment among all the Company’s divisions. In doing so, we have appointed a university professor 
as a consultant to support us in this process. In 2022 we are focusing our efforts in redesigning the sales and marketing 
division. In front of increasing opportunities ahead of us, but also increasing complexities, we have engaged a consulting 
company that will support us in better defining which are our strategic priorities, key verticals and products to dedicate most 
of our efforts. Compliance with each of the principles set out in the QCA code is summarized in this section. 

Role of the Chairman 
The Board as a whole is responsible for effective corporate governance. 
As Chairman of the Board, I have overall responsibility for the corporate 
governance arrangements of the Company in addition to ensuring 
that corporate governance arrangements are fully adopted within 
the Company. 

In addition, my role as Chairman is to lead the Board, ensuring its 
smooth running and the effective contribution of all Board members. 

Strategy and business model 
The Company’s business model, strategy and key markets are set out in 
the Chief Executive Officer’s review on pages 10 to 15. 

Relations with shareholders 
The Chief Executive Officer and Chief Financial Officer are responsible 
for shareholder liaison and have regular dialogue with institutional 
investors in order to develop an understanding of their views. 

Meetings with analysts and institutional shareholders of the Company 
take place following the interim and annual results announcements as 
well as on an ad hoc basis. These presentations are given by the Chief 
Executive Officer and the Chief Financial Officer, updating on relevant 
matters and in particular, on the progress of the Company in terms of its 
operational performance, financial and strategic direction. 

The Annual Report and accounts are published on the Company’s 
website, www.directa-plus.com, and can be accessed by shareholders 
and non-shareholders. Shareholders have the opportunity to meet 
members of the Board at the Annual General Meeting of the Company 
where Board members will be happy to respond to questions.

Due to the Covid-19 pandemic all the interactions with shareholders 
have been carried out through virtual meetings. However, this appears 
not to have interfered with the effectiveness of the discussions. 

The Board believes that its current approach to shareholder 
engagement is successful, based on the feedback received and the 
Proactive Investor interviews publicly available. In addition, as 
Chairman, I remain available to talk to shareholders whenever required. 

Stakeholder and social responsibilities 
The Board considers its key stakeholder groups to include: 

•

•

•

•

workforce – we are a responsible employer, compliant with relevant 
human resources legislation and recommended practices, as well as 
Health, Safety and Environmental Protection regulations. In 2020 the 
Covid-19 pandemic encouraged the Board to strengthen its security 
and health measures towards its employees and community in 
general. Being the pandemic still a serious threat at the time of this 
report, those measures have been carried out also in 2021. The Group 
implemented an anti-contamination protocol shared with all its 
employees, foreseeing the provision of protection tools, constant 
disinfection of all areas and common rooms, safety distancing and 
body temperature controls; 

customers – deep and wide relationships with our customers are 
crucial for the success of our business in developing novel solutions 
with our customers and in developing their next generation of products; 

suppliers – we aim to develop strong relationships with our suppliers 
based on trust, understanding and respect; and 

partners – we engage with commercial and scientific partners and we 
work with them to develop new applications, building strong and 
long-lasting relationships.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

25 

The Company obtains feedback from stakeholder groups by way of: 

•

•

•

•

informal meetings and consultation with employees’ representatives, 
and reports received through the Group’s Whistleblowing policy; 

regular meetings with main suppliers and undertaking a formal 
assessment at least once a year; 

formal survey sent at least once a year to the main customers to 
assess our level of service; and 

maintaining a social media presence in order to understand the 
sentiment of and obtain feedback from the our stakeholders. 

Directors 
The Directors continue to remain satisfied that the Board is well 
balanced and that the Directors possess the sufficient breadth of skills, 
relevant experience, variety of backgrounds and knowledge to ensure 
the Board functions appropriately, without being dominated by any 
one Director. Details of qualities and capabilities that each Director 
brings to the Board are added in the Director biography section. The 
Board acknowledges that there are currently no appointed female 
Directors, however, it will continue to review this moving forwards. 
Moreover, diversity will be strongly considered in further recruiting 
process ensuring the appropriate balance of the Board is developed. 

The Company has always considered the health and safety of people 
and environmental protection as top priorities. We take a proactive 
approach to health, safety and environmental protection by monitoring 
our production process and products and continuously reviewing our 
policies. Further information about the Company’s approach to 
sustainability is set out in the Health, Safety and Environmental 
Protection section of the Company’s website. 

Full biographies of each Director can be found on pages 18 and 19. 

The Board keeps under review the skills required to effectively pursue 
the Company’s strategy and discharge its duties. The Chief Financial 
Officer is also the Company Secretary; the Board does not feel that a 
full time Company Secretary is currently required but will keep this 
under review. 

Risk management 
The Directors are responsible for establishing and maintaining the 
Company’s system of internal control and reviewing its effectiveness. 
Pages 21 to 23 set out the Company’s approach to risk management 
and lists those risks which are considered to have a serious adverse 
impact on the Company’s performance. 

Page 27 includes additional information about the Company’s internal 
control system. 

The Board 
The primary function of the Board is to provide effective leadership and 
direction to enhance the long-term value of the Company to its 
shareholders and other stakeholders. The Board has overall 
responsibility for reviewing the strategic plans and performance 
objectives, financial plans and annual budget, key operational 
initiatives, major funding and investment proposals, financial 
performance reviews, and corporate governance practices. 

The Chief Executive ensures that the Directors’ knowledge is kept up to 
date on key issues and developments pertaining to the Group, its 
operational environment and to the Directors’ responsibilities as 
members of the Board. During the course of the year, Directors received 
updates from the Company Secretary and, if required, from external 
advisers on a number of corporate governance matters. 

The Board consists in two Executive Directors and four Non-Executive 
Directors. The Board considers all the Non-Executive Directors to be 
independent. 

The number of meetings attended by the Board are disclosed on 
page 26.

Board performance 
The Board continually reflects on its performance to identify potential 
areas for improvement. 

Ethical values and behaviours 
The Board is committed to ensuring the highest legal and ethical 
standards and acknowledges its responsibilities in relation to 
corporate governance. 

The Board has produced an Ethical Code which aims to ensure that the 
Company’s employees conduct themselves respectfully and honestly 
in all their dealings with other employees as well as third parties 
including clients, suppliers, public institutions, the media, competitors 
and legal authorities. 

Governance structure and processes 
Delivering growth and long-term shareholder value with effective and 
efficient decision-making is of high importance to the Board. 

There is a clear division of responsibilities between the Chairman, who 
is responsible for the effective leadership and smooth running of the 
Board, and the Chief Executive Officer who, with the other Executive 
Director, is responsible for the running of the Company. 

The Company has established an Audit Committee and a 
Remuneration Committee. Both committees meet at least twice a year. 
Details of both committees and a report of the activities undertaken 
during the 2021 financial year can be found on page 30.

®

26 

Directa Plus  
Annual Report & Accounts 2021 

Corporate governance report 
continued

Board 
The Board consists of two executive Director and four Non-Executive Directors. The Board considers all the Non-Executive Directors to be 
independent. The current members of the Board and their membership on the Board committees of the Company are as follows: 

                                                                                                                                                                                                                                                                                                               Board committees as 
                                                                                                                                                                        Board appointments                                                                                          Chairman or member 

                                                                                                                                                                             Non-                                                                               Non- 
                                                                                                                      Executive                         Executive                 Independent                  independent                                  Audit               Remuneration 
Name of Director                                                                                      Director                            Director                            Director                            Director                     Committee                     Committee 

Sir Peter Middleton                                                                                                            3                                3                                                         –                                   – 
Giulio Cesareo                                                                                3                                                                                                              –                                   – 
Giorgio Bonfanti                                                                            3                                                                                                              –                                   – 
David Michael Gann                                                                                                          3                                3                                       Member                    Member 
Neil William Warner                                                                                                           3                                3                                    Chairman                    Member 
Richard Hickinbotham                                                                                                     3                                3                                          Member                 Chairman 

The Board recognises the importance of ensuring the flow of complete, 
adequate and timely information on an ongoing basis to enable decisions 
to be made on an informed basis and to enable the Board to effectively 
discharge their duties and responsibilities. To allow Directors sufficient 
time to prepare for the meetings, all Board and board committee papers 
are distributed to Directors a week in advance of the meetings, with any 
additional material or information provided on request. Directors have 
unrestricted access to management and receive briefings from them, 
which enable the Directors to keep abreast of the latest developments. 
Furthermore, the Company has implemented the appropriate 
procedures to support Directors in obtaining independent professional 
advice at the expense of the Company as and when required. Directors 
receive regular updates in relation to changes in UK adopted accounting 
standard and regulation. 

Committees 
The Board has delegated certain functions to its two committees, the Audit 
Committee and the Remuneration Committee. These committees have 
their own written terms of reference and their actions are reported to and 

monitored by the Board. The Board accepts that while these committees 
have the authority to examine particular issues and will report back to the 
Board with their decisions and/or recommendations, the ultimate 
responsibility on all matters lies with the Board. The functions typically 
refer to the Nomination Committee currently remain with the Board. 

Time commitments 
The Directors devote a sufficient amount of time in order to discharge 
their duties to the Company both at and outside of Board Meetings. In 
order to ensure continue this commitment the Board meet at least 6 
times a year. In addition to the formal Board Meetings the Board will 
meet throughout the year as and when required for specific matters. 

The time commitments of the Non-executive Directors are carefully 
reviewed by the Board and it is noted that Peter Middleton, David Gann, 
Neil Warner and Richard Hickinbotham devote at least 2 days a month 
to the Company. Details of the Directors’ attendance at each of the 
scheduled Board and Committee Meetings for the 2021 financial year 
are listed below:

                                                                                                                                Board meetings                                             Audit Committee meetings                        Remuneration Committee meetings 

Name of Director                                                                                     No. held                 No. attended                           No. held                 No. attended                           No. held                 No. attended 

Sir Peter Middleton                                                                         9                                   9                              N/A                              N/A                              N/A                              N/A 

Giulio Cesareo                                                                                   9                                   9                              N/A                              N/A                              N/A                              N/A 

Giorgio Bonfanti                                                                               1                                   1                              N/A                              N/A                              N/A                              N/A 

Marco Ferrari                                                                                      2                                   2                              N/A                              N/A                              N/A                              N/A 

David Michael Gann                                                                       9                                   9                                   4                                   4                                   2                                   2 

Neil William Warner                                                                        9                                   9                                   4                                   4                                   2                                   2 

Richard Hickinbotham                                                                  9                                   9                                   4                                   4                                   2                                   2

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

27 

Internal control 
The Directors are responsible for establishing and maintaining the 
Company’s system of internal control and reviewing its effectiveness. 

The system of internal control is designed to manage, rather than 
eliminate, the risk of failure to achieve business objectives and can only 
provide reasonable but not absolute assurance against material 
misstatement or loss. 

The main features of the internal control system are as follows: 

•

•

•

Close management of the business by the Executive Director. There 
are clearly delineated approval limits throughout the Company and a 
well-defined organisational structure. Controls are monitored at the 
appropriate level; 

monthly management accounts are prepared and reviewed by the 
Board, including reviewing variances against prior months and 
against budgets; 

clear segregation of duties within the Company’s finance function 
help ensure the Company’s assets are safeguarded and that proper 
financial records are maintained; and 

•

a list of matters is reserved for the approval of the Board. 

The Company has adopted a share dealing code for the Directors and 
certain applicable employees, which is appropriate for a company 
whose shares are admitted to trading on AIM (particularly relating to 
dealing during close periods in accordance with Rule 21 of the AIM 
Rules for Companies) and the Company takes all reasonable steps to 
ensure compliance by the Directors and any relevant employees. 

Going concern 
The Group meets its working capital requirements through the receipt 
of revenues from the provision of its services and sale of products 
mainly in Europe, the management of capital and operating 
expenditure, from the working capital and other borrowing facilities 
available to it and from the issue of equity capital. 

The COVID-19 pandemic has had a significant, immediate impact on the 
global economies and on the operations and operational funding of 
participants in international supply chains. Moreover, the recent events 
in connection with the conflict in Ukraine constitute and additional 
cause of uncertainty on the macro-economic scenario that most likely 
will significantly affect the political and business environment. 

b) the inflation trend, mainly driven by the increase in the 

transportation and energy costs, could make pressures on the 
Group’s margins. However, a careful control and monitoring over the 
industrial administrative costs, and the fact that the Company has a 
relatively low energy consumption production process, could allow 
the Group not to be negatively affected. 

Management believes that the Group has the systems and protocols in 
place to address these challenges. At the date of approval of these 
financial statements it is not clear how long the current circumstances 
are likely to last and what the long-term impact will be. 

In December 2021 the Group successfully completed a £7m gross 
capital raise, fully subscribed by current and new investors, to deploy 
new projects with a high growth potential and sustain working capital. 
As of 31 December 2021, the Group had net assets of €16.03m (2020: 
€10.66m) and cash and cash equivalent of €11.13m (2020: €7.08m). 

The Directors prepare the 2 years plan 2022-2023 in order to ensure 
that they have sufficient liquidity in place in the business. In addition, 
the Directors, in formulating the plan and strategy for the future 
development of the business, considered even a stress scenario with 
a reduction in forecast revenues from c10% to 15%. The Group is 
projected to have the financial capacity to support its viability until at 
least the end of 2023. 

The Directors review regularly updates to the scenario planning such 
that it can put in place mitigating actions and maintain the viability of 
the company and will keep stakeholders informed as necessary. 

The Directors have taken steps to use the various support mechanisms, 
such us redundancy funds or equivalent and soft loan specifically 
foreseen by governments to support companies during the general 
global economy slowdown due to COVID-19. Moreover, the Directors 
consider several options in terms of regional and European grants able 
to provide funding in the following months to sustain the R&D activities. 

Having regard to the above, and based on their latest assessment of the 
budgets and forecasts for the business of the Company, the Directors 
consider that there are sufficient funds available to the Group and 
Company to enable it to meet its liabilities as they fall due for a period of 
not less than twelve months from the date of approval of the financial 
statements. The Directors therefore consider it appropriate to adopt the 
going concern basis of accounting in preparing the financial statements. 

The Directors are aware that the current situation could have an impact 
on the Group’s operations, as of today still difficult to assess. Further 
details of the current assessment of the impact on the business are set 
out in the strategic report. 

Sir Peter Middleton 
Non-Executive Chairman 
4 May 2022

Based on very recent projections, the Directors believe that: 

a) the demand for graphene products will be volatile, although the 

positive outlook and general market appetite is confirmed;

®

 
28 

Directa Plus  
Annual Report & Accounts 2021 

Directors’ remuneration report

The Company is not required to prepare a Directors’ remuneration 
report for each financial year and so the Company makes the following 
disclosure voluntarily. 

The Remuneration Committee is responsible for recommending the 
remuneration and other terms of employment for the Executive 
Directors of Directa Plus plc. 

In determining remuneration for the year, the committee has given 
consideration to the requirements of the QCA code. 

Remuneration policy 
The objective of the remuneration policy is to attract, retain and 
motivate high calibre executives to deliver outstanding shareholder 
returns and at the same time maintain an appropriate compensation 
balance with the other employees of the Group.

Directors’ remuneration 
The normal remuneration arrangements for Executive Directors consists of 
base salary, performance bonuses and other benefits as determined by 
the Remuneration Committee. Each of the Executive Directors has a 
service agreement that can be terminated at any time by either party 
giving notice, the length of such notice period being determined pursuant 
to the applicable National Collective Bargaining Agreement (NCBA), 
governed by Italian law, depending upon accrued length of service. 

Non-Executive Directors are remunerated solely in the form of Director 
fees determined by the Board and are not entitled to pensions, annual 
bonuses or employee benefits. Each of the Non-Executive Directors’ 
appointment may be terminated by either party giving three months’ 
prior written notice. 

Directors are not involved in specific discussions on their own 
remuneration. 

The remuneration of the Directors, in Euros, for the year ended 
31 December 2021 was as follows and is audited:

                                                                                                                                                                                                                                                   National                                                                                           Total  
                                                                                                                                                                                                                                                Insurance                                  Pension                       emoluments 
                                                                                                                                      Salary/Fees                                     Bonus                       contributions                       contributions                                         2021 
2021                                                                                                                                       €’000                                        €’000                                        €’000                                        €’000                                       €’000 

Non-Executive Chairman 
Sir Peter Middleton                                                                                        71                                        –                                        –                                        –                                     71 

Executive 
Giulio Cesareo                                                                                               292                                   129                                     11                                     95                                   527 
Giorgio Bonfanti*                                                                                           14                                     29                                        1                                        3                                     47 

Non-Executive 
David Gann                                                                                                       43                                        –                                        –                                        –                                     43 
Neil Warner                                                                                                       43                                        –                                        –                                        –                                     43 
Richard Hickinbotham                                                                                43                                        –                                        –                                        –                                     43 

Total                                                                                                                  506                                   158                                     12                                     98                                   774

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

29 

                                                                                                                                                                                                                                                   National                                                                                            Total  
                                                                                                                                                                                                                                                Insurance                                  Pension                        emoluments 
                                                                                                                                      Salary/Fees                                     Bonus                       contributions                       contributions                                         2020 
2020                                                                                                                                       €’000                                        €’000                                        €’000                                        €’000                                        €’000 

Non-Executive Chairman 
Sir Peter Middleton                                                                                        56                                        –                                        –                                        –                                     56 

Executive 
Giulio Cesareo                                                                                               291                                   111                                     11                                     82                                   495 
Marco Ferrari**                                                                                              133                                     15                                        8                                     28                                   184 

Non-Executive 
David Gann                                                                                                       34                                        –                                        –                                        –                                     34 
Neil Warner                                                                                                       34                                        –                                        –                                        –                                     34 
Richard Hickinbotham                                                                                34                                        –                                        –                                        –                                     34 

Total                                                                                                                  582                                   126                                     19                                   110                                   837 

*    Giorgio Bonfanti was appointed as a Director on 16 November 2021. The emoluments shown refer to the period of Directorship between 16 November 2021 and 31 December 2021. 
**  Marco Ferrari resigned as a Director on 18 March 2021 

Total emoluments for Giulio Cesareo (CEO) increased by 6.5% over the prior year mainly due to an annual bonus award reflecting the achievement 
of both financial and personal objectives. Total emoluments for Giorgio Bonfanti (CFO) refer to the period of Directorship from 16 November 2021 
to the year end and include an annual bonus that is payable in respect of the period since joining the Company on 31 May 2021, assessed against 
financial and personal objectives. The CEO and CFO bonus payments represented 42% and 57% respectively of the maximum bonus opportunity. 

In June 2021, the Company increased the annual fees for Non-Executive Directors. The Chairman’s fee increased from £50,000 to £65,000 per year, 
while the other Non-Executive Directors received an increase in fees from £30,000 to £40,000 per year. This is the first increase in annual fees since 
the Company’s IPO in 2016 and followed a benchmarking exercise against companies of similar size and complexity. 

At 31 December 2021 Directors’ interest were the following: 

Directors’ interests 
                                                                                                                                                                                                                                                                                                 Number of                            Number of 
                                                                                                                                                                                                                                             Percentage                  vested ordinary             unvested ordinary  
                                                                                                                                                                                           Number of                                of issued                        shares under                        shares under  
Director                                                                                                                                                                 ordinary shares                        share capital                                     option                                     option 

Sir Peter Middleton                                                                                                                          51,333                                  0.08                          100,000                                        – 

Giulio Cesareo*                                                                                                                           3,958,228                                  5.99                          200,000                          400,000 

Giorgio Bonfanti                                                                                                                                          –                                        –                                        –                          150,000 

David Gann                                                                                                                                       121,693                                  0.18                             60,000                                        – 

Neil Warner                                                                                                                                         26,730                                  0.04                             60,000                                        – 

Richard Hickinbotham                                                                                                                100,000                                  0.15                             60,000                                        – 

*    Giulio Cesareo and his family are the sole beneficiaries of 3,863,589 ordinary shares held by Galbiga Immobiliare S.r.l. that are included in the above holding of ordinary shares. 

In aggregate, Non-Executive Directors hold a total of 280,000 vested ordinary shares under a previous share option plan, a legacy from the initial 
remuneration package assigned to Non-Executive Directors in the context of the Company’s IPO in 2016 and following the appointment of a 
Director in 2017. There have been no additional option awards under the NED share scheme which was subject only to market conditions, with 
an exercise price of 75 pence/share. The Remuneration Committee and the Board of Directors have no intention of issuing share options to 
Non-Executive Directors in the future.  

The terms of the share options plans in place are reported in Note 24. 

®

30 

Directa Plus  
Annual Report & Accounts 2021 

Audit Committee report

Membership 
The Board has established an Audit Committee with the appropriate 
Terms of Reference, which is comprised of Neil Warner (chairman), 
David Gann and Richard Hickinbotham. The Committee reports to the 
Board in respect of its responsibilities. 

Responsibilities 
The Committee met four times in 2021 to discuss its ongoing 
responsibilities, including such matters as the existing risk 
management and internal control systems in place, its financial 
reporting obligations and external audit findings. 

An outline of the key responsibilities undertaken by the Committee 
in the year are set out below: 

•

•

•

•

•

•

review of the Annual and Interim Accounts; 

review of the Auditor’s Report and meeting with the Auditor; 

review of the going concern assumption in line with management’s 
cash flow forecasts; 

performance of sensitivity analysis on the assumptions included 
within the forecast; 

matching results against management forecasts for the year ended 
31 December 2021; and 

meeting with management to discuss the Directors’ plans for future 
actions in relation to its going concern assessment, taking into 
account any relevant events subsequent to the balance sheet date.

Internal Controls 
The Committee continues to monitor and review the Company’s 
financial reporting and internal control procedures. It has been 
concluded that a separate internal audit function is not justified at this 
time because of the size and scope of the Company’s business 
activities. However, as the company continues to grow the need for 
this function will be regularly assessed. 

External Audit 
The Board understands the importance of engaging with the external 
auditors and in order to support this relationship the external auditor is 
invited to attend at least one meeting of the Audit Committee each year. 

The Committee maintains the responsibility of making 
recommendations to the Board in respect of the appointment, 
reappointment and removal of the external auditors. In the 
reappointment of the Committee the Board carefully considers their 
performance in discharging the audit, the terms of engagement, 
and their independence. 

Neil Warner 
Chair of the Audit Committee

 
Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Remuneration Committee report

Directa Plus  
Annual Report & Accounts 2021 

31 

Membership 
The Board has established a Remuneration Committee with approved 
Terms of Reference, which is comprised of Richard Hickinbotham 
(Chairman), Neil Warner, and David Gann. The Committee reports to 
the Board in respect of its responsibilities. 

Responsibilities 
The Committee met twice in 2021 to discuss its ongoing 
responsibilities, including such matters as recommendations to the 
Board on all aspects and policies relating to the remuneration of 
Executive Directors and Senior Managers of the Company. 

An outline of the key responsibilities undertaken by the Committee 
in the year are set out below: 

•

•

•

•

The setting of financial and personal performance targets for the 
Executive Directors and Senior Managers of the Company; 

Approval of annual bonus awards, determined against Company 
(60% of total) and individual performance targets (40% of total); 

An annual review of remuneration for all Executive Directors and 
Senior Managers of the Company; and 

Approval of the grant of awards for an Executive Director of 
the Company under the 2020 Employees’ Share Scheme. 

Richard Hickinbotham 
Chair of the Remuneration Committee

®

 
32 

Directa Plus  
Annual Report & Accounts 2021 

Independent auditor’s report 
to the members of Directa Plus Plc

Opinion on the financial statements 
In our opinion: 

•

•

•

the financial statements give a true and fair view of the state of the 
Group’s and of the Parent Company’s affairs as at 31 December 2021 
and of the Group’s loss for the year then ended; 

the Group financial statements have been properly prepared in 
accordance with UK adopted international accounting standards; 

the Parent Company financial statements have been properly 
prepared in accordance with UK adopted international accounting 
standards and as applied in accordance with the provisions of the 
Companies Act 2006; and 

•

the financial statements have been prepared in accordance with the 
requirements of the Companies Act 2006. 

We have audited the financial statements of Directa Plus Plc (the 
‘Parent Company’) and its subsidiaries (the ‘Group’) for the year ended 
31 December 2021 which comprise the Consolidated Statement of 
Comprehensive Income, the Consolidated and Company Statement of 
Financial Position, the Consolidated Statement of Changes in Equity, 
the Company Statement of Changes in Equity, the Consolidated and 
Company Statement of Cash Flows and notes to the financial 
statements, including a summary of significant accounting policies. 
The financial reporting framework that has been applied in their 
preparation is applicable law and UK adopted international accounting 
standards and, as regards the Parent Company financial statements, as 
applied in accordance with the provisions of the Companies Act 2006. 

Basis for opinion 
We conducted our audit in accordance with International Standards on 
Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under 
those standards are further described in the Auditor’s responsibilities 
for the audit of the financial statements section of our report. We 
believe that the audit evidence we have obtained is sufficient and 
appropriate to provide a basis for our opinion. 

Independence 
We remain independent of the Group and the Parent Company in 
accordance with the ethical requirements that are relevant to our audit 
of the financial statements in the UK, including the FRC’s Ethical 
Standard as applied to listed entities, and we have fulfilled our other 
ethical responsibilities in accordance with these requirements.

Conclusions relating to going concern 
In auditing the financial statements, we have concluded that the 
Directors’ use of the going concern basis of accounting in the preparation 
of the financial statements is appropriate. Our evaluation of the Directors’ 
assessment of the Group and the Parent Company’s ability to continue 
to adopt the going concern basis of accounting included: 

•

•

•

•

•

•

Critically assessing the Directors’ going concern assessment, 
including the reasonableness of assumptions applied, specifically 
the revenue growth year on year, gross margins, working capital 
movements and downside stress case sensitivities using both our 
underlying knowledge of the business and with regard to scenarios 
being applied across the market. 

Challenging the potential impact of the Ukrainian conflict on going 
concern with the Directors and the Audit Committee including the 
impact on operations to date and their assessment of continued risks 
and uncertainties associated with areas such as the ability to obtain 
new revenue contracts in the pipeline, deliver into those contracts to 
realise the forecast operating results and maintain margins, meet 
committed spend and repay loan interest and principle as and when 
they fall due. We considered this against our own assessment of risks 
and uncertainties developed through our understanding of the 
business and the sector. 

Agreeing the opening cash position of the Group to support the 
opening cash position applied by Directors in their cash flow forecast. 

Comparing performance against budget in FY2021 and FY2022 year 
to date to assess the quality of the Directors’ budgeting process. 

Considering the key sensitivities applied in the cash flow model 
pertaining to revenue and cost base in regards to current trading since 
January 2022, the overall contract pipeline in place and management 
of the Group’s and Parent Company’s cost base. 

Assessing the completeness and accuracy of the matters covered in 
the going concern disclosure with reference to the Directors’ going 
concern assessment. 

Based on the work we have performed, we have not identified any 
material uncertainties relating to events or conditions that, individually 
or collectively, may cast significant doubt on the Group and the 
Parent Company’s ability to continue as a going concern for a period 
of at least twelve months from when the financial statements are 
authorised for issue. 

Our responsibilities and the responsibilities of the Directors with 
respect to going concern are described in the relevant sections of 
this report.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Overview 

Coverage

Key audit 
matters

•
•
•

99% (2020: 99%) of Group profit before tax 
100% (2020: 100%) of Group revenue 
97% (2020: 98%) of Group total assets 

                                                                                         2021          2020 

Revenue Recognition                                    X              X 

Going Concern                                                                  X 

Going Concern is no longer considered to be a 
key audit matter following the fundraise in 
December 2021 and our risk assessment.

Materiality

Group financial statements as a whole 
2021: €129,000 based on 1.5% of revenue. 
(2020: €210,000 based on 2% of net assets)

An overview of the scope of our audit 
Our Group audit was scoped by obtaining an understanding of the 
Group and its environment, including the Group’s system of internal 
control, and assessing the risks of material misstatement in the 
financial statements. We also addressed the risk of management 
override of internal controls, including assessing whether there was 
evidence of bias by the Directors that may have represented a risk 
of material misstatement. 

The Group comprises of the UK Parent Company and a number of 
subsidiaries, which are incorporated in Italy and Romania. Full scope 
audits were performed over the Group’s significant components 
comprising Directa Plus PLC, Directa Plus S.p.A and Sectar S.A. Specific 
audit procedures on significant risks were carried out on Directa Textiles 
Solutions Srl by a local BDO network member firm in Italy under our 
instructions. The audits of the Italian and Romanian significant 
components were performed in Italy and Romania respectively by local 
BDO network member firms. The audits of the Parent Company and 
Group consolidation were performed in the United Kingdom by the 
Group audit team. The procedures performed in these audits provided 
the coverage set out in the table above. 

Directa Plus  
Annual Report & Accounts 2021 

33 

The remaining component of the Group was considered non-significant 
and its financial information was principally subject to analytical review 
procedures and obtaining bank confirmations which was performed by 
the Group audit team. 

Our involvement with component auditors 
For the work performed by component auditors, we determined the 
level of involvement needed in order to be able to conclude whether 
sufficient appropriate audit evidence has been obtained as a basis for 
our opinion on the Group financial statements as a whole. Our 
involvement with component auditors included the following: 

•

•

•

The Group audit team was actively involved in the direction and 
supervision of the audits performed by the component auditors 
along with the consideration of findings and determination of 
conclusions drawn; 

As part of our audit strategy, we issued detailed group instructions 
to component auditors detailing the our risk assessment and audit 
procedures to be performed; 

We held virtual meetings with management and component 
auditors during the planning and execution phases of the audit as 
well as held clearance meetings; and 

•

We performed a detailed review of the component auditor 
working papers. 

Key audit matters 
Key audit matters are those matters that, in our professional 
judgement, were of most significance in our audit of the financial 
statements of the current period and include the most significant 
assessed risks of material misstatement (whether or not due to fraud) 
that we identified, including those which had the greatest effect on: 
the overall audit strategy, the allocation of resources in the audit, and 
directing the efforts of the engagement team. These matters were 
addressed in the context of our audit of the financial statements as a 
whole, and in forming our opinion thereon, and we do not provide a 
separate opinion on these matters.

®

34 

Directa Plus  
Annual Report & Accounts 2021 

Independent auditor’s report 
continued

Key audit matter

How the scope of our audit addressed the key audit matter

Revenue recognition 
The applicable accounting policies are detailed in note 1 (j) and disclosures in note 3. 

The Group earned revenue of €8.6m (2020: €6.4m) in the year ended 
31 December 2021. 

A significant portion of the revenue generated relates to two 
components, Directa Plus S.p.A and Setcar S.A. 

In accordance with applicable auditing standards, revenue recognition 
was presumed to be a matter giving rise to significant risk of material 
misstatement in the financial statements. This consideration was 
further heightened by the fact that there are various revenue streams, 
being the sale of goods and the provision of environmental services, 
which exist within the Group as well as the wide geographic 
dispersion of sales. 

Due to the fact that there are multiple revenue streams and revenue is 
recognised both at a point in time and over time, revenue recognition 
represented a significant audit risk and a key focus area for our audit.

Our procedures included the following: 

•

•

•

•

In respect of Directa Plus S.p.A., we agreed a sample of sales in the 
year to sales invoices issued to customers and goods delivery notes 
and site acceptance sign offs to check revenue was recognised 
appropriately. 

In respect of Sectar S.A., we reviewed the key revenue contracts to 
check that the underlying performance obligations has been 
appropriately accounted for according to the Group’s revenue 
recognition policy by agreeing to the confirmation of services 
performed from the customer. 

In respect of the sale of residual goods by Setcar S.A. we agreed a 
sample of sales in the year to sales invoices issued to customers and 
goods delivery notes to check revenue was recognised appropriately. 

We selected a sample of recorded sales from either side of the year-
end for purposes of cut-off testing and agreed these to sales invoices, 
transport and delivery documents, site acceptance sign off and 
customer confirmation of service completed, as applicable, to 
check that sales were recognised in the correct period. Contract 
terms were reviewed to determine whether the point in time sales 
made around the year end should be recognised at the port of 
departure or port of arrival. 

Inspected a sample of credit notes issued during the year and post 
year end, and agreed this to the related revenue documentation to 
check that where this related to revenue for the current year, it was 
appropriately adjusted for.

Key observations 

Based on our procedures performed we did not identify any matters to suggest that the recognition of revenue was not appropriate.

Our application of materiality 
We apply the concept of materiality both in planning and performing 
our audit, and in evaluating the effect of misstatements. We consider 
materiality to be the magnitude by which misstatements, including 
omissions, could influence the economic decisions of reasonable users 
that are taken on the basis of the financial statements. 

Importantly, misstatements below these levels will not necessarily be 
evaluated as immaterial as we also take account of the nature of 
identified misstatements, and the particular circumstances of their 
occurrence, when evaluating their effect on the financial statements 
as a whole. 

In order to reduce to an appropriately low level the probability that any 
misstatements exceed materiality, we use a lower materiality level, 
performance materiality, to determine the extent of testing needed. 

Based on our professional judgement, we determined materiality 
for the financial statements as a whole and performance materiality 
as follows:

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

35 

Group financial statements

Parent company financial statements

2021

Materiality

€129,000

2020

€210,000

2021

€55,000

2020

€120,000

Basis for determining 
materiality

Rationale for the 
benchmark applied

Performance 
materiality

Basis for determining 
performance 
materiality

1.5% of revenue

2% of net assets

Revenue has been selected 
as we consider it to be the 
most relevant benchmark 
as the Group has entered 
into mainstream trading 
and service related 
business activities.

Net assets had been 
selected as we considered 
it to be the most relevant 
benchmark as the Group 
was still in a development 
stage and the net assets 
benchmark reflected 
a key measure of 
shareholder value.

2% of net assets capped 
at 43% of Group 
Materiality

2% of net assets capped 
at 57% of Group 
Materiality

Directa Plus Plc is a holding company with investments 
in subsidiaries. We have therefore considered net assets 
to be the most appropriate benchmark. 

Materiality was capped at a percentage of Group 
materiality given the assessment of aggregation risk. 

€100,000

€160,000

€41,000

€90,000

75% of materiality and considering factors such as the nature of activities and historic audit adjustments.

Component materiality 
We set materiality for each component of the Group based on a 
percentage of between 43% and 93% of Group materiality dependent 
on the size and our assessment of the risk of material misstatement of 
that component. Component materiality ranged from €55,000 to 
€120,000. In the audit of each component, we further applied 
performance materiality levels of 75% of the component materiality to 
our testing to ensure that the risk of errors exceeding component 
materiality was appropriately mitigated. 

Reporting threshold 
We agreed with the Audit Committee that we would report to them all 
individual audit differences in excess of €3,000 (2020: €5,000). We also 
agreed to report differences below this threshold that, in our view, 
warranted reporting on qualitative grounds.

Other information 
The Directors are responsible for the other information. The other 
information comprises the information included in the Consolidated 
financial statements other than the financial statements and our auditor’s 
report thereon. Our opinion on the financial statements does not cover 
the other information and, except to the extent otherwise explicitly stated 
in our report, we do not express any form of assurance conclusion 
thereon. Our responsibility is to read the other information and, in doing 
so, consider whether the other information is materially inconsistent with 
the financial statements or our knowledge obtained in the course of the 
audit, or otherwise appears to be materially misstated. If we identify such 
material inconsistencies or apparent material misstatements, we are 
required to determine whether this gives rise to a material misstatement 
in the financial statements themselves. If, based on the work we have 
performed, we conclude that there is a material misstatement of this 
other information, we are required to report that fact. 

We have nothing to report in this regard.

®

36 

Directa Plus  
Annual Report & Accounts 2021 

Independent auditor’s report 
continued

Other Companies Act 2006 reporting 
Based on the responsibilities described below and our work performed 
during the course of the audit, we are required by the Companies Act 
2006 and ISAs (UK) to report on certain opinions and matters as 
described below.

Strategic report 
and Directors’ 
report

In our opinion, based on the work undertaken in 
the course of the audit: 

•

•

the information given in the Strategic report 
and the Directors’ report for the financial year 
for which the financial statements are prepared 
is consistent with the financial statements; and 

the Strategic report and the Directors’ report 
have been prepared in accordance with 
applicable legal requirements. 

In the light of the knowledge and understanding 
of the Group and Parent Company and its 
environment obtained in the course of the audit, 
we have not identified material misstatements 
in the strategic report or the Directors’ report.

Matters on which 
we are required 
to report by 
exception

We have nothing to report in respect of the 
following matters in relation to which the 
Companies Act 2006 requires us to report to 
you if, in our opinion: 

•

•

•

•

adequate accounting records have not been 
kept by the Parent Company, or returns 
adequate for our audit have not been received 
from branches not visited by us; or 

the Parent Company financial statements are 
not in agreement with the accounting records 
and returns; or 

certain disclosures of Directors’ remuneration 
specified by law are not made; or 

we have not received all the information and 
explanations we require for our audit.

Responsibilities of Directors 
As explained more fully in the Statement of Directors’ responsibilities, 
the Directors are responsible for the preparation of the financial 
statements and for being satisfied that they give a true and fair view, 
and for such internal control as the Directors determine is necessary 
to enable the preparation of financial statements that are free from 
material misstatement, whether due to fraud or error. 

In preparing the financial statements, the Directors are responsible for 
assessing the Group’s and the Parent Company’s ability to continue as 
a going concern, disclosing, as applicable, matters related to going 
concern and using the going concern basis of accounting unless the 
Directors either intend to liquidate the Group or the Parent Company 
or to cease operations, or have no realistic alternative but to do so. 

Auditor’s responsibilities for the audit 
of the financial statements 
Our objectives are to obtain reasonable assurance about whether the 
financial statements as a whole are free from material misstatement, 
whether due to fraud or error, and to issue an auditor’s report that 
includes our opinion. Reasonable assurance is a high level of 
assurance, but is not a guarantee that an audit conducted in 
accordance with ISAs (UK) will always detect a material misstatement 
when it exists. Misstatements can arise from fraud or error and are 
considered material if, individually or in the aggregate, they could 
reasonably be expected to influence the economic decisions of users 
taken on the basis of these financial statements. 

Extent to which the audit was capable of detecting 
irregularities, including fraud 
Irregularities, including fraud, are instances of non-compliance with laws 
and regulations. We design procedures in line with our responsibilities, 
outlined above, to detect material misstatements in respect of 
irregularities, including fraud. The extent to which our procedures are 
capable of detecting irregularities, including fraud is detailed below: 

•

•

•

Holding discussions with management and the audit committee to 
consider any known or suspected instances of non-compliance with 
laws and regulations or fraud identified by them; 

Gaining an understanding of the legal and regulatory framework 
applicable to the Group and the industry in which it operates, 
through discussion with management and the audit committee 
and our knowledge of the industry; 

Considering the significant laws and regulations of Italy, Romania 
and the UK to be those relating to the industry, financial reporting 
framework, tax legislation and the listing rules;

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

37 

A further description of our responsibilities is available on the Financial 
Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. 
This description forms part of our auditor’s report. 

Use of our report 
This report is made solely to the Parent Company’s members, as a 
body, in accordance with Chapter 3 of Part 16 of the Companies Act 
2006. Our audit work has been undertaken so that we might state to the 
Parent Company’s members those matters we are required to state to 
them in an auditor’s report and for no other purpose. To the fullest 
extent permitted by law, we do not accept or assume responsibility to 
anyone other than the Parent Company and the Parent Company’s 
members as a body, for our audit work, for this report, or for the 
opinions we have formed. 

Peter Acloque (Senior Statutory Auditor) 
For and on behalf of BDO LLP, Statutory Auditor 
London 
United Kindgom 

4 May 2022 

BDO LLP is a limited liability partnership registered in England and Wales 
(with registered number OC305127). 

•

•

•

•

•

•

•

•

Assessing the susceptibility of the Group’s financial statements to 
material misstatement, including how fraud might occur and 
determined these areas to be management override of control and 
the risk of fraud in revenue recognition; 

In response to the risk of fraud in revenue recognition, the procedures 
set out in the key audit matters section above; 

Testing the appropriateness of journal entries made through the year 
by applying specific criteria to detect possible irregularities and fraud 
and agreeing to supporting documentation; 

Performing a detailed review of the Group’s year-end adjusting entries 
and investigating any that appear unusual as to nature or amount and 
agreeing to supporting documentation; 

For significant and unusual transactions, particularly those occurring 
at or near year-end, obtaining evidence for the rationale of these 
transactions and the sources of financial resources supporting the 
transactions; 

Assessing whether the judgements made in accounting estimates 
were indicative of a potential bias; 

Reviewing minutes from board meetings of those charges with 
governance to identify any instances of non-compliance with laws 
and regulations; and 

Directing the work of the significant component auditors to ensure 
an assessment is performed on the extent of the components 
compliance with the relevant local and regulatory framework. 
Reviewing this work and work performed in respect of the above 
mentioned fraud risk areas and holding meetings with relevant 
internal management and external third parties to form our own 
opinion on the extent of Group wide compliance including any 
incidents of suspected and/or fraudulent activity. 

Our audit procedures were designed to respond to risks of material 
misstatement in the financial statements, recognising that the risk of 
not detecting a material misstatement due to fraud is higher than the 
risk of not detecting one resulting from error, as fraud may involve 
deliberate concealment by, for example, forgery, misrepresentations 
or through collusion. There are inherent limitations in the audit 
procedures performed and the further removed non-compliance with 
laws and regulations is from the events and transactions reflected in 
the financial statements, the less likely we are to become aware of it.

®

 
 
38 

Directa Plus  
Annual Report & Accounts 2021 

Consolidated statement of comprehensive income 
for the year ended 31 December 2021

                                                                                                                                                                                                                                                                                              31 Dec 2021                          31 Dec 2020 
                                                                                                                                                                                                                                                           Note                                                €                                                € 

Continuing operations 
Revenue                                                                                                                                                                                                     3                      8,615,098                       6,434,480 
Other income                                                                                                                                                                                       3/4                          831,405                          345,826 
Changes in inventories of finished goods and work in progress                                                                                                                     12,960                          213,229 
Raw materials and consumables used                                                                                                                                        6                    (3,634,311)                    (2,564,317) 
Employee benefits expenses                                                                                                                                                            7                    (4,296,955)                    (3,769,274) 
Depreciation and amortisation                                                                                                                                                11/12                    (1,543,567)                    (1,690,872) 
Other expenses                                                                                                                                                                                       8                    (3,516,424)                    (3,279,927) 

Results from operating activities                                                                                                                                                                        (3,531,794)                    (4,310,855) 

Finance Income                                                                                                                                                                                      9                          221,622                               1,175 
Finance expenses                                                                                                                                                                                   9                           (74,681)                       (347,707) 

Net finance costs                                                                                                                                                                                                               146,941                         (346,532) 

Loss before tax                                                                                                                                                                                                              (3,384,853)                    (4,657,387) 

Tax (expense)/income                                                                                                                                                                       10                           (44,620)                         124,414 

Loss after tax from continuing operations                                                                                                                                                     (3,429,473)                    (4,532,973) 

Loss of the year                                                                                                                                                                                                            (3,429,473)                    (4,532,973) 

Other comprehensive income items that will not be reclassified to profit or loss 
Defined Benefit Plan re-measurement gains and losses                                                                                                   20                             (6,457)                              7,821 

Other comprehensive income/(expense) for the year (net of tax)                                                                                                              (6,457)                              7,821 

Total comprehensive (expense)/income for the year                                                                                                                               (3,435,930)                    (4,525,152) 

Loss attributable to 
Owner of the Parent                                                                                                                                                                                                    (3,652,364)                    (4.195,011) 
Non-controlling interests                                                                                                                                                                                               222,891                         (337,962) 

                                                                                                                                                                                                                                              (3,429,473)                    (4,532,973) 
Total comprehensive (expense)/income attributable to: 
Owners of the Company                                                                                                                                                                                           (3,658,821)                    (4,187,190) 
Non-controlling interests                                                                                                                                                                                               222,891                         (337,962) 

                                                                                                                                                                                                                                              (3,435,930)                    (4,525,152) 

Loss per share 
Basic loss per share                                                                                                                                                                             23                                (0.06)                               (0.07) 
Diluted loss per share                                                                                                                                                                         23                                (0.06)                               (0.07) 

The notes on pages 42 to 70 form part of these financial statements.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

39 

Consolidated and Company statement of financial position 
for the year ended 31 December 2021

                                                                                                                                                                                                                  Group                                                                                     Company

                                                                                                                                                                                             31 Dec 21                               31 Dec 20                              31 Dec 21                               31 Dec 20 
                                                                                                                                                     Note                                                €                                                €                                                €                                                € 

Assets 
Intangible assets                                                                                              11                      1,792,277                       2,042,767                                        –                                        – 
Investments                                                                                                       13                                        –                                        –                   25,680,336                    23,680,336 
Property, plant and equipment                                                                12                      3,982,966                       4,209,267                                        –                                        – 
Other receivables                                                                                            14                          185,623                          140,649                                        –                                        – 

Non-current assets                                                                                                                 5,960,866                       6,392,683                   25,680,336                    23,680,336 

Inventories                                                                                                           5                      1,370,875                       1,375,947                                        –                                        – 
Trade and other receivables                                                                       14                      3,305,493                       2,857,460                          205,291                          166,262 
Cash and cash equivalent                                                                           16                   11,130,468                       7,080,492                      9,430,364                       4,283,625 

Current assets                                                                                                                         15,806,836                    11,313,899                      9,635,655                       4,449,887 

Total assets                                                                                                                               21,767,702                    17,706,582                   35,315,991                    28,130,223 

Equity 
Share capital                                                                                                     17                          205,393                          190,996                          205,393                          190,996 
Share premium                                                                                                17                   39,159,027                    31,395,612                   39,159,027                    31,395,612 
Foreign currency translation reserve                                                     17                           (23,109)                            (7,015)                                      –                                        – 
Retained earnings                                                                                           17                  (25,352,139)                 (21,824,229)                   (4,220,247)                    (3,573,130) 

Equity attributable to owners of Group                                                                    13,989,172                       9,755,364                   35,144,173                    28,013,478 

Non-controlling interests                                                                             17                      2,041,938                          906,885                                        –                                        – 

Total equity                                                                                                                              16,031,110                    10,662,249                   35,144,173                    28,013,478 

Liabilities 
Loans and borrowings                                                                                  18                      2,403,881                       1,017,716                                        –                                        – 
Lease liabilities                                                                                                 19                          463,047                          627,138                                        –                                        – 
Employee benefits provision                                                                     20                          500,535                          444,483                                        –                                        – 
Other payables                                                                                                 21                            64,357                             65,397                                        –                                        – 
Deferred tax liabilities                                                                                    15                            89,497                               8,423                                        –                                        – 

Non-current liabilities                                                                                                           3,521,317                       2,163,157                                        –                                        – 

Loans and borrowings                                                                                  18                            65,840                          981,065                                        –                                        – 
Lease liabilities                                                                                                 19                          217,537                          214,935                                        –                                        – 
Trade and other payables                                                                           21                      1,931,898                       3,685,176                          171,818                          116,745 

Current liabilities                                                                                                                     2,215,275                       4,881,176                          171,818                          116,745 

Total liabilities                                                                                                                           5,736,592                       7,044,333                          171,818                          116,745 

Total equity and liabilities                                                                                                21,767,702                    17,706,582                   35,315,991                    28,130,223 

The Company has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own 
statement of comprehensive income in these financial statements. The Company loss after tax for the year was €709,825 (2020: €956,408). 

The financial statements were approved and authorized for issue by the board and were signed on its behalf by: 

Giulio Cesareo 
Chief Executive Officer 
4 May 2022 

The notes on pages 42 to 70 form part of these financial statements.

®

 
 
40 

Directa Plus  
Annual Report & Accounts 2021 

Consolidated statement of changes in equity 
for the year ended 31 December 2021

                                                                                                                                                                                                                        Foreign 
                                                                                                                                                                                                                      currency                                                                                       Non-                                  
                                                                                                                                                           Share                    Share          translation              Retained                                          controlling                      Total 
                                                                                                                                                         capital             premium                 reserve               earnings                      Total               interests                   equity 
                                                                                                                                                                    €                              €                              €                              €                              €                              €                              € 

Balance at 31 December 2019                                                           190,512     31,395,612                4,147   (17,656,325)   13,933,946       1,240,194     15,174,140 

Total comprehensive (expense)/income for the year 
Loss of the year                                                                                                        –                         –                         –      (4,195,011)     (4,195,011)        (337,962)     (4,532,973) 
Total other comprehensive (expense)/income                                         –                         –                         –                7,821                7,821                         –                7,821 
Total comprehensive (expense)/income for the period                     –                         –                         –      (4,187,190)     (4,187,190)        (337,962)     (4,525,152) 
Capital raised                                                                                                       484                         –                         –                         –                    484                         –                    484 
Translation reserve                                                                                                 –                         –            (11,162)                       –            (11,162)                       –            (11,162) 
Share-based payment                                                                                          –                         –                         –             19,286             19,286                         –             19,286 
Increase in share capital of Directa Textile Solutions                              –                         –                         –                         –                         –                4,653                4,653 

Balance at 31 December 2020                                                           190,996     31,395,612               (7,015)  (21,824,229)      9,755,364           906,885     10,662,249 

Total comprehensive (expense)/income for the year 
Loss of the year                                                                                                        –                         –                         –      (3,652,364)     (3,652,364)          222,891      (3,429,473) 
Total other comprehensive (expense)/income                                         –                         –                         –               (6,457)             (6,457)                       –               (6,457) 
Total comprehensive (expense)/income for the period                     –                         –                         –      (3,658,821)     (3,658,821)          222,891      (3,435,930) 
Capital raised                                                                                                 14,397       8,306,293                        .-                         –       8,320,690                         –       8,320,690 
Expenditure related to the issuance of shares                                           –          (542,878)                       –                         –          (542,878)                       –          (542,878) 
Translation reserve                                                                                           (167)                       –            (16,094)                       –            (16,094)                       –            (16,094) 
Share-based payment                                                                                          –                         –                         –           130,910           130,910                         –           130,910 
Increase in share capital of Setcar                                                                   –                         –                         –                         –                         –           912,162           912,162 

Balance at 31 December 2021                                                           205,393    39,159,027           (23,109) (25,352,139)  13,989,172      2,041,938    16,031,110 

Company statement of changes in equity 
for the year ended 31 December 2021 

                                                                                                                                                                                                      Share                                       Share                                Retained                                         Total 
                                                                                                                                                                                                    capital                               premium                                 earnings                                      equity 
                                                                                                                                                                                                               €                                                €                                                €                                                € 

Balance at 31 December 2019                                                                                               190,512                    31,395,612                     (2,616,722)                   28,969,402 

Loss for the year                                                                                                                                           –                                        –                         (956,408)                       (956,408) 
Capital raised                                                                                                                                           484                                        –                                        –                                   484 
Expenditure related to the issuance of shares                                                                               –                                        –                                        –                                        – 
Share-based payment                                                                                                                              –                                        –                                        –                                        – 

Balance at 31 December 2020                                                                                               190,996                    31,395,612                     (3,573,130)                   28,013,478 

Loss for the year                                                                                                                                           –                                        –                         (709,825)                       (709,825) 
Capital raised                                                                                                                                     14,397                       8,306,293                                        –                       8,320,690 
Expenditure related to the issuance of shares                                                                               –                         (542,878)                                      –                         (542,878) 
Share-based payment                                                                                                                              –                                        –                             62,708                             62,708 

Balance at 31 December 2021                                                                                              205,393                   39,159,027                    (4,220,247)                  35,144,173 

The notes on pages 42 to 70 form part of these financial statements.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

41 

Consolidated and Company statement of cash flows 
for the year ended 31 December 2021

                                                                                                                                                                                                                  Group                                                                                     Company

                                                                                                                                                                                             31 Dec 21                               31 Dec 20                              31 Dec 21                               31 Dec 20 
                                                                                                                                                     Note                                                €                                                €                                                €                                                € 

Cash flows from operating activities 
Loss for the year before tax                                                                                                 (3,384,853)                    (4,657,387)                       (709,825)                       (956,408) 
Adjustments for: 
Depreciation                                                                                                      12                          994,021                       1,020,387                                        –                                        – 
Amortisation of intangible assets                                                            11                          549,547                          670,485                                        –                                        – 
Share-based payment expense                                                                  7                          130,910                             19,286                            62,708                                        – 
Finance income                                                                                                 9                        (221,622)                            (1,175)                       (211,056)                                (867) 
Finance expense                                                                                                                              56,524                          326,118                                   988                          227,367 
Interest of lease liabilities                                                                              9                            18,157                             21,589                                        –                                        – 

                                                                                                                                                        (1,857,316)                    (2,600,697)                       (857,185)                       (729,908) 
Increase/decrease in: 
– inventories                                                                                                                                         5,072                         (280,011)                                      –                                        – 
– trade and other receivables                                                                    14                        (493,008)                         179,292                           (39,029)                           37,142 
– trade and other payables                                                                                                 (1,207,601)                    (1,398,380)                           55,073                             33,047 
– provisions and employee benefits                                                                                       37,457                             24,844                                        –                                        – 

Net cash from operating activities                                                                                (3,515,396)                    (4,074,952)                       (841,141)                       (659,720) 

Cash flows from investing activities 
Interest received                                                                                                9                               1,616                               1,175                                        –                                   867 
Investment in intangible assets                                                                                            (299,056)                       (434,898)                                      –                                        – 
Investment in subsidiary                                                                             13                                        –                                        –                    (2,000,000)                    (2,500,000) 
Contingent consideration                                                                           21                        (572,268)                       (208,097)                                      –                                        – 
Acquisition of property, plant and equipment                                                              (767,719)                       (195,991)                                      –                                        – 

Net cash used in investing activities                                                                            (1,637,427)                       (837,811)                   (2,000,000)                    (2,499,133) 

Cash flows from financing activities 
Proceeds from Capital raise                                                                       17                      8,320,690                                   484                      8,320,690                                   484 
Expenditure related to the issuance of shares                                   17                        (542,878)                                      –                        (542,878)                                      – 
Interest paid                                                                                                        9                           (45,426)                          (45,647)                                (988)                            (2,148) 
New Borrowings                                                                                              18                      1,511,719                       1,874,243                                        –                                        – 
Repayment of borrowings                                                                          18                           (81,666)                       (360,164)                                      –                                        – 
Repayment of lease liabilities                                                                                                (179,646)                       (100,235)                                      –                                        – 

Net cash from/(used in) financing activities                                                              8,982,793                       1,368,681                      7,776,824                              (1,664) 

Net increase/(decrease) in cash and cash equivalent                                          3,829,970                     (3,544,082)                    4,935,683                     (3,160,516) 
Cash and cash equivalent at beginning of the year                                               7,080,492                    10,906,076                      4,283,625                       7,669,360 

Exchange (losses)/gains on cash and cash equivalents                                          220,006                         (281,502)                        211,056                         (225,219) 

Cash and cash equivalent at end of the year                                                          11,130,468                       7,080,492                      9,430,364                       4,283,625 

The notes on pages 42 to 70 form part of these financial statements.

®

 
42 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
for the year ended 31 December 2021

1. Basis of preparation 
a)  Statement of compliance 
These consolidated and Parent Company financial statements have been prepared in accordance with UK-adopted International Accounting 
Standards (IFRSs). The principal accounting policies are summarised below. They have all been applied consistently throughout the year and the 
preceding year, unless otherwise stated. 

All notes, except as otherwise indicated, are presented in Euros (“€”). 

I.  Going Concern 
As of 31 December 2021, the Group (including the Company) had net assets of €16.03m (2020: €10.66m) and cash and cash equivalent of €11.13m 
(2020: €7.08m). 

The Directors are aware that there is an ongoing need to monitor the cash flow requirements of the Company and Group for the upcoming months, 
particularly in light of the recent developments in the markets due to the COVID-19 pandemic, the recent war in Ukraine and inflation trends, which 
have had a significant, impact on global economies and more likely will affect the upcoming months. In this regard, the Group prepares annual 
budgets and forecasts in order to ensure that they have sufficient liquidity to meet liabilities and commitments as they fall due. The Directors 
regularly review updates to the scenario planning such that the Board can put in place appropriate mitigating actions within their control. 

Considering the recent capital raise undertaken in December 2021, which resulted in £7 million of additional gross funds, and based on the most 
recent cash flow projections, the Directors believe that the Group will have sufficient funds in place, up to a period of 12 months from the approval 
date of the financial statements, to meet liabilities as and when they fall due. Despite this, given the current global economic status, the Directors 
have carried out a downward sensitivity analysis stressing the base financial projections by applying a further material reduction in forecast 
revenues, and modelling mitigation or deferral of capital and operational expenditure within the control of Management and the Board. Based 
on these downward scenarios, the Directors believe that the Company will still have the funds to support the Group as a going concern until the 
end of 2023. 

The Directors therefore consider it appropriate to adopt the going concern basis of accounting in preparing the financial statements. 

b)  Basis of consolidation 
I.  Business combination 
The Group accounts for business combination using the acquisition method of accounting. The cost of the business combination is measured as 
the aggregate of the fair value of the assets acquired, liabilities incurred or assumed, and equity instruments issued. Costs attributable to the 
business combination are expensed as incurred. 

The acquiree’s identifiable assets and liabilities which meet the recognition conditions are recognised at the fair values at the acquisition date. 

Contingent liabilities are only included in the identifiable assets and liabilities of the acquiree where there is a present obligation at acquisition 
date that arises from past events and its fair value can be measured reliably. 

Any difference arising between the fair value and the tax base of the acquiree’s assets and liabilities that give rise to a taxable or deductible 
difference results in the recognition of a deferred tax liability or asset. 

Non-controlling interest arising from a business combination is measured at their share of the fair value of the assets and liabilities of the acquiree. 

Goodwill is not amortised, but it is tested on an annual basis for impairment. 

II.  Subsidiaries 
Where the Company has control over an investee, it is classified as a subsidiary. The Company controls an investee if all three of the following elements 
are present: power over the investee, exposure to variable returns from the investee, and the ability of the investor to use its power to affect those 
variable returns. Control is reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of control. 

The total comprehensive income of non-wholly owned subsidiaries is attributed to owners of the parent and to the non-controlling interests in 
proportion to their relative ownership interests.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

43 

1. Basis of preparation continued 

III.  Transactions eliminated on consolidation 
The consolidated financial statements present the results of the Company and its subsidiaries (“the Group”) as if they formed a single entity. 
Intercompany transactions and balances between Group companies are therefore eliminated in full. 

IV.  Non-controlling interest 
Non-controlling interest in the net assets of the consolidated subsidiaries are identified separately from the Group’s equity. Non-controlling 
interests consist of the amount of those interests at the date of the original business combination and the non-controlling shareholder’s share 
changes in equity since the date of the combination. The non-controlling interest’s share of losses, where applicable, are attributed to the non-
controlling interests irrespective of whether the non-controlling shareholders have a binding obligation and are able to make an additional 
investment to cover the losses. 

c)  Functional and presentation currency 
These financial statements are presented in Euro (“€”) and is considered by the Directors to be the most appropriate presentation currency to assist 
the users of the financial statements. The functional currency of the Company and of the Italian operating subsidiaries is Euro (“€”). The functional 
currency of the Romanian subsidiary is RON. 

d)  Use of estimates and judgements 
The preparation of the financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that 
affect the application of accounting policies and the reported amounts of assets and liabilities. The estimates and associated assumptions are 
based on historical experience and various other factors that are believed to be reasonable under the circumstances and the results of which form 
the basis of making judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may 
differ from these estimates. 

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which 
the estimates are revised if the revision affects only that period. 

Critical estimates and judgements that have the most significant effect on the amounts recognised in the financial statements and/or have a 
significant risk of resulting in a material adjustment within the next financial year are as follows. 

Estimates 
I.  Valuation of share based payments 
The estimation related to share based payment expenses includes the selection of an appropriate valuation option pricing model, consideration 
as to the inputs necessary for the valuation model chosen, and the estimation of the number of awards that will ultimately vest. Inputs subject to 
estimation relate to the future volatility of the share price which has been estimated based on the historical observed volatility from trading in the 
Company’s shares, over a historical period of time between the date of the grant and the date of exercise. Management has used a Monte-Carlo 
model to calculate the fair value of the awards which include market based performance conditions. Further disclosure of inputs relevant to the 
calculations is set out in Note 24 to the financial statements. 

II.  Carrying value of goodwill 
The carrying value of goodwill, and the cash generating units (CGUs) to which it relates, is assessed annually for impairment through comparing 
the recoverable amount to the CGU’s carrying value. The value in use calculations require estimates in relation to uncertain items, including 
management’s expectations of future revenue growth, operating costs, profit margins, operating cash flows and the discount rate applied. Future 
cash flows used in the value in use calculations are based on our latest two-year financial plans. Expectations about future growth reflect 
expectations of growth in the markets applicable to the Group. The future cash flows are discounted using a pre-tax discount rate that reflects 
current market assessments of the time value of money. The discount rate used is adjusted for the specific risk to the Group, including the 
countries to which cash flows will be generated. Further disclosure of evaluations is set out in Note 11 to the financial statements.

®

44 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

1. Basis of preparation continued 

III.  Valuation of inventory 
Inventories are stated at the lower of cost or net realisable value. The cost of inventories comprises of net prices paid for materials purchased, 
production labour cost and factory overhead. Net realisable value represents the estimated selling price less all estimated costs of completion and 
costs to be incurred in marketing, selling and distribution. Inventory provisions are recognised for slow-moving, obsolete or unsaleable inventory 
and are reviewed on a six-monthly basis. The valuation of Inventory includes key estimates and judgments made by Management including 
normal production capacity, market demand and selling opportunities. If actual demand or usage were to be lower than estimated, inventory 
provisions for excess or obsolete inventory may be required. 

2. Significant accounting policies 
a)  Functional currency 
The financial statements of each Group company are measured using the currency of the primary economic environment in which that company 
operates (the functional currency). The consolidated financial statements record the results and financial position of each Group company in Euro, 
which is the functional currency of the Company and the presentational currency for the consolidated financial statements. 

I.  Transaction and balances 
Transactions in foreign currencies are converted into the respective functional currencies at initial recognition, using the exchange rates at the 
transaction date. Monetary assets and liabilities at the end of the reporting period are translated at the rates ruling at the reporting date. Non-
monetary assets and liabilities are not retranslated. All exchange differences are recognised in profit or loss. On consolidation, the results of 
overseas operations not in Euro are translated at the rates approximating to those ruling when the transactions took place. All assets and liabilities 
of overseas operations are translated at the rate ruling at the reporting date. Exchange differences arising on translating the opening net assets at 
closing rate and the results of overseas operations at actual rate are recognised in other comprehensive income. 

b)  Financial instruments 
There are no other categories of financial assets other than those listed below: 

I.  Trade and other receivables and amounts due from subsidiaries 
Trade and other receivables and amounts due from subsidiaries are recognised and carried at the original invoice amount less any provision 
for impairment. 

The Group recognises a loss allowance for expected credit losses (“ECL”) on financial assets that are measured at amortised cost which comprise 
mainly of trade receivables. The amount of expected credit losses is updated at each reporting date to reflect changes in credit risk since initial 
recognition of the respective financial instrument. 

The Group always recognises lifetime ECL on trade receivables. The expected credit losses on these financial assets are estimated using a provision 
matrix based on the Group’s historical credit loss experience, adjusted for factors that are specific to the debtors, general economic conditions and an 
assessment of both the current as well as the forecast direction of conditions at the reporting date, including time value of money where appropriate. 

II.  Cash and cash equivalents 
Cash and cash equivalents comprise demand deposits with an original maturity of up to 3 months which are readily convertible to a known 
amount of cash and are subject to an insignificant risk of change in value. 

There are no other categories of financial liabilities other than those listed below: 

III.  Trade and other payables 
Trade payables are stated at their amortised cost. 

IV.  Financial liabilities and equity 
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. At initial 
recognition, financial liabilities are measured at their fair value, minus transaction costs that are directly attributable, and are subsequently 
measured at amortised cost. 

An equity instrument is any contract that evidences a residual interest in the asset of the Group after deducting all of its liabilities. Equity 
instruments issued by the Company are recorded at the proceeds received net of direct issue costs.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

45 

2. Significant accounting policies continued 

V.  Leases 
On commencement of a contract which gives the Group the right to use assets for a period of time in exchange for consideration, the Group recognises 
a right-of-use asset and a lease liability. The right-of-use asset is measured at cost, which is made up of the initial measurement of the lease liability, any 
initial direct costs incurred by the Group, an estimate of any costs to dismantle and remove the asset at the end of the lease, and any lease payment 
made in advance of the lease commencement date (net of any incentives received). The Group depreciates the right-of-use assets on a straight-line 
basis from the lease commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term. The Group also 
assesses the right-of-use asset for impairment when such indicators exist. At the commencement date, the Group measures the lease liability at the 
present value of the lease payment unpaid at that date, discounted using the interest rate implicit in the lease if that rate is readily available or the 
Group’s incremental borrowing rate. Lease payments included in the measurement of the lease liability are made up of fixed payments, variable 
payments based on an index or rate, amounts expected to be payable under a residual value guarantee and payments arising from options reasonably 
certain to be exercised. Subsequent to initial measurement, the liability will be reducing for payment made and increased for interest. It is remeasured 
to reflect any reassessment or modification, or if there are changes in in-substance fixed payments. When the lease liability is remeasured, the 
corresponding adjustment is reflected in the right-of-use asset, or profit and loss if the right-of-use asset is already reduced to zero. 

c)  Share capital 
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new shares or options are netted off against share premium. 

d)  Property, plant and equipment 
I.  Recognition and measurement 
Property, plant and equipment are measured at cost less accumulated depreciation, Government grants received (where applicable) and 
accumulated impairment losses. 

Costs capitalised include expenditure that are directly attributable to the acquisition of the asset. 

When parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items (major components) 
of property, plant and equipment. 

Any gain or loss on disposal of an item of property, plant and equipment (calculated as the difference between the net proceeds from disposal and 
the carrying amount of the item) are recognised in profit or loss. 

II.  Subsequent costs 
Subsequent expenditure is capitalised only when it is probable that the future economic benefits associated with the expenditure will flow to the 
Group. Ongoing repairs and maintenance are expensed as incurred. 

III.  Depreciation 
Items of property, plant and equipment are depreciated on a straight-line basis in the statement of comprehensive income over the estimated 
useful lives of each component. 

Items of property, plant and equipment are depreciated from the date that they are installed and are ready for use, or in respect of internally 
constructed assets, from the date that the asset is completed and ready for use. 

The estimated useful lives of significant items of property, plant and equipment are as follows: 

•

•

IT equipment from 3 to 5 years. 

Industrial equipment, office equipment and plant and machinery from 5 to 10 years. 

Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted where appropriate.

®

46 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

2. Significant accounting policies continued 

e)  Intangible assets 
Intangible assets are measured at cost less accumulated amortisation and Government grants received (where applicable). The carrying value of 
intangible assets is reviewed annually for impairment. 

Patent rights acquired and development expenditure are recognised at cost. 

Expenditure on internally developed products is capitalised if it can be demonstrated that: 

•

•

•

•

•

•

it is technically feasible to develop the product; 

adequate resources are available to complete the development; 

there is an intention to complete and sell the product; 

the Group is able to sell the product; 

sale of the product will generate future economic benefits; and 

expenditure on the project can be measured reliably. 

Capitalised development costs are amortised over the period the Group expects to benefit from selling the products developed (Useful Economic 
Life). The amortisation expense is included within the cost of sales in the consolidated statement of comprehensive income. 

Development expenditure not satisfying the above criteria and expenditure on the research phase of internal projects are recognised in the 
consolidated statement of comprehensive income as incurred. 

Capitalised development expenditure is measured at cost less accumulated amortisation and impairment losses. 

Other intangible assets that are acquired by the Group and have finite useful lives are measured at cost less accumulated amortisation and 
accumulated impairment losses. 

I.  Amortisation 
Intangible assets are amortised on a straight-line basis in profit or loss over their estimated useful lives, from the date that they are available for use. 
The estimated useful lives of significant intangible assets are as follows: 

•

•

•

•

Patents concerning G+® technology generate significant value to the Group over a period of 20 years, in line with the legal duration of the patent 
and their useful lives. However, on a conservative basis, such costs are amortised over a period of 10 years. 

Brand: 5 years. 

Development costs concerning personnel capitalised: 5 years. 

Others: 5 years. 

f)  Inventories 
Inventories are stated at the lower of cost or net realisable value. The cost of inventories comprises of net prices paid for materials purchased, 
production labour cost and factory overhead. Net realisable value represents the estimated selling price less all estimated costs of completion and 
costs to be incurred in marketing, selling and distribution. Inventory provisions are recognised for slow-moving, obsolete or unsaleable inventory 
and are reviewed on a six months basis. 

g)  Goodwill 
Goodwill represents the excess of the cost of a business combination over the Group’s interest in the fair value of identifiable assets, liabilities and 
contingent liabilities acquired. 

Cost comprises the fair value of assets given, liabilities assumed and equity instruments issued, plus the amount of any non-controlling interests 
in the acquiree plus, if the business combination is achieved in stages, the fair value of the existing equity interest in the acquiree. Contingent 
consideration is included in cost at its acquisition date fair value and, in the case of contingent consideration classified as a financial liability, 
remeasured subsequently through profit or loss. 

Goodwill is capitalised as an intangible asset with any impairment in carrying value being charged to the consolidated statement of 
comprehensive income. Where the fair value of identifiable assets, liabilities and contingent liabilities exceed the fair value of consideration paid, 
the excess is credited in full to the consolidated statement of comprehensive income on the acquisition date.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

47 

2. Significant accounting policies continued 

h)  Impairment 
Impairment tests on goodwill and other intangible assets with indefinite useful economic lives are undertaken annually at the financial year end. 
Other non-financial assets are subject to impairment tests whenever events or changes in circumstances indicate that their carrying amount may 
not be recoverable. For the purpose of impairment testing, assets are grouped together into the smallest group of assets that generates cash 
inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets (CGUs). The Group’s CGUs generally 
align with each subsidiary. The recoverable amount is then estimated. The recoverable amount of an asset or a CGU is the greater of its net present 
value and its fair value less costs to sell. 

Net present value is generally computed as the present value of the future cash flows, discounted to present value using a pre-tax discount rate that 
reflects current market assessments of the time value of money and the risks specific to the asset. 

An impairment loss is recognised if the carrying amount of an asset or a CGU exceeds its estimated recoverable amount. Impairment losses are 
recognised in profit or loss. Impairment losses recognised in respect of CGUs are allocated first to reduce the carrying amount of any goodwill 
allocated to the unit and then to reduce the carrying amounts of the other assets in the unit on a pro rata basis. 

An impairment loss in respect of goodwill is not reversed. In respect of other assets, impairment losses recognised in prior years are assessed at each 
reporting date for any indications that the loss has decreased or no longer exists. An impairment loss is reversed if there has been a change in the 
estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not 
exceed the carrying amount that would have been determined, net of depreciation and amortisation, if no impairment loss had been recognised. 

i)  Employee benefits 
Defined benefit scheme surpluses and deficits are measured at: 

•

•

•

•

the fair value of plan assets at the reporting date; less 

plan liabilities calculated using the projected unit credit method discounted to its present value using yields available on high quality corporate 
bonds that have maturity dates approximating to the terms of the liabilities; plus 

unrecognised past service costs; less 

the effect of minimum funding requirements agreed with scheme trustees. 

Remeasurements of the net defined obligation are recognised directly within equity. The remeasurements include: 

•

•

•

Actuarial gains and losses. 

Return on plan assets (interest exclusive). 

Any asset ceiling effects (interest exclusive). 

Service costs are recognised in profit or loss and include current and past service costs as well as gains and losses on curtailments. 

Net interest expense (income) is recognised in profit or loss and is calculated by applying the discount rate used to measure the defined benefit 
obligation (asset) at the beginning of the annual period to the balance of the net defined benefit obligation (asset), considering the effects of 
contributions and benefit payments during the period. 

Gains or losses arising from changes to scheme benefits or scheme curtailment are recognised immediately in profit or loss. 

Settlements of defined benefit schemes are recognised in the period in which the settlement occurs. 

For more information please see Note 20.

®

48 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

2. Significant accounting policies continued 

j)  Revenues 
The Group operates diverse businesses and accordingly applies different methods for revenue recognition, based on the principles set out in IFRS 15. 

The revenue and profits recognised in any reporting period are based on the delivery of performance obligations and an assessment of when 
control is transferred to the customer. In determining the amount of revenue and profits to record, and associated balance sheet items, 
management is required to review performance obligations within individual contracts. This may involve some judgemental areas. 

Revenue is recognised either when the performance obligation in the contract has been performed (so ‘point in time’ recognition) or ‘over time’ as 
control of the performance obligation is transferred to the customer. 

For each performance obligation to be recognised over time, the Group applies a revenue recognition method that faithfully depicts the Group’s 
performance in transferring control of the goods or services to the customer. This decision requires assessment of the real nature of the goods or 
services that the Group has promised to transfer to the customer. 

•

Revenues from sale of graphene based products are typically recognised at a point in time when goods are delivered to the customer as with this, 
the customer gains the right of control over the goods. However, for export sales, control might also be transferred when delivered either to the 
port of departure or port of arrival, depending on the specific terms of the contract with a customer. 

•

Revenues from sale of equipment (such as Mobile Production Units) are typically recognised at point in time when goods are delivered to the 
customers and site acceptance test is successfully performed. 

•

Revenues from services relates mainly to environmental services provided by Setcar which are recognised: 

– at a point in time basis when contracts include an obligation to process waste once the process occurred according with the contract in place; 

– at the point in time when the waste is delivered to our platform with no further performance obligations; and 

– over time in accordance with agreed project milestones being delivered. 

Where cost has been incurred to undertake a performance obligation but this has not been realised at the year end the attributable costs are 
carried forward as work in progress 

k)  Government grants 
Government grants are recognised when there is reasonable assurance that the entity will comply with the relevant conditions and the grant will 
be received. Grants are recognised in profit or loss on a systematic basis where the Group has recognised the initial expenses that the grants are 
intended to compensate. Where a grant has been received as a contribution for property, plant and equipment, or capitalised development costs, 
the income received has been credited against the asset in the statement of financial position. 

l)  Finance income and finance costs 
Finance income comprises interest income on funds invested. Interest income is recognised in the profit or loss, using the effective interest 
method. Finance costs comprise interest expense on borrowings. 

Borrowing costs that are not directly attributable to the acquisition, construction or production of a qualifying asset are recognised in profit or loss 
using the effective interest method. 

m)  Investments in subsidiaries (Company only) 
Investments are stated at their cost less any provision for impairment (for details refer to Note h). 

n)  Taxation 
Tax expense comprises current and deferred tax. Current and deferred tax is recognised in the profit or loss except to the extent that it relates to a 
business combination, or items recognised directly in equity or in other comprehensive income. 

Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at 
the reporting date, and any adjustment to tax payable in respect of previous years. 

Deferred tax is recognised in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting 
purposes and the amounts used for taxation purposes.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

49 

2. Significant accounting policies continued 

Deferred tax is not recognised for: 

•

•

temporary differences on the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither 
accounting nor taxable profit or loss; 

temporary differences related to investments in subsidiaries and jointly controlled entities to the extent that it is probable that they will not 
reverse in the foreseeable future; and 

•

taxable temporary differences arising on the initial recognition of goodwill. 

Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when they reverse, using tax rates enacted or 
substantively enacted at the reporting date. 

A deferred tax asset is recognised for deductible temporary differences to the extent that it is probable that future taxable profits will be available 
against which they can be utilised. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer 
probable that the related tax benefit will be realised. 

Adoption of new and revised standards 
New standards, interpretations and amendments effective from 1 January 2021 
The IFRS financial information has been drawn up on the basis of accounting policies consistent with those applied in the financial statements for 
the year to 31 December 2020, except for the following: 

•

Interest Rate Benchmark Reform – Amendment to IFRS 7, IFRS 9, IFRS 16 and IAS 39. 

The application of the above standards has had no impact on the disclosures or the amounts recognised in the Group’s consolidated financial 
statements. 

New standards, interpretations and amendments not yet effective 
There are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future 
accounting periods that the Group has decided not to adopt early. 

The following amendments are effective for the period beginning 1 January 2022: 

•

•

•

•

Onerous Contracts – Cost of Fulfilling a Contract (Amendments to IAS 37); 

Property, Plant and Equipment: Proceeds before Intended Use (Amendments to IAS 16); 

Annual Improvements to IFRS Standards 2018-2020 (Amendments to IFRS 1, IFRS 9, IFRS 16 and IAS 41); and 

References to Conceptual Framework (Amendments to IFRS 3). 

The following amendments are effective for the period beginning 1 January 2023: 

•

•

•

Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2); 

Definition of Accounting Estimates (Amendments to IAS 8); and 

Deferred Tax Related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12).

®

50 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

2. Significant accounting policies continued 

In January 2020, the IASB issued amendments to IAS 1, which clarify the criteria used to determine whether liabilities are classified as current or 
non-current. These amendments clarify that current or non-current classification is based on whether an entity has a right at the end of the 
reporting period to defer settlement of the liability for at least twelve months after the reporting period. The amendments also clarify that 
‘settlement’ includes the transfer of cash, goods, services, or equity instruments unless the obligation to transfer equity instruments arises from 
a conversion feature classified as an equity instrument separately from the liability component of a compound financial instrument. The 
amendments were originally effective for annual reporting periods beginning on or after 1 January 2022. However, in May 2020, the effective date 
was deferred to annual reporting periods beginning on or after 1 January 2023. In response to feedback and enquiries from stakeholders, in 
December 2020, the IFRS Interpretations Committee (IFRIC) issued a Tentative Agenda Decision, analysing the applicability of the amendments 
to three scenarios. However, given the comments received and concerns raised on some aspects of the amendments, in April 2021, IFRIC decided 
not to finalise the agenda decision and referred the matter to the IASB. In its June 2021 meeting, the IASB tentatively decided to amend the 
requirements of IAS 1 with respect to the classification of liabilities subject to conditions and disclosure of information about such conditions 
and to defer the effective date of the 2020 amendment by at least one year. The Group is currently assessing the impact of these new UK adopted 
accounting standards and amendments. The Group will assess the impact of the final amendments to IAS 1 on classification of its liabilities once 
the those are issued by the IASB. 

The Group does not believe that the amendments to IAS 1, in their present form, will have a significant impact on the classification of its liabilities, 
as the conversion feature in its convertible debt instruments is classified as an equity instrument and therefore, does not affect the classification 
of its convertible debt as a non-current liability. 

3. Operating segments 
IFRS 8 requires operating segments to be identified on the basis of internal reports about components of the Group that are regularly reviewed 
by the chief operating decision makers (CEO, CFO, COO and CTO), as defined in IFRS 8, in order to allocate resources to the segments and to 
assess its performance. 

For management purposes, also considering the materiality the Group is organized into the following segments: 

•

•

•

Textile. 

Environmental. 

Others. 

Textile and Environmental were considered by Management the strategic segments able to sustain the growth. Management’s strategic needs are 
constantly monitored and an update of the segments will be provided if required. Any further update of the segment analysis will be reflected in 
this section. 

Segment profit/(loss) represents the profit/(loss) earned by each segment, including all the direct costs that are directly correlated with the 
segment. Overhead, assets and liabilities not directly attributable to a specific segment have been allocated as Head Office. 

As the business evolves this is an area that will be assessed on a regular basis and additional segmental reporting will be provided at the 
appropriate time.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

51 

3. Operating segments continued 

                                                                                                                                                 Textile                   Environmental                                    Others                          Head office                      Consolidated 
2021                                                                                                                                               €                                                €                                                €                                                €                                                € 

Revenue                                                                                              1,843,506                      6,560,771                          210,821                                        –                      8,615,098 
Cost of sales*                                                                                  (1,002,845)                   (3,030,602)                      (107,310)                                      –                    (4,140,757) 

Gross profit                                                                                          840,661                    (3,530,169)                        103,511                                        –                      4,474,341 

Other income                                                                                       174,484                          607,049                                        –                            49,872                          831,405 
Other expenses: 
– R&D expense                                                                                   (317,422)                         (45,450)                         (25,966)                                      –                        (388,838) 
– Advisory                                                                                               (50,004)                      (481,992)                                      –                        (887,722)                   (1,419,718) 
– Operating expenses                                                                     (536,615)                   (2,519,008)                      (135,782)                   (2,294,012)                   (5,485,417) 
– Depreciation and amortisation                                              (331,492)                   (1,177,445)                         (34,630)                                      –                    (1,543,567) 

Operating loss                                                                                   (220,388)                         (86,677)                         (92,867)                   (3,131,862)                   (3,531,794) 

Net financial costs                                                                                            –                                        –                                        –                          146,941                          146,941 
Tax                                                                                                                           –                           (44,620)                                      –                                        –                           (44,620) 

Loss of the year                                                                                 (220,388)                      (131,297)                         (92,867)                   (2,984,921)                   (3,429,473) 

Total assets                                                                                       5,642,443                   15,086,933                      1,038,326                                        –                   21,767,702 

Total liabilities                                                                                  1,746,301                      3,739,745                          250,546                                        –                      5,736,592 

                                                                                                                                                 Textile                    Environmental                                     Others                           Head office                       Consolidated 
2020                                                                                                                                               €                                                €                                                €                                                €                                                € 

Revenue                                                                                               1,943,924                       4,360,864                          129,692                                        –                       6,434,480 
Cost of sales*                                                                                    (1,221,579)                    (1,971,859)                          (74,872)                                      –                     (3,268,310) 

Gross profit                                                                                           722,345                       2,389,005                             54,820                                        –                       3,166,170 

Other income                                                                                          85,980                          204,450                             27,206                             28,189                          345,826 
Other expenses: 
– R&D expense                                                                                      (96,915)                          (25,500)                                      –                                        –                         (122,415) 
– Advisory                                                                                                (50,752)                       (335,248)                                      –                         (905,021)                    (1,291,022) 
– Operating expenses                                                                  (1,332,294)                    (2,214,108)                       (138,874)                    (1,033,266)                    (4,718,541) 
– Depreciation and amortisation                                               (508,331)                    (1,143,250)                          (39,291)                                      –                     (1,690,872) 

Operating loss                                                                                (1,179,967)                    (1,124,652)                          (96,138)                    (1,910,098)                    (4,310,855) 

Financial costs                                                                                                   –                                        –                                        –                         (346,532)                       (346,532) 
Tax                                                                                                                           –                                        –                                        –                          124,414                          124,414 

Loss of the year                                                                              (1,179,967)                    (1,124,652)                          (96,138)                    (2,132,216)                    (4,532,973) 

Total assets                                                                                        5,609,005                    11,083,261                       1,014,317                                        –                    17,706,582 

Total liabilities                                                                                   2,443,527                       2,680,121                       1,920,685                                        –                       7,044,333 

*Includes changes in inventories of finished goods.

®

52 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

3. Operating segments continued 
                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Sale of products                                                                                                                                                                                                             2,898,224                       2,137,289 
Sale of services                                                                                                                                                                                                                5,716,874                       4,297,191 
Government grants                                                                                                                                                                                                           166,112                          159,815 
Other                                                                                                                                                                                                                                       665,293                          186,011 

Total income                                                                                                                                                                                                                   9,446,503                       6,780,306 

Geographical breakdown of revenues is: 
                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Italy                                                                                                                                                                                                                                       1,755,329                       1,555,622 
Romania                                                                                                                                                                                                                            6,563,839                       4,495,661 
Rest of the world                                                                                                                                                                                                                295,930                          383,197 

Total                                                                                                                                                                                                                                     8,615,098                       6,434,480 

The Group has transacted with 3 main customers in 2021, which accounted for more than 10% of Group revenues for sales of products and services. 
This largest customer accounted for 16% of revenues (€1,349,981), the second largest to 12% (€1,006,649), whilst the third for 11% (€907,323). 

Other Income of €831,405 mainly includes the release of an undue obligation for €503,904, as the former shareholders of Setcar renounced to 
dividends not paid yet, Government Grants for €166,112, and R&D Expenditure Credit (RDEC) for €33,425. The RDEC is an Italian incentive scheme 
(art.3 DL 145/2013) designed to encourage companies to invest in research and development. The credit can be used to reduce corporation tax or 
to offset outstanding payables related to social security. 

4. Government grants 
Information regarding government grants: 
                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Innodriver                                                                                                                                                                                                                                25,000                                        – 
Inno4covid                                                                                                                                                                                                                               99,889                                        – 
Green.Tex                                                                                                                                                                                                                                  30,616                             54,278 
COVID-19 government grants                                                                                                                                                                                                     –                          103,536 
Techfast                                                                                                                                                                                                                                    10,607                                        – 

Total                                                                                                                                                                                                                                         166,112                          157,814 

During 2021, the Company took part in Inno4Covid, a European project for fostering innovation, prevention and surveillance in response to 
Covid-19. The project was 100% financed for a total amount of €99,889, of which 50% was collected during the year. 

Directa Plus keeps investing in the activities related to the Green.Tex project, whose deadline was extended up until April 2022. 

In 2021, the Company was also awarded with the inclusion in the Tech Fast project, with an overall value of approximately €290,000, financed at 
50%. The tender, concerning eco-innovation for industrial antimicrobial and antiviral filtration through the use of graphene, will end in 2022. 

Directa Plus also obtained the Innodriver grant (€25,000) to support the study of new products in the textile sector.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

53 

4. Government grants continued 

The key terms of government grants are: 

                                                                                                                                           Green.Tex                                Tech fast                           Inno4covid                             Innodriver                                 Ecopave 

Starting date                                                                                                2020                                2021                                2021                                2021                                2017 

Ending date                                                                                                 2022                                2022                                2021                                2021                                2021 

Duration (months)                                                                                         21                                     12                                        8                                   n.a.                                     37 

Total amount                                                                                           96,192                          147,028                             99,889                             25,000                          214,000 

Final report submitted                                                                   on-going                       on-going                                    Yes                                    Yes                                    Yes 

There are no capital commitments built into the ongoing grants. Government grants have been recognised within other income. 

5. Inventory 
                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Finished products                                                                                                                                                                                                          1,141,372                       1,071,173 
Spare parts                                                                                                                                                                                                                              76,663                          110,808 
Raw material                                                                                                                                                                                                                          93,798                             97,712 
Working in progress                                                                                                                                                                                                            59,042                             96,254 

Total                                                                                                                                                                                                                                     1,370,875                       1,375,947 

As of 31 December 2021, total inventory value is in line with 2020;the finished products mainly referred to Directa Plus SpA. Spare parts inventory 
was required to enhance maintenance efficiency and is composed of a small number of critical items with a material cost per unit. 

6. Raw materials and consumables 
                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Raw material and consumables                                                                                                                                                                             2,711,528                       1,670,305 
Textile products                                                                                                                                                                                                                  922,783                          894,012 

Total                                                                                                                                                                                                                                     3,634,311                       2,564,317 

The increase in raw materials is in line with the business growth.

®

54 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

7. Employee benefits expenses 
                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Wages and salaries                                                                                                                                                                                                        3,525,876                       3,264,227 
Social security costs                                                                                                                                                                                                         559,856                          496,428 
Employee benefits                                                                                                                                                                                                            111,964                             89,169 
Share option expense                                                                                                                                                                                                      130,910                             19,286 
Other costs                                                                                                                                                                                                                            103,877                             62,099 

Total                                                                                                                                                                                                                                     4,432,483                       3,931,208 

Capitalised cost in “Intangible assets”                                                                                                                                                                    (135,528)                       (161,935) 

Total charged to the Income Statement                                                                                                                                                           4,296,955                       3,769,274 

The average number of employees (excluding Non-Executive Directors) during the period was as follows: 

                                                                                                                                                                                                                                                                                                              2021                                         2020 

Sales and Administration                                                                                                                                                                                                           30                                     27 
Engineering, R&D and production                                                                                                                                                                                      165                                   166 

Total                                                                                                                                                                                                                                                  195                                   193 

The total average number of employees of the Group as at 31 December 2021 was 195 (2020: 193), of which 166 employed by Setcar. 

The Directors’ emoluments (including Non-Executive Directors) are as follows: 

                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Wages and salaries                                                                                                                                                                                                            773,683                          836,709 

Total                                                                                                                                                                                                                                         773,683                          836,709 

The aggregate emoluments (wages, salaries and social contributions) of the highest paid Director totalled €527k (2020: €495k). 

Share-base payment expenses were €130,910, of which €62,708 accounted for in the Parent Company accounts as directly attributable to the 
Executive Directors. 

A detailed analysis of the remuneration of the Directors is detailed within the Directors’ Remuneration Report on pages 28 to 29.

Directa Plus  
Annual Report & Accounts 2021 

55 

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

8. Other expenses: 

Other expenses include: 

                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Audit of the Group and Company financial statements                                                                                                                                      81,991                             79,347 
Audit of the subsidiaries’ financial statements                                                                                                                                                       36,230                             37,968 
Other non-audit services provided by Group’s auditor                                                                                                                                          5,978                               4,422 
Tool manufacturing                                                                                                                                                                                                          296,965                          508,363 
Analyses & tests                                                                                                                                                                                                                  377,028                          128,152 
Travel                                                                                                                                                                                                                                         69,659                             78,012 
Technical consultancies                                                                                                                                                                                                 277,117                          223,732 
Shipping and logistic expenses                                                                                                                                                                                   260,014                          365,317 
Insurance                                                                                                                                                                                                                               165,347                          112,122 
Marketing                                                                                                                                                                                                                                 32,989                             27,866 
Legal, tax and administrative consultancies                                                                                                                                                          915,234                          962,365 

Analyses & tests expenses (€377,028) and technical consultancies refer to R&D activities outsourced to external labs and universities. Both cost 
categories have increased over the last year in line with the business growth. 

The increase in the insurance expenses (€165,347) was mainly driven by the hard market conditions, which led to a general increase in premiums. 

9. Net finance expenses 
Finance expenses include: 

                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Interest Income                                                                                                                                                                                                                      (1,616)                            (1,175) 
Interest on loans and other financial costs                                                                                                                                                               45,426                             45,719 
Interest on lease liabilities                                                                                                                                                                                                18,157                             21,589 
Interest cost for benefit plan                                                                                                                                                                                            11,098                             10,131 
Foreign exchanges losses/(gains)                                                                                                                                                                             (220,006)                         270,268 

Total                                                                                                                                                                                                                                       (146,941)                         346,532 

Foreign exchange income of €220,006 (2020: -€270,268) includes €211,056 of Sterling to Euro movement in the Group’s Sterling bank accounts.

®

56 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

10. Taxation 
                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Current tax (expense)/income                                                                                                                                                                                         (1,727)                                 404 
Deferred tax expense/(recovery)                                                                                                                                                                                  (42,893)                       (124,818) 

Total tax expenses                                                                                                                                                                                                             (44,620)                       (124,414) 

Reconciliation of tax rate 
                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Loss before tax                                                                                                                                                                                                               (3,384,853)                    (4,657,387) 
Italian statutory tax rate                                                                                                                                                                                                          24%                                 24% 

                                                                                                                                                                                                                                                 (812,365)                    (1,117,773) 
Impact of temporary differences                                                                                                                                                                                     4,431                          155,430 
Losses recognised                                                                                                                                                                                                              (49,052)                          (31,016) 
Impact of tax rate in foreign jurisdiction                                                                                                                                                                   (35,491)                           47,820 
Losses not utilised                                                                                                                                                                                                             847,857                       1,069,953 

Total tax expenses                                                                                                                                                                                                             (44,620)                       (124,414) 

Tax losses carried forward have been recognised as a deferred tax asset up to the point that they are recoverable against taxable temporary 
differences. All other tax losses are carried forward and not recognised as a deferred tax asset due to the uncertainty regarding generating future 
taxable profits. Tax losses carried forward are €31,494,057 (€27,762,446 in 2020).

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

57 

11. Intangible assets 
                                                                                                                                  Development 
                                                                                                                                                      cost                         Patents                      Goodwill                           Others                          Brands                              Total 
                                                                                                                                                            €                                      €                                      €                                      €                                      €                                      € 

Cost 
Balance at 31/12/2019                                                                 2,765,023                  437,933                  303,552                  249,580                  384,124              4,140,213 
Additions                                                                                                379,998                  111,151                               –                    35,814                               –                  526,963 
Currency translation differences                                                           (218)                    (3,344)                    (5,204)                        (289)                    (7,107)                  (16,162) 

Balance at 31/12/2020                                                                 3,144,804                  545,740                  298,348                  285,105                  377,017              4,651,014 
Additions                                                                                                135,527                  172,307                               –                     (1,063)                              –                  306,771 
Currency translation differences                                                           (184)                              –                      (4,391)                    (3,059)                    (5,996)                  (13,630) 

Balance at 31/12/2021                                                                3,280,147                 718,047                 293,957                 280,983                 371,021             4,944,154 

Amortisation 
Balance at 31/12/2019                                                                 1,731,795                  145,349                               –                    54,214                       6.402              1,937,760 
Amortisation 2020                                                                              357,746                  218,247                               –                    18,593                    75,899                  670,485 

Balance at 31/12/2020                                                                 2,089,541                  363,596                               –                    72,807                    82,301              2,608,245 
Amortisation 2021                                                                              389,299                    71,829                               –                    13,797                    74,621                  549,547 
Currency translation differences                                                           (271)                              –                                –                      (3,313)                    (2,330)                    (5,914) 

Balance at 31/12/2021                                                                2,478,569                 435,425                               –                    83,291                 154,592             3,151,877 

Carrying amounts 
Balance 31/12/2019                                                                      1,033,228                  292,584                  303,552                  196,811                  377,722              2,202,452 

Balance 31/12/2020                                                                      1,055,262                  182,145                  298,348                  213,743                  294,715              2,042,767 

Balance 31/12/2021                                                                         801,578                 282,623                 293,957                 199,137                 216,428             1,792,277 

As disclosed in Note 1(d) development costs capitalised in the year are mainly based on time spent by employees who are directly engaged in 
the development of the G+® technology. 

Management, throughout the support of external experts, carried out an impairment test on goodwill accounted following the acquisition of 
Setcar S.A. in 2019. 

The CGU is represented by Setcar itself, whose carrying amount as of 31 December 2021 was estimated equal to €5.1m. 

The impairment review of the CGU is based on an assessment of the CGU’s value in use (“VIU”). In calculating VIU, the estimated future cash flows 
are discounted to their present value using a pre-tax discount rate of 10.9% that reflects current market assessments of the time value of money 
and the risks specific to the asset/CGU and a perpetual annual growth rate of 1.6%. 

Based on such assumptions, the recoverable amount was estimated equal to €27.4m. In addition, a sensitivity analysis was performed, 
assuming a +/- 0.5% variation in the discount rate and a +/- 0.5% variation in the perpetuity growth rate. This led to a recoverable amount 
estimated in the range of €26m and €29m. 

As a conclusion, the verifications have shown that the book values can be fully recovered and no goodwill impairment is required as of 
31 December 2021.

®

58 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

12. Property, plant and equipment 
                                                                                                    Industrial             Computer                       Office                    Plant &                                                            ROU                     Under 
                                                                                                 equipment           equipment           equipment            machinery                        Land                      assets        construction                        Total 
Cost                                                                                                          €                                €                                €                                €                                €                                €                                €                                € 

Balance at 31/12/2019                                1,235,693               56,554             179,469         4,202,028             608,395             456,819                  2,445         6,741,402 
Additions                                                                  52,825               17,967                  9,391             171,819                          –             322,309                          –             574,356 
Disposals                                                                              –                          –                          –              (23,343)                         –                          –                          –              (23,343) 
Currency translation differences                     (21,101)                         –              (16,232)             (53,298)             (11,257)                         –                          –            (101,934) 

Balance at 31/12/2020                                1,267,415               74,521             172,627         4,297,207             597,138             779,128                  2,445         7,190,481 
Additions                                                                392,141               10,095               13,934             416,922                          –                          –                          –             833,092 
Disposals                                                                    (6,435)                         –                (3,143)            (31,124)                         –                          –                          –              (40,703) 
Currency translation differences                     (32,070)                         –                 (2,228)             (50,895)               (9,498)                         –                       (38)             (94,728) 

Balance at 31/12/2021                               1,621,051               84,616            181,189        4,632,110            587,640            779,128                 2,407        7,888,141 

Depreciation 
Balance at 31/12/2019                                    193,331               36,113               67,587         1,637,482                          –               76,136                          –         2,010,649 
Depreciation 2020                                              378,873                  7,693               35,432             517,406                          –               80,984                          –         1,020,388 
Currency translation differences                     (17,894)                         –                 (2,356)             (30,851)                         –                          –                          –              (51,101) 

Balance at 31/12/2020                                    556,309               43,807             100,663         2,123,314                          –             157,120                          –         2,981,213 
Depreciation 2021                                              287,741                  9,312               49,791             544,774                          –             102,402                          –             994,021 
Currency translation differences                     (21,983)                         –                 (4,986)             (43,089)                         –                          –                          –              (70,059) 

Balance at 31/12/2021                                   822,067               53,119            145,468        2,624,999                          –            259,522                          –        3,905,175 

Carrying amounts 
Balance 31/12/2019                                      1,042,362               20,440             111,882         2,564,546             608,395             380,683                  2,445         4,730,752 

Balance 31/12/2020                                         711,106               30,714               71,965         2,173,892             622,008             597,138                  2,445         4,209,268 

Balance 31/12/2021                                        798,985               31,496               35,722        2,007,110            519,606            519,606                 2,407        3,982,966 

Asset held under financial leases with a net book value of € 557,243 are included in the above table within Plant & Machinery. 

13. Investments in subsidiaries 
Details of the Company’s subsidiaries as at 31 December 2021 are as follows: 
                                                                                                                                                                                                                                                                                                                 Shareholding 

Subsidiaries                                                            Country                              Principal activity                                                                                                                                       2021                                         2020 

Directa Plus S.p.A.                                  Italy                              Producer and supplier of graphene-based                                                  100%                               100% 
                                                                                                              materials and related products 

Directa Textile Solutions Srl               Italy                              Commercialise textile membranes,                                                               73.5%                              73.5% 
                                                                                                              including graphene-based technical and 
                                                                                                              high-performance membranes 

Setcar S.A.                                                 Romania                    Waste management and decontamination                                                   52%                                 51% 
                                                                                                              services business 

Subsidiaries                                                                        Place of Business                             Registered Office                                                                                           Place of Business 

Directa Plus Spa                                               Italy                                              Via Cavour 2, Lomazzo (CO) Italy                                      See registered office 

Directa Textile Solutions Srl                         Italy                                              Via Cavour 2, Lomazzo (CO) Italy                                      See registered office 

Setcar S.A.                                                           Romania                                    Str. Gradinii Publice 6, Braila Romania                           See registered office

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

59 

13. Investments in subsidiaries continued 

The Company’s investment as capital contributions in Directa Plus S.p.A. are as follows: 
                                                                                                                                                                                                                                                                                                                                                Directa S.p.A. 

At 31 December 2019                                                                                                                                                                                                                                           21,180,336 
Additions                                                                                                                                                                                                                                                                       2,500,000 

At 31 December 2020                                                                                                                                                                                                                                           23,680,336 
Additions                                                                                                                                                                                                                                                                       2,000,000 

At 31 December 2021                                                                                                                                                                                                                                          25,680,336 

14. Trade and other receivables 
                                                                                                                                                                                                                  Group                                                                                     Company 

                                                                                                                                                                                                       2021                                         2020                                         2021                                         2020 
Current                                                                                                                                                                                          €                                                €                                                €                                                € 

Account receivables                                                                                                                 2,339,369                       2,174,967                                        –                                        – 
Tax Receivables                                                                                                                              465,953                          443,857                            49,539                             23,265 
Other receivables                                                                                                                          500,171                          238,636                          155,752                          142,997 

Total                                                                                                                                                3,305,493                       2,857,460                          205,291                          166,262 

                                                                                                                                                                                                                  Group                                                                                     Company 

                                                                                                                                                                                                       2021                                         2020                                         2021                                         2020 
Non-current                                                                                                                                                                              €                                                €                                                €                                                € 

Other receivables                                                                                                                          185,623                          140,649                                        –                                        – 

Total                                                                                                                                                   185,623                          140,649                                        –                                        – 

Group account receivables of €2,339,369 are mainly composed by seven major clients, covering 60% of the total amount. 

Group Tax Receivables are composed of Italian VAT receivables of €278,812, UK VAT receivables of €49,539, Romanian VAT receivables of €50,785, 
RDEC Tax Credit receivables of €73,894 and other Italian Tax receivables of €12,923. 

Other receivables are mainly composed of governments grants for €213,160 and prepayments for €277,089. 

Non-current other receivables of €185,623 refer to specific projects where the collection of a certain amount, although due, is postponed to the 
end of the project itself.

®

60 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

14. Trade and other receivables continued 
As at 31 December 2021 the ageing of account receivables was: 
                                                                                                                                                                                                                                                                                                              2021                                         2020 
Days overdue                                                                                                                                                                                                                                                                                €                                                € 

0-60                                                                                                                                                                                                                                      1,771,113                       1,895,323 
61-180                                                                                                                                                                                                                                     251,458                             50,372 
181-365                                                                                                                                                                                                                                   101,450                          231,109 
365 +                                                                                                                                                                                                                                        215,348                             57,786 

Total                                                                                                                                                                                                                                     2,339,369                       2,174,967 

As at 31 December 2021 the Group recognised provision for €46,892€ mainly referred to Setcar’s overdue debts. 

15. Deferred tax liabilities 
                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Deferred tax liabilities                                                                                                                                                                                                      174,158                          138,147 
Deferred tax assets – losses                                                                                                                                                                                            (84,661)                       (129,724) 

Total                                                                                                                                                                                                                                           89,497                               8,423 

Deferred tax assets have been recognised on losses brought forward to the extent that they can be offset against taxable temporary differences 
in line with the requirements of IAS 12. 

The deferred tax liabilities arise from the capitalisation of development costs and defined benefit scheme are detailed below: 

                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Deferred tax liabilities – cost capitalised                                                                                                                                                                    86,313                          121,504 
Deferred tax liabilities – other                                                                                                                                                                                          (1,652)                              8,220 
Deferred tax liabilities arising from acquisition                                                                                                                                                       89,497                               8,423 
Deferred tax assets – losses exc. Setcar                                                                                                                                                                     (84,661)                       (129,724) 

Total                                                                                                                                                                                                                                           89,497                               8,423 

16. Cash and cash equivalents 
                                                                                                                                                                                                                  Group                                                                                     Company 

                                                                                                                                                                                                       2021                                         2020                                         2021                                         2020 
                                                                                                                                                                                                               €                                                €                                                €                                                € 

Cash at bank                                                                                                                             11,126,683                       7,075,447                      9,430,364                       4,283,625 
of which restricted cash                                                                                                                 40,000                                        –                                        –                                        – 
Cash in hand                                                                                                                                        3,785                               5,045                                        –                                        – 

Total                                                                                                                                             11,130,468                       7,080,492                      9,430,364                       4,283,625 

The Company holds €40,000 of restricted cash as a guarantee for a performance bond provided by a bank for a major contract in the 
Environmental vertical.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

61 

17. Equity 
                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Share capital                                                                                                                                                                                                                        205,393                          190,996 
Share premium                                                                                                                                                                                                            39,159,027                    31,395,612 
Foreign currency translation reserve                                                                                                                                                                         (23,109)                            (7,015) 
Retained earnings                                                                                                                                                                                                      (25,352,139)                 (21,824,229) 
Non-controlling interests                                                                                                                                                                                           2,041,938                          906,885 

Balance at 31 December                                                                                                                                                                                         16,031,110                    10,662,249 

                                                                                                                                                                                                                                                                                                 Number of                                       Share 
Share capital                                                                                                                                                                                                                                                    ordinary shares                                capital (€) 

At 31 December 2019                                                                                                                                                                                                60,998,983                          190,512 
Share issue on 26 June                                                                                                                                                                                                    111,980                                   309 
Share issue on 30 June                                                                                                                                                                                                       63,624                                   175 

At 31 December 2020                                                                                                                                                                                                61,174,587                          190,996 

Share issue on 14 January *                                                                                                                                                                                          190,872                                   535 
Share issue on 29 December – capital raise **                                                                                                                                                   1,670,518                               4,962 
Share issue on 30 December – capital raise **                                                                                                                                                   2,996,149                               8,900 

At 31 December 2021                                                                                                                                                                                               66,032,126                          205,393 

* On 14 January 2021, 190,872 ordinary shares with a nominal value of £0.0025 each were issued as effect of the exercise of options of ordinary shares for Directors and Senior Managers. 
** On 29 and 30 December 2021, 4,666,667 ordinary shares with a nominal value of £0.0025 each were issued as effect of the Company’s capital raise. 

                                                                                                                                                                                                                                                                                                                                          Share premium 
Share premium                                                                                                                                                                                                                                                                                                                              € 

At 31 December 2019                                                                                                                                                                                                                                           31,395,612 

Shares issued                                                                                                                                                                                                                                                                               – 
Expenditure relating to the raising of shares                                                                                                                                                                                                                  – 

At 31 December 2020                                                                                                                                                                                                                                           31,395,612 

Shares issued                                                                                                                                                                                                                                                              8,306,293 
Expenditure relating to the raising of shares                                                                                                                                                                                                   (542,878) 

At 31 December 2021                                                                                                                                                                                                                                          39,159,027 

On 29 and 30 December 2021, as a result of the Company’s capital raise, 4,666,667 ordinary shares were issued at a price of £1.5 each. The Company 
accounted for €8,306,293 of gross share premium reserve, net of €542,878 of expenditure directly referred to the transaction. 

Share capital 
Financial instruments issued by the Directa Plus Group are treated as equity only to the extent that they do not meet the definition of a financial 
liability. The Directa Plus Group’s ordinary shares are classified as equity instruments. 

Share premium 
To the extent that the company’s ordinary shares are issued for a consideration greater than the nominal value of those shares (in the case of the 
company, £0.0025 per share), the excess is deemed Share Premium. Costs directly associated with the issuing of those shares are deducted from 
the share premium account, subject to local statutory guidelines. 

Foreign currency translation reserve 
Exchange differences resulting from the consolidation process of Setcar are recognised in the translation reserve for an amount of € 7,183. 

Non- controlling interest 
Non-controlling interest refers to the minority shareholders of the company who own less than 50% of the overall share capital. 

As of 31 December 2021, non-controlling interest is composed by 48% of Setcar S.A. and 26.46% of Directa Textile Solutions Srl.

®

62 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

18. Loans and borrowings 
                                                                                                                                                                                                                  Group                                                                                     Company 

                                                                                                                                                                                                       2021                                         2020                                         2021                                         2020 
                                                                                                                                                                                                               €                                                €                                                €                                                € 

Non-current Loans and borrowings                                                                                 2,403,881                       1,017,716                                        –                                        – 
Current Loans and borrowings                                                                                                 65,840                          981,065                                        –                                        – 

Total                                                                                                                                                2,469,721                       1,998,781                                        –                                        – 

                                                                                                                                                    2021                                   Current                          Non current 
                                                                                                                                                            €                                                €                                                €                           Repayment                          Interest rate 

Bank of Transilvania                                                                          660,328                                        –                          660,328                   36-months                         Variable 
                                                                                                                                                                                                                                                                                   4.7% ROBOR 
                                                                                                                                                                                                                                                                               3M + 2,5%/year 

Bank of Transilvania IMM INV                                                        464,143                                        –                          464,143                   60-months                         Variable 
                                                                                                                                                                                                                                                                                 4.11% ROBOR 
                                                                                                                                                                                                                                                                                      3M +2.11%/ 
                                                                                                                                                                                                                                                                                            year+2% 

GVC Investment Company LMT                                                      16,630                             16,630                                        –                   12-months                     1.5%/year 

Intesa San Paolo                                                                                 300,000                             18,393                          281,607                   72-months                     1.5%/year 
                                                                                                                                                                                                                                                                                + EURIBOR 3M 

Intesa San Paolo                                                                                   25,000                               3,076                             21,924                   72-months                     1.5%/year 
                                                                                                                                                                                                                                                                                + EURIBOR 3M 

Intesa San Paolo                                                                                 500,000                                        –                          500,000                   72-months                     1.5%/year 
                                                                                                                                                                                                                                                                                + EURIBOR 3M 

Banca Popolare di Sondio                                                             500,000                             24,121                          475,879                   72-months                     1.5%/year 
                                                                                                                                                                                                                                                                                + EURIBOR 3M 

Reconciliation of liabilities arising from financing activities 
                                                                                                                                                                          Cash flows                                                                   Non cash flows 

                                                                                                           1 January                                Capital                           Liabilities                              Accrued                           Liabilities                  31 December  
                                                                                                                      2021                        repayment                            acquired                               interest                            acquired                                    2021 
                                                                                                                              €                                            €                                            €                                            €                                            €                                            € 

Borrowings                                                               1,998,781                        (81,666)                  1,511,719                            1,642                     (960,755)                 2,469,721 

Total                                                                             1,998,781                        (81,666)                  1,511,719                            1,642                     (960,755)                 2,469,721 

19. Leases liabilities 
The following table details the movement in the Group’s lease obligations for the period ended 31 December 2021: 

                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Non-current lease liabilities                                                                                                                                                                                          463,047                          627,138 
Current lease liabilities                                                                                                                                                                                                    217,537                          214,935 

Total                                                                                                                                                                                                                                         680,584                          842,073

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

63 

20. Employee benefits provision 
                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Employee benefits                                                                                                                                                                                                            500,535                          444,483 

Total                                                                                                                                                                                                                                         500,535                          444,483 

Provisions for benefits upon termination of employment primarily related to provisions accrued by Italian companies for employee retirement, 
determined using actuarial techniques and regulated by Article 2120 of the Italian Civil code. The benefit is paid upon retirement as a lump sum, 
the amount of which corresponds to the total of the provisions accrued during the employees’ service period based on payroll costs as revalued 
until retirement. Following the changes in the law regime, from January 1 2007 accruing benefits have been contributing to a pension fund or a 
treasury fund held by the Italian administration for post-retirement benefits (INPS). For companies with less than 50 employees it will be possible to 
continue this scheme as in previous years. Therefore, contributions of future TFR provisions to pension funds or the INPS treasury fund determines 
that these amounts will be treated in accordance to a defined contribution scheme, not subject to actuarial evaluation. Amounts already accrued 
before 1 January 2007 continue to be accounted for a defined benefit plan and to be assessed on actuarial assumptions. 

The breakdown for 2020 and 2021 is as follows: 
                                                                                                                                                                                                                                                                                                                                                                         € 

Amount at 31 December 2019                                                                                                                                                                                                                               406,534 

Service cost                                                                                                                                                                                                                                                                        57,081 
Interest cost                                                                                                                                                                                                                                                                        10,131 
Actuarial gain/losses                                                                                                                                                                                                                                                       (7,821) 
Past service cost                                                                                                                                                                                                                                                                          – 
Benefit paid                                                                                                                                                                                                                                                                      (21,442) 

Amount at 31 December 2020                                                                                                                                                                                                                               444,483 

Service cost                                                                                                                                                                                                                                                                        47,536 
Interest cost                                                                                                                                                                                                                                                                        11,098 
Actuarial gain/losses                                                                                                                                                                                                                                                        6,457 
Benefit paid                                                                                                                                                                                                                                                                         (9,039) 

Amount at 31 December 2021                                                                                                                                                                                                                              500,535 

Variables analysis 
Detailed below are the key variables applied in the valuation of the defined benefit plan liabilities. 

                                                                                                                                                                                                                                                                                                              2021                                         2020 

Annual rate interest                                                                                                                                                                                                              2.30%                              2.30% 

Annual rate inflation                                                                                                                                                                                                            1.10%                              1.10% 

Annual increase TFR                                                                                                                                                                                                            7.41%                              7.41% 

Tax on revaluation                                                                                                                                                                                                              17.00%                           17.00% 

Social contribution                                                                                                                                                                                                               0.50%                              0.50% 

Increase salary male                                                                                                                                                                                                            1.20%                              1.20% 

Increase salary female                                                                                                                                                                                                        1.15%                              1.15% 

Rate of turnover male                                                                                                                                                                                                          1.70%                              1.70% 

Rate of turnover female                                                                                                                                                                                                      1.50%                              1.50%

®

64 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

20. Employee benefits provision continued 

Sensitivity analysis 
Detailed below are tables showing the impact of movements on key variables: 

Actuarial hypothesis – 2021 
                                                                                                                                                                                                          Decrease 10%                                                                         Increase 10%  

                                                                                                                                                                                                                                                  Variation                                                                                   Variation 
                                                                                                                                                                                                        Rate                                      DBO €                                          Rate                                      DBO € 

Increase salary                                                                                           Male                              1.08%                              (4,767)                            1.32%                               1,277 
                                                                                                                     Female                              1.04%                                                                        1.27% 

Turnover                                                                                                        Male                              1.53%                              (4,962)                            1.87%                               1,325 
                                                                                                                     Female                              1.35%                                                                        1.65% 

Interest rate                                                                                                                                         2.07%                             11,788                              2.53%                           (14,631) 
Inflation rate                                                                                                                                        0.99%                              (6,032)                            1.21%                               2,546 

21. Trade and other payables 
                                                                                                                                                                                                                  Group                                                                                     Company 

                                                                                                                                                                                                       2021                                         2020                                         2021                                         2020 
Non-current                                                                                                                                                                              €                                                €                                                €                                                € 

Other payables                                                                                                                                 64,357                             65,397                                        –                                        – 

Total                                                                                                                                                      64,357                             65,397                                        –                                        – 

                                                                                                                                                                                                                  Group                                                                                     Company 

                                                                                                                                                                                                       2021                                         2020                                         2021                                         2020 
Current                                                                                                                                                                                          €                                                €                                                €                                                € 

Trade payables                                                                                                                               946,694                       1,364,787                            93,332                             54,725 
Employment costs                                                                                                                       609,397                          519,466                                        –                                        – 
Other payables                                                                                                                              375,807                       1,228,655                            78,486                             62,020 
Contingent consideration at fair value through P&L                                                                   –                          572,268                                        –                                        – 

Total                                                                                                                                                1,931,898                       3,685,176                          171,818                          116,745 

In 2021 Setcar released an obligation to its former shareholders for a total amount of €504k, accounted as other income in the Consolidated 
statement of comprehensive income. As of December 2020, this amount was accounted within other payables. 

Over 2021 the Group paid the last tranches of contingent consideration to the former shareholders of Setcar for a total amount of €572,268.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

65 

22. Financial instruments 
Financial risk management 
The Group’s business activities expose the Group to the following financial risks: 

a)  Market risk 
Market risk arises from the Group’s use of interest bearing, tradable and foreign currency financial instruments. It is the risk that the fair value of 
future cash flow of a financial instrument will fluctuate because of changes in interest rates or foreign exchange rates. As at 31 December 2021 the 
Group is exposed to variable interest rate risk for a short term revolving loan and for the loans recently issued by Directa Plus SpA under the Italian 
Government Covid-19 Recovery Plan. Those loans, being 90% guaranteed by the Italian Government, bear a low interest rate (1.5% + EURIBOR) 
and, if the interest rate had increased or decreased by 100 basis points during the year the reported loss after taxation would not have been 
materially different to that reported. 

b)  Capital Risk 
The Group’s objectives for managing capital are to safeguard the Group’s ability to continue as going concern, so that it can continue to provide 
returns for shareholders and benefits for other stakeholders and to provide an adequate return to shareholders by pricing products and services 
commensurately with the level of risk. There were no changes in the Group’s approach to capital management during the year. 

c)  Credit Risk 
Credit risk is the risk of financial loss to the Group if a customer or counterparty to a financial instrument fails to meet its contractual obligations. 
The Group’s credit risk is primarily attributable to its trade receivables that the Company consider defaulted if any instalment is unpaid more than 
sixty (60) days past its original due date or where there is evidence that identifies the debtor’s state of insolvency. 

The Group’s cash and cash equivalents and restricted cash are held with major financial institutions. The Group monitors credit risk by reviewing 
the credit quality of the financial institutions that hold the cash and cash equivalents and restricted cash. 

The Group’s trade receivables consist of receivables for revenue mainly in Italy and Romania. Management believes that the Group’s exposure to 
credit risk is manageable and currently the Group’s standard payment terms are 30 to 60 days from date of invoice are largely met from the clients. 
At the end of the period, 74% of account receivables have an ageing less of 60 days and refers to orders delivered close to the year end. As at 
31 December 2021 the Group recognised a cumulated bad debt provision for €46,893. 

Every new customer is internally analysed for creditworthiness before the Group’s standard payment and delivery terms and conditions are 
offered. Advance payment usually applies for the first order and the exposure to credit risk is approved and monitored on an ongoing basis 
individually for all significant customers. The maximum exposure to credit risk is represented by the carrying amount of each financial asset in 
the statement of financial position. The Group does not require collateral in respect of financial assets. 

d)  Exposure to credit risk 
                                                                                                                                                                                                                                                                                                              2021                                         2020 
Group                                                                                                                                                                                                                                           Note                                                €                                                € 

Trade receivables                                                                                                                                                                                 14                      2,339,369                       2,174,967 
Cash and cash equivalent                                                                                                                                                                16                   11,130,468                       7,080,492 

Total                                                                                                                                                                                                                                  13,469,837                       9,255,459 

The largest customer within trade receivables account for 13% of debtors. Management continually monitors this dependence on the largest 
customers and are continuing to develop the commercial pipeline to reduce this dependence, spreading revenues across a variety of customers.

®

66 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

22. Financial instruments continued 

e)  Liquidity risk 
It is the risk that the Group will encounter difficulty in meeting its financial obligations as they fall due. Liquidity risk arises from the Group’s 
management of working capital and the finance charges and principal repayments on its debt instruments. The Group manages liquidity risk by 
maintaining adequate reserves and banking facilities and by continuously monitoring forecast and actual cash flows. The Board reviews regularly 
the cash position to ensure there are sufficient resources for working capital requirements and to meet the Group’s financial commitments. 

                                                                                                                                                                                                                                Carrying amount                         Up to 1 year                                1-5 years 
2021                                                                                                                                                                                                                                                      €                                                €                                                € 

Financial liabilities 
Trade payables                                                                                                                                                                         946,694                          946,694                                        – 
Lease liabilities                                                                                                                                                                         680,584                          217,537                          463,047 
Loans                                                                                                                                                                                        2,469,721                            65,840                      2,403,881 

Total                                                                                                                                                                                          4,096,999                      1,230,071                      2,866,928 

                                                                                                                                                                                                                                 Carrying amount                          Up to 1 year                                1-5 years 
2020                                                                                                                                                                                                                                                      €                                                €                                                € 

Financial liabilities 
Trade payables                                                                                                                                                                      1,364,787                       1,364,787                                        – 
Lease liabilities                                                                                                                                                                          842,073                          214,935                          627,138 
Loans                                                                                                                                                                                         1,998,781                          959,520                       1,064,310 

Total                                                                                                                                                                                           4,205,641                       2,539,242                       1,691,448 

f)  Currency risk 
The Group usually raises money issuing shares in pounds, it follows that the Group usually holds sterling bank accounts as result of capital raise. 
Sterling bank accounts are mainly used to manage expenses of the Company (such as UK advisors, LSE fees and costs related to the Board) in UK. 
The cash held in Sterling continues to be subject to currency risk. 

                                                                                                                                                                                                                                                                                                                                                                  EUR 

Cash held in GBP                                                                                                                                                                                                                                                       9,159,734 

As of January 2022, to reduce the exposure to liquidity risk, Directors decided to translate GBP 4.5 million into EUR. As at 24 March 2022 the total 
cash held in GBP is equal to £3.5 million. If the exchange rate EUR/GBP increase by 10% the impact on P&L would be a loss equal to €0.4 million 
(if decrease by 10% would be a profit equal to €0.4 million). 

The Group holds accounts also in other currency (such as USD and RON) but just for business purposes and for not material amount.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

67 

23. Earnings per share 
                                                                                                                                                                                             Change in                                                                                                                                     Weighted  
                                                                                                                                                                                            number of                       Total number                                                                                number of  
                                                                                                                                                                                 ordinary shares             of ordinary shares                                         Days                  ordinary shares 

At 31 December 2020                                                                                                                 175,604                    61,174.587                                   365                    61,087,158 

Existing shares                                                                                                                                              –                    61,174,587                                     13                       2,178,821 
Issued on 14 Jan 2021                                                                                                                 190,872                    61,365,459                                   349                    58,675,466 
Issued on 29 Dec 2021                                                                                                             1,670,518                    63,035,977                                        2                          345,403 
Issued on 30 Dec 2021                                                                                                             2,996,149                    66,032,126                                        1                          180,909 

At 31 December 2021                                                                                                             4,857,539                   66,032,126                                   365                   61,380,599 

                                                                                                                                                                                                                   Basic                                                                                         Diluted 

                                                                                                                                                                                                       2021                                         2020                                         2021                                         2020 
                                                                                                                                                                                                               €                                                €                                                €                                                € 

Loss attributable to the owners of the Parent                                                            (3,652,364)                    (4,195,011)                   (3,652,364)                    (4,195,011) 
Weighted average number of ordinary shares 
  in issue during the year                                                                                                     61,380,599                    61,087,158                                        –                                        – 
Fully diluted average number of ordinary shares 
  during the year                                                                                                                                          –                                        –                   61,649,085                    61,477,110 

Loss per share                                                                                                                                     (0.06)                               (0.07)                              (0.06)                               (0.07) 

The effect of anti-dilutive potential ordinary shares is ignored in calculating the diluted loss per share. 

24. Share schemes 
The 2020 Employees’ Share Scheme is administered by the Remuneration Committee. 

The Directors are entitled to grant awards over up to 10 per cent of the Company’s issued share capital from time to time. 

Under the 2020 Employees’ Share Scheme, in November 2020 1,801,000 options over Ordinary Shares were granted to key employees and 
additional 150,000 options were granted to an Executive Director in June 2021 under the same Scheme. As of 31 December 2021, the total number 
of outstanding Ordinary Shares awards is 1,184,000, of which 517,000 vested after the first year and 250,000 were revoked. 

At the date of this report, an additional 539,080 share options had vested in 2020 under the 2016 Employees’ and NED Share Schemes that have 
not yet been exercised. 

The main terms of the 2020 Employee’s Share Schemes are set out below: 

Eligibility 
All persons who at the date on which an award is granted under the Employees’ Share Scheme are employees (or employees who are also office-
holders) of a member of the Group and are eligible to participate. The Remuneration Committee decides to whom awards are granted under the 
Employees’ Share Scheme, the number of Ordinary Shares subject to an award, the exercise date(s) (subject to the below) and the conditions 
which must be achieved in order for the award to be exercisable.

®

68 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

24. Share schemes continued 

Types of award 
Awards granted under the Employees’ Share Scheme have the form of market value share options. “Market value share options” are share options 
with an exercise price equal to the market value of a share at the date of grant. The right to exercise the award is generally dependent upon the 
participant remaining an officer or employee throughout the performance period. This is subject to the good leaver provisions described below. 
Awards granted under the Share Schemes will not be pensionable. 

Individual limits 
The value of Ordinary Shares over which an employee or Executive Director may be granted awards under the Employees’ Share Scheme in any 
financial year of the Company shall not exceed 200 per cent of his basic rate of salary at the date of grant. 

Variation of share capital 
Awards granted under the Share Schemes may be adjusted to reflect variations in the Company’s share capital. 

Vesting of awards 
Outstanding awards will vest over three years in equal one third tranches on each anniversary of the grant date to the extent that the market-based 
performance targets have been met. Vested awards may generally be exercised between the third and tenth anniversaries from the date of grant. 
75% of vested shares can be exercised after the third anniversary, while the remaining 25% from the fourth. 

The inputs to the Monte-Carlo simulation were as follows: 

Monte-Carlo simulation                                                                                                                                                                                                                                                                     Market value shares 

Share price                                                                                                                                                                                                                                                                               60p 
Exercise price                                                                                                                                                                                                                                                                           66p 
Expected volatility                                                                                                                                                                                                                                                               54% 
Compounded Risk-Free Interest Rate                                                                                                                                                                                                                     0.10% 
Expected life                                                                                                                                                                                                                                                                      6 years 
Number of options issued*                                                                                                                                                                                                                                   1,801,000 

*Number of options issued is an input of the Monte-Carlo simulation and refers to the total options granted by the Company in November 2020. This is not representing any 
option issued in the period. 

Details of the number of share options outstanding are as follows: 

                                                                                                   Granted           Cancelled               Expired                 Vested        Outstanding            Exercisable  
                                                      Outstanding at         during the           during the         during the                 during                at end of                     period                                                           Exercisable  
                                                        start of period                 period                   period                 period                 period                     period          option price                   Grant date                                date 

31 December 2019           1,639,877                       –            (25,523)      (733,066)       (821,288)              60,000                      75p         12 May 2017         12 May 2020 

31 December 2020                  60,000      1,801,000                        –                       –           (60,000)        1,801,000                      66p         12 Nov 2020         12 Nov 2023 

31 December 2021          1,801,000         150,000         (250,000)                     –       (517,000)      1,184,000      66p – 118p     12 Nov 2020 –     12 Nov 2023 –  
                                                                                                                                                                                                                                                  15 Jun 2021        15 Jun 2023 

Cancellation of share options during the period relates to the resignation of employees. Share options expired over the period refers to those 
performance share options that did not meet the performance criteria on the third anniversary of their granting. Vested share options are Market 
share options that met the criteria on the third anniversary. 

As of 14 January 2021, two Directors and two Senior Managers of the Company had exercised 190,872 ordinary shares, originally vested under the 
2016 Employees Share Scheme.

Overview 
Strategic Report 
Governance 
Financial statements 
Additional information 

Directa Plus  
Annual Report & Accounts 2021 

69 

25. Related parties 
Transactions between the Company and its subsidiaries, which are related parties, have been eliminated on consolidation and are not 
disclosed in this note. 

Remuneration of key management personnel 
The below figures represent remuneration of key management personnel for the Group, who are part of the Executive Management Team 
but not part of the Board of Directa Plus PLC. The remuneration is set out below in aggregate for each of the categories specified in IAS 24 
‘Related Party Disclosures’. 

                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Short-term employee benefits and fees                                                                                                                                                                  407,451                          278,619 
Social security costs                                                                                                                                                                                                         102,469                             68,576 

                                                                                                                                                                                                                                                   509,920                          347,195 

The increase in 2021 is mainly explained by the fact that during the year an employee was appointed as part of the Executive Management Team 
of Directa Plus SpA. 

For Directors remuneration please see Director’s Remuneration Report. 

Transactions with shareholders 
The following sales with shareholder of the Group were recorded, excluding VAT, during the year: 

                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Sale of products                                                                                                                                                                                                                                –                               3,948 

Products are sold on normal commercial terms and conditions. 

Other transaction Group 
Other related party transactions during the year under review are shown in the table below: 

                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Sale of products                                                                                                                                                                                                                    19,395                             15,886 

Products are sold on normal commercial terms and conditions.

®

70 

Directa Plus  
Annual Report & Accounts 2021 

Notes to the consolidated financial statements 
continued

26. Contingent liabilities and commitments 
The Group has the following contingent liabilities relating to bank guarantees on operating lease arrangements and government grants. 

                                                                                                                                                                                                                                                                                                              2021                                         2020 
                                                                                                                                                                                                                                                                                                                     €                                                € 

Bank guarantees                                                                                                                                                                                                                163,340                          141,553 

27. Post balance sheet events 
At the date of this report, it is still unrealistic to properly assess the potential impacts of the Ukrainian conflict on the Group. Directors are 
monitoring the evolution of the macro-economic scenario and consequently re-adjusting, where necessary, the Group’s strategy and operational 
priorities. The Group is likely to be hit by inflation trends (as a consequence of the increase in energy and transportation costs) and, presumably, 
by some contracts slowdown. However, Directors believe that overall, the conflict will not affect the going concern of the Group, and, under certain 
circumstances, it will create some potential opportunities, such as from the price increase of oil and other materials could generate significant out-
turns for the Group and its clients. 

On 15th March 2022, Directa Plus S.p.A. granted its subsidiary Setcar SA a loan of €1 million, payable in 1 year with an annual interest rate of 4.5%. 
Those funds, raised in the context of the capital increase completed in December 2021, will support Setcar in responding to significant new tenders 
and provide additional liquidity for its general working capital purposes. 

Directa Plus  
Annual Report & Accounts 2021 

Directa Plus  
Annual Report & Accounts 2021 

Directa Plus in 2021

Discover how we are using graphene to help customers’  
revolutionise the performance of their products. 

Directa Plus is one of the largest producers and suppliers 
worldwide of graphene nanoplatelets-based products for use 
in consumer and industrial markets. 

Our graphene nanoplatelets-based products are natural, chemical-free and 
sustainably produced. Our production process is designed to meet large 
supply chains' requirements for volume, cost and quality control. 

By incorporating Directa Plus’s unique graphene blends, identified by  
the G+® brand, our customers can revolutionise the performances  
of their own end products in commercial applications such as 
textiles, composite materials and environmental solutions. 
We partner with our customers to enable them to 
offer the high-performance benefits of  G+® in 
their own products. 

Our company has a unique and patented 
technology process and a scalable and portable 
manufacturing model. We produce graphene 
nanoplatelets-based products at our own 
factory near Milan, Italy, and can set up 
additional production at customer locations to 
reduce transport costs, waste and time-to-
utilisation. We are strongly committed to 
environmental sustainability and abided by a strong 
Code of Ethics in all aspects of our business practice.

Contents

01 Highlights 
02 Chairman’s review 
03 At a glance   
04 Target market progress 
06 Our strategy and business model 
08 Market review  
10 Chief Executive Officer’s review  
16 Chief Financial Officer’s review  
18 Directors’ biographies 
20 Section 172 
21 Directors’ report  
24 Corporate governance report 

28 Directors’ remuneration report  
30 Audit Committee report  
31 Remuneration Committee report  
32 Independent auditor’s report 
38 Consolidated statement of comprehensive income  
39 Consolidated and Company statement of financial position 
40 Consolidated statement of changes in equity  
40 Company statement of changes in equity  
41 Consolidated and Company statement of cash flows  
42 Notes to the consolidated financial statements 
IBC Directors, secretary and advisers  

Directors, secretary and advisers

Directors 
Sir Peter Middleton – Non-Executive Chairman 

Giulio Cesareo – CEO and Founder 

Giorgio Bonfanti – Chief Financial Officer 

David Gann – Non-Executive Director 

Neil Warner – Non-Executive Director 

Richard Hickinbotham – Non-Executive Director  

Company Secretary 
Giorgio Bonfanti 

Registration number 
04679109 

Registered office 
3rd Floor 
11-12 St James’s Square 
London SW1Y 4LB 
United Kingdom 

Principal place of business 
Directa Plus Plc 
ComoNExT Science Park 
Via Cavour 2 
22074 Lomazzo (Co)  
Italy 

Nominated adviser and joint  broker 
Cenkos Securities 
6.7.8 Tokenhouse Yard 
London EC2R 7AS 
United Kingdom 

Joint broker 
Singer Capital Markets 
1 Bartholomew Lane 
London EC2N 2AX 
United Kingdom 

Auditors  
BDO LLP 
55 Baker Street 
London W1U 7EU 
United Kingdom 

Legal advisers 
Fox Williams LLP 
10 Finsbury Square 
London EC2A 1AF 
United Kingdom 

Registrar 
Link Market Services Limited 
The Registry 
34 Beckenham Road 
Beckenham 
Kent BR3 4TU 
United Kingdom 

Financial PR adviser 
Tavistock  
1 Cornhill 
London EC3V 3ND 
United Kingdom 

y
b
d
e
c
u
d
o
r
p
d
n
a
d
e
n
g
i
s
e
D

Printed sustainably in the UK  
by Pureprint, a CarbonNeutral® 
company with FSC® chain  
of custody and an ISO 14001-
certified environmental 
management system recycling 
over 99% of all dry waste.

 
 
 
 
Directa Plus Plc 
3rd Floor 
11-12 St. James’s Square 
London 
SW1Y 4LB 
United Kingdom 

www.directa-plus.com

Graphene is the 
material of  the future 

D
i
r
e
c
t
a
P
l
u
s
A
n
n
u
a
l

R
e
p
o
r
t
&
A
c
c
o
u
n
t
s
2
0
2
1

Annual Report & Accounts 2021